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General introduction, aims and design
Obesity is a major public health problem in the general adult population.1 The prevalence of 
obesity worldwide has more than doubled in the last decades. The World Health Organization 
(WHO) estimated that 13% of the world´s adult population were obese in 2014.1 Overweight 
and obesity have been considered the fifth leading global risk for mortality in the world.2 
Common health consequences of overweight and obesity include cardiometabolic diseases 
(e.g., mainly diabetes, stroke and heart diseases), musculoskeletal disorders and certain types 
of cancers such as breast and colon cancer.3 Globally, the burden of diabetes, ischemic heart 
disease and certain cancers is about 44%, 23% and 7-41% attributable to overweight and 
obesity, respectively.2 
Concurrent with this, the prevalence of overweight and obesity in childhood is also reach-
ing alarming levels worldwide. The WHO estimated that 41 million children worldwide under 
the age of 5 years were overweight or obese in 2014.4 Childhood obesity is associated with a 
higher risk of obesity, cardiovascular disease, premature death and disability in adulthood.5 In 
addition to increased future risks, obese children experience breathing difficulties, increased 
risk of fractures, early markers of cardiovascular disease (e.g., hypertension, non-alcoholic 
fatty liver disease, adverse lipid profile, insulin resistance), depression and other psychologi-
cal effects.5
In the past few decades, there has been mounting evidence suggesting that obesity and 
cardiometabolic diseases in childhood and adulthood at least partly originate in fetal or 
early postnatal life.6-11 The Developmental Origins of Health and Disease (DOHaD) hypothesis 
proposes that alterations in the intrauterine environment during critical periods of cellular 
proliferation and differentiation can affect the developing fetus leading to structural and 
functional alterations in cells, tissues and organ systems. These alterations may have lifelong 
consequences for body composition and cardiometabolic health in later life.6 Maternal 
adiposity during pregnancy, among other lifestyle prenatal factors, has been identified as 
an important risk factor that might lead, through intrauterine programming, to obesity and 
cardiometabolic dysfunction in the offspring.6 Along with intrauterine life, infancy seems also 
to be a critical period for the development of obesity and cardiometabolic diseases.7 A large 
body of evidence has suggested that nutrition and growth in infancy are related to obesity 
and cardiovascular disease risk in later life.9-11 In particular, rapid weight gain in infancy is 
associated with an adverse cardiovascular profile in adulthood.8
Assessing the contribution of maternal adiposity during pregnancy and infant adiposity to 
later adverse body composition and cardiometabolic risk status broadens the understanding 
on their short- and long-term health consequences. Furthermore, this may help to develop 
future preventive strategies aimed at improving body composition and cardiovascular health 
throughout the life course and in future generations. Therefore, studies included in this thesis 
were designed to clarify the adiposity and cardiovascular health related consequences of 
maternal and infant adiposity (Figure 1).
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Figure 1. Overview of the assessed associations in this thesis
 Maternal adiposity during pregnancy 
Pre-pregnancy body mass index, gestational weight gain 
Infant adiposity 
Body mass index, subcutaneous fat (skinfold thicknesses) 
Childhood adiposity 
Body mass index, anthropometric indices based on waist 
circumference, total, abdominal and organ fat (bioelectric 
impedance, dual-energy X-ray absorptiometry, ultrasound and 
magnetic resonance imaging) 
Childhood cardiovascular 
risk factors 
Blood pressure, blood lipids 
and insulin 
MATERnAl ADIPoSITy DuRInG PREGnAnCy
Obesity in women of reproductive age is increasing in prevalence worldwide.12 Maternal 
pre-pregnancy obesity is an important risk factor for pregnancy and birth complications.13-16 
In addition to short-term adverse health eff ects, maternal obesity seems also to aff ect long-
term health of the off spring. A meta-analysis of published studies showed an increased risk 
of overweight in off spring of mothers with overweight and obesity, as compared to off spring 
of mothers with normal weight.17 Next to maternal obesity, excessive gestational weight gain 
also seems to be associated with an increased risk of childhood obesity.18-20 Gestational weight 
gain is a complex trait, which refl ects multiple components including maternal nutritional 
status, the fetus, amniotic fl uid, placenta, uterine and mammary tissue expansion, increased 
blood volume, and extracellular fl uid.21 Intrauterine programming might be involved in 
the associations of maternal obesity and excessive gestational weight gain with a greater 
risk of obesity in later life. It has been suggested that a maternal obesogenic environment 
during pregnancy leads to higher maternal plasma concentrations of glucose, amino acids 
and free fatty acids that are transferred to the developing fetus and might cause permanent 
changes in the development of adipocytes, and in the appetite control system.6 Maternal 
pre-pregnancy body mass index and gestational weight gain are important modifi able fac-
tors that might greatly impact maternal health and health of the off spring. Thus, obtaining 
a better understanding of the infl uence of maternal pre-pregnancy body mass index and 
gestational weight gain on more detailed off spring fat measures, such as abdominal and 
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organ fat, already from early infancy onwards and their underlying mechanisms is of utmost 
importance for development of preventive strategies.  
InFAnT ADIPoSITy
Infant growth patterns, such as rapid postnatal weight gain, are recognized as critical for 
the development of overweight and obesity and for an adverse body fat distribution in later 
life.7,9,11,22,23 Also, infant overweight and obesity are important risk factors for overweight and 
obesity in childhood.24,25 Besides the effect on adiposity, early infant growth seems also to 
affect cardiovascular disease risk throughout the life course. Rapid weight gain in the first 3 
months of life has been associated with an unfavorable cardiovascular and metabolic health 
profile in adulthood.8 
Infancy seems to be characterized by a specific body fat development. During the first 4 
months of life approximately 90% of body fat is located subcutaneously,26 and preperitoneal 
fat mass seems to increase only from the second year of life onwards.27 Skinfold thickness, 
which is a valid measurement of total and regional subcutaneous fat,28 might be particularly 
relevant in infancy due to the pattern of fat deposition observed in this period. 
Altogether, these studies suggest that infancy may be a critical period that influences the 
development of an adverse body fat profile and cardiovascular disease in later life. Thus, 
obtaining a better understanding of the influence of more detailed fat mass measures during 
infancy on fat mass measures and cardiovascular risk factors later in life helps to further un-
derstand the stability of body fat measures across the life course and to identify early critical 
periods of fat development important for the risk of cardiovascular disease in adulthood. 
CHIlDHooD ADIPoSITy AnD CARDIovASCulAR RISk FACToRS
The majority of studies addressing the adiposity related consequences of maternal adiposity 
during pregnancy and infant adiposity have used body mass index, which is a safe, inexpen-
sive and an easy to obtain population-level diagnostic tool for defining general adiposity. 
However, body mass index is a suboptimal measure of body fat mass, especially in children, 
and provides no information about body fat distribution.29 
Previous studies have suggested that body fat distribution, rather than body mass index, is 
related to the risk of cardiovascular and metabolic diseases.30 Waist circumference and other 
indices based on waist circumference, such as waist-to-height ratio and waist-to-hip ratio, 
have been used in clinical practice to estimate abdominal fat. However, waist circumference 
has been more strongly correlated with body mass index and total body fat than with ab-
dominal visceral fat,31,32 raising doubts about its use and the use of waist-to-height ratio for 
assessing abdominal fat. Waist-to-hip ratio has been suggested to be a good predictor of 
cardiovascular disease risk because it includes a measurement of hip circumference, which 
has been negatively associated with diabetes, cardiovascular disease and mortality.33,34 In line 
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with this, in a meta-regression analysis of 15 prospective studies, waist-to-hip ratio tended to 
be more strongly associated with cardiovascular events than waist circumference.35 Although 
easier to obtain and cheaper, anthropometric measurements are more likely to be affected 
by measurement error. As an alternative, dual-energy X-ray absorptiometry is an imaging 
technique that quantifies total and regional body fat content with high precision.28 
These measures do not give any insight into the amount of subcutaneous, visceral and 
organ fat compartments, which have been described as better indicators of cardiometabolic 
risk.30,36,37 Large cohort studies such as the Framingham Heart Study and the Jackson Heart 
Study have reported that excess visceral adiposity and ectopic fat deposition (such as ex-
cess heart, liver and intrathoracic fat) is related to various cardiometabolic abnormalities, 
independently of total or subcutaneous fat.38-44 Magnetic resonance imaging is a high quality 
imaging and gold standard technique for the measurement of intra-abdominal and organ fat 
deposition.45-48 Abdominal ultrasound is also a valid method to estimate subcutaneous fat 
mass and preperitoneal fat mass, as a proxy for visceral fat mass.46,49 Overall, the cardiometa-
bolic risk associated with adipose tissue seems to be mainly related to abdominal and organ 
fat and thus it is important to gain more knowledge on the associations of early life factors 
with these measures of adiposity later in life.
Cardiovascular disease events are more frequent from the fifth decade of life onwards but 
the precursors of cardiovascular disease seem to originate in childhood. Previous studies 
have shown that increased blood pressure levels during childhood strongly predict hyper-
tension in young adulthood.50 Also, a long exposure to raised concentrations of low-density 
lipoprotein (LDL)-cholesterol increases the risk of cardiovascular events.51 In line with this, an 
adverse cardiovascular risk profile characterized by high levels of LDL-cholesterol, systolic 
blood pressure, body mass index and cigarette smoking in 12- to 18-year-old adolescents was 
associated with carotid intima media thickness in adulthood, independently of current risk 
factors.52 Higher glucose, insulin and insulin resistance in childhood have also been associ-
ated with a higher risk of diabetes and an adverse cardiovascular profile in adulthood.53,54 
Exposure to cardiovascular risk factors early in life may contribute to the development of 
cardiovascular disease events in adulthood and thus it is important to obtain further insight 
into their determinants and underlying mechanisms.
GEnERAl AIM 
The general aim of this thesis was to assess the adiposity and cardiovascular health related 
consequences of maternal and infant adiposity.
SPECIFIC AIMS
The specific aims of this thesis are addressed in the studies presented in Chapter 2 and 
Chapter 3. In Chapter 2, studies on the influence of maternal adiposity during pregnancy 
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on infant and childhood outcomes are described. In Chapter 2.1, we reviewed the childhood 
cardiometabolic, respiratory and cognitive-related health consequences of maternal obesity 
during pregnancy. In Chapter 2.2, we studied the influence of maternal body mass index, 
and gestational weight gain on body mass index and subcutaneous fat at the ages of 1.5, 6 
and 24 months. In Chapter 2.3, we addressed the associations of maternal gestational weight 
gain, diabetes and smoking on total and regional adiposity at the age of 7 years and explored 
whether these associations were through direct intrauterine mechanisms or through birth 
weight. The associations of maternal body mass index, and gestational weight gain on body 
mass index, and total, abdominal, pericardial and liver fat at the age of 10 years are described 
in Chapter 2.4. In Chapter 3, studies on the influence of infant adiposity on childhood 
outcomes are described. In Chapter 3.1, we examined the accuracy of single and combined 
anthropometric indices for assessing body fat and clarified the use of indices based on waist 
circumference as measures of adiposity in children. The influence of infant body mass index 
and subcutaneous fat on childhood adiposity and cardiovascular risk factors is studied in 
Chapter 3.2 and Chapter 3.3, respectively.
GEnERAl DESIGn
The studies presented in this thesis were embedded in the Generation XXI, Porto, Portugal 
and in the Generation R Study, Rotterdam, the Netherlands.
Generation XXI
The Generation XXI is a population-based birth cohort assembled in Porto, Portugal.55 The 
Generation XXI was designed to chart the growth and development of children born at the 
dawn of the new millennium seeking to better understand health during childhood and later 
in adolescence and adulthood, thereby contributing to health gains among the population. 
Mothers resident in the catchment area who delivered a live-born child, with a gestational 
age≥24 weeks, in one of the public maternity units covering the metropolitan area of Porto, 
between April 2005 and August 2006, were eligible for enrolment in this study. Mothers 
were invited to participate, 24 to 72 hours after delivery, and of the invited mothers, 91% 
accepted to participate. A total of 8647 children and 8495 mothers were enrolled at baseline. 
Follow-up evaluations at ages 6, 15 and 24 months were restricted to sub-samples of chil-
dren. Re-evaluations of the entire cohort were conducted at 4 years old (between 2009 and 
2011; 86% of all children re-evaluated) and at 7 years old (between 2012 and 2014; 80% of all 
children re-evaluated). Currently, they are being evaluated at 10 years old. The Generation 
XXI has been collecting parental and child data through interviewer- and self-administered 
questionnaires and diaries, performing detailed physical examinations and collecting bio-
logical samples. The studies presented in this thesis used data from enrolment and from the 
7-year-old re-evaluation.
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Generation R Study
The Generation R Study is a population-based prospective cohort study from fetal life until 
young adulthood in Rotterdam, the Netherlands.56 The Generation R Study was designed to 
identify early environmental and genetic determinants of growth, development and health 
in fetal life and childhood. All pregnant women living in the study area with a delivery date 
between April 2002 and January 2006 were eligible for enrolment in this study. Enrolment 
was aimed at early pregnancy, but was possible until the birth of the child. In total, 9778 
mothers were enrolled in the study, of whom 8880 (91%) were included during pregnancy. 
Assessments were planned in early-, mid-, and late-pregnancy (<18, 18-25 and ≥25 weeks of 
gestation, respectively) and included parental physical examinations, blood and urine col-
lection, fetal ultrasound examinations, and self-administered questionnaires. Assessments 
of the newborn at birth included a physical examination and cord blood tests. Additional 
detailed assessments of fetal and postnatal growth and development were conducted in a 
subgroup of Dutch mothers and their children from late pregnancy onwards. From birth to 
4 years of age, data on growth, development and health of the participating children were 
obtained by questionnaires and visits to the routine child health care centers. At the age 
of 6 and 10 years, all children were invited to participate in detailed body composition and 
cardiovascular follow-up measurements. Currently, they are being evaluated at 13 years old. 
The studies presented in this thesis used data from pregnancy, birth, infancy and 6 and 
10-year-old re-evaluations.
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AbSTRACT 
background: Obesity is a major public health problem among women of reproductive age. 
In a narrative review, we examined the influence of maternal obesity during pregnancy on 
fetal outcomes and childhood adiposity, cardio-metabolic, respiratory and cognitive-related 
health outcomes. We discuss results from recent studies, the causality and potential underly-
ing mechanisms of observed associations and challenges for future epidemiological studies.
Summary: Evidence from observational studies strongly suggests that maternal pre-
pregnancy obesity and excessive gestational weight gain are associated with increased risks 
of fetal pregnancy complications and adverse childhood cardio-metabolic, respiratory and 
cognitive-related health outcomes. It remains unclear whether these associations are due to 
intrauterine mechanisms or explained by confounding family-based sociodemographic, life-
style and genetic factors. The underlying mechanisms have mainly been assessed in animal 
studies and small human studies, and are yet to be further explored in large human studies. 
key message: Maternal obesity is an important modifiable factor during pregnancy that is 
associated with a variety of adverse offspring health outcomes. Further studies are needed to 
explore the causality and underlying mechanisms of the observed associations. Ultimately, 
preventive strategies focused on reducing maternal obesity and excessive weight gain dur-
ing pregnancy may reduce common diseases in future generations. 
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InTRoDuCTIon
Obesity is a major public health problem worldwide.1 The World Health Organization esti-
mated that 11% men and 15% women of the world’s adult population were obese in 2014.1 The 
strong increase in obesity prevalence also affected women of reproductive age. Over time, 
studies from the US and UK showed an increase in maternal obesity at the start of pregnancy 
from approximately 10% around 1990 to approximately 16-22% in the early 2000s.2, 3 To date, 
the obesity prevalence rate in pregnant women is estimated to be as high as 30% in Western 
countries.4-7 In these countries, an even higher percentage of women gain an excessive 
amount of weight during pregnancy based on the US Institute of Medicine (IOM) guide-
lines, which define optimal ranges of maternal weight gain during pregnancy according 
to a mother’s pre-pregnancy body mass index (BMI) based on evidence from observational 
studies (Table 1).5, 8-11 An accumulating body of evidence suggests that maternal obesity and 
excessive weight gain during pregnancy are not only associated with adverse maternal and 
fetal pregnancy outcomes, but also have a long-term adverse influence on common health 
outcomes in the offspring.11, 12 
In this narrative review, we provide a review update of the findings from recent obser-
vational studies and meta-analyses focused on the associations of maternal obesity and 
excessive weight gain during pregnancy with fetal outcomes and offspring adiposity, cardio-
metabolic, respiratory and cognitive-related health outcomes throughout childhood.11, 12 We 
also discuss the causality and potential mechanisms underlying the observed associations as 
well as challenges for future research. 
Table 1. IOM criteria for gestational weight gain1
Pre-pregnancy body mass index
Recommended amount of 
total gestational weight gain, kg
Underweight 
(Body mass index < 18.5 kg/m2)
12.5–18
Normal weight
(Body mass index ≥ 18.5–24.9 kg/m2)
11.5–16
Overweight 
(Body mass index ≥ 25.0–29.9 kg/m2)
7–11.5
Obesity 
(Body mass index ≥ 30.0 kg/m2)
5–9
1Recommended gestational weight gain guidelines according to women’s pre-pregnancy body mass index. Adapted from 
the IOM criteria.8 
FETAl ouTCoMES
Maternal pre-pregnancy obesity and excessive gestational weight gain are important risk 
factors for multiple adverse fetal outcomes (Figure 1).11-13 Several large meta-analyses have 
shown that a higher maternal pre-pregnancy or early pregnancy BMI is associated with 
increased risks of fetal death, stillbirth, neonatal death and the development of various con-
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genital anomalies.14, 16 Thus far, increased gestational weight gain seems not to be associated 
with fetal death or still birth. Both higher maternal pregnancy BMI and increased gestational 
weight gain are well-known risk factors for delivering large size for gestational age infants. A 
meta-analysis among 13 studies showed that, as compared to normal maternal pre-pregnancy 
weight, maternal pre-pregnancy obesity was associated with a 2-fold higher risk of deliver-
ing a large size for gestational age infant.17 Similarly, a meta-analysis among 15 cohort and 
case-control studies showed that excessive gestational weight gain based on the IOM criteria 
was associated with a 2-fold higher risk of macrosomia.18 Based on studies that assessed the 
associations of gestational weight gain during specific periods of pregnancy, it appears that 
especially higher second and third trimester maternal weight gain are associated with an 
increased risk of delivering a large size for gestational age infant.19, 20 Also, both maternal 
pre-pregnancy BMI and gestational weight gain seem to be associated with common adverse 
neonatal outcomes, such as preterm birth, a low Apgar score, neonatal hypoglycemia and 
referral to the neonatal intensive care unit, with stronger and more consistent associations 
for maternal pre-pregnancy BMI than for gestational weight gain.20-25 
Thus, both maternal pre-pregnancy obesity and excessive gestational weight gain lead 
to increased risks of fetal complications throughout pregnancy. Overall, the associations for 
maternal pre-pregnancy obesity with adverse fetal outcomes seem to be more consistent 
and stronger than for excessive gestational weight gain.13, 20  
Figure 1. Maternal obesity during pregnancy and adverse childhood outcomes 
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CHIlDHooD ouTCoMES
An accumulating body of evidence suggests that maternal obesity during pregnancy 
adversely affects a variety of childhood health outcomes.11 Most studies that assessed the 
influence of maternal gestational obesity on common childhood health outcomes focused 
on childhood adiposity and cardio-metabolic development (Figure 1).12 Across studies from 
different countries, maternal pre-pregnancy obesity and excessive gestational weight gain 
are associated with an increased risk of obesity throughout childhood.26 Two meta-analyses 
based on results from observational studies showed that both maternal pre-pregnancy obe-
sity and excessive gestational weight gain according to the IOM criteria were associated with 
a 3-fold higher risk of childhood obesity, as compared to normal weight women and to a rec-
ommended amount of gestational weight gain, respectively.27, 28 However, during childhood, 
BMI might not be an appropriate measure of fat mass because an increase in BMI may reflect 
an increase in lean mass instead of fat mass.29, 30 It has been shown that detailed fat mass 
measures, such as total body fat mass and abdominal fat mass, are more strongly associated 
with cardio-metabolic risk factors in childhood and adulthood and the risk of mortality in 
later life.31-33 Several studies also showed that a higher maternal pre-pregnancy BMI and total 
gestational weight gain are independently associated with a higher childhood waist circum-
ference, total body fat mass and abdominal fat mass levels, although the associations for total 
gestational weight gain are less consistent.10, 34-39 Maternal weight gain in early pregnancy 
appears to be a specific critical period for the development of adiposity in childhood.12 Three 
population-based prospective cohort studies showed that especially maternal gestational 
weight gain in early pregnancy was associated with a higher childhood BMI, total body fat 
mass and abdominal fat mass from the age of 4−9 years.10, 19, 35 These associations appeared 
to be independent from maternal pre-pregnancy BMI and weight gain later in pregnancy. 
Both maternal pre-pregnancy obesity and excessive gestational weight gain are associ-
ated with a suboptimal childhood cardio-metabolic profile.12 In the Generation R Study, a 
population based prospective cohort study in Rotterdam, the Netherlands, we observed that 
a higher maternal pre-pregnancy BMI was associated with a higher childhood systolic blood 
pressure, left ventricular mass, aortic root diameter and insulin levels, and lower high-density 
lipoprotein (HDL)-cholesterol levels at the age of 6 years.34, 40 As compared to children from 
normal weight mothers, children from obese mothers had a 3-fold higher risk of an adverse 
childhood cardio-metabolic risk profile, which included high abdominal fat mass, high blood 
pressure, high insulin and triglycerides levels and low HDL-cholesterol level.34 Similarly, 
higher maternal early pregnancy weight gain, but not weight gain later in pregnancy, was 
associated with an increased risk of an adverse childhood cardio-metabolic risk profile.35 An-
other Dutch study among 1,459 mothers and their 5-6 year old children showed that a higher 
maternal pre-pregnancy BMI was associated with higher childhood systolic blood pressure 
and overall metabolic score, as a measure of a metabolic syndrome like phenotype, but not 
with childhood sympathetic drive, parasympathetic drive or heart rate.39, 41 A study among 
5,154 UK mother-offspring pairs showed that higher maternal pre-pregnancy weight and 
gestational weight gain in mid-pregnancy were associated with higher childhood levels of 
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triglycerides, HDL-cholesterol, apolipoprotein A1 and interleukin (IL)-6 at the age of 9 years.10 
A study among 1,090 mother-child pairs participating in a pre-birth cohort in the USA showed 
that a higher maternal pre-pregnancy BMI was associated with higher mid-childhood leptin, 
high sensitivity C-reactive protein and IL-6 levels, and lower adiponectin levels, whereas a 
higher total gestational weight gain was only associated with higher mid-childhood leptin 
levels.36 Across different studies, these associations with cardio-metabolic risk factors are not 
explained by birth weight, but seem to be largely mediated by childhood BMI.12 
A higher maternal pre-pregnancy BMI and increased gestational weight gain may affect 
respiratory outcomes throughout childhood (Figure 1). A meta-analysis among 14 European 
birth cohort studies showed that maternal overweight and obesity during pregnancy were 
associated with the risk of ever wheezing and recurrent wheezing until the age of 2 years.42 
Accordingly, a more recent meta-analysis among 14 studies with over 108,000 mother–child 
pairs showed that maternal obesity during pregnancy was associated with a 31% increased 
risk of asthma or ever wheezing in children aged 14 months to 16 years.43 Each 1-kg/m2 in-
crease in maternal BMI led to a 3% increased risk of childhood asthma.43 High gestational 
weight gain was associated with a 16% higher risk of ever asthma or wheeze, but not with 
current asthma or wheeze.43 In both meta-analyses, the observed associations could not be 
explained by multiple socioeconomic, lifestyle and birth characteristics or by the child’s BMI 
at the time of assessment of the outcome.42, 43 Asthma is partly considered an atopic disorder. 
However, thus far, the associations of maternal pre-pregnancy obesity with other atopic 
disorders including allergic rhinitis, hay fever, atopic dermatitis or inhalant and food allergen 
sensitization are inconsistent.44-48 In addition, only few studies assessed the associations with 
more detailed childhood lung function measurements directly and have shown inconsistent 
results.45, 46 
Less is known about the associations of maternal obesity during pregnancy with cognitive 
outcomes in the offspring (Figure 1).49-59 Several studies showed that maternal pre-pregnancy 
obesity is associated with a lower cognitive function in children, but results are not consis-
tent.49-57 Total weight gain during pregnancy seems not be associated with childhood cogni-
tive function.54, 56, 60 However, a study among 5,191 mother-offspring pairs restricted to term 
deliveries from the UK showed small positive associations of maternal weight gain in each 
trimester of pregnancy with IQ scores at 8 years of age, without remarkable differences in 
strength of the effect estimates for different periods of maternal weight gain.61 Similarly, a 
study among normal weight Scandinavian mothers and their children, showed that maternal 
third trimester weight gain was only associated with child IQ scores at 5 years of age when 
the sample was limited to term deliveries.62 In a meta-analysis among 5 observational studies, 
maternal obesity during pregnancy was associated with a 1.5-fold higher risk of childhood 
autism spectrum disorder.63 A Swedish study among 333,057 participants also showed that 
both low and high maternal gestational weight gain were associated with an increased risk 
of autism spectrum disorder in children.64 A combined study among 12,556 school-aged 
children and their mothers from 3 prospective Scandinavian cohorts showed that maternal 
pre-pregnancy obesity was associated with an increased risk of childhood attention deficit 
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hyperactivity disorder (ADHD) symptoms rated by teachers.65 No associations of maternal 
gestational weight gain with ADHD symptoms seem to be present.66 
Thus, in line with the risks of adverse fetal outcomes, maternal pre-pregnancy obesity and 
excessive gestational weight gain also lead to increased risks of adverse adiposity, cardio-
metabolic, respiratory and cognitive-related outcomes in childhood. Most consistent as-
sociations have been reported for childhood adiposity outcomes, whereas especially the 
associations with childhood cognitive outcomes seem to be weaker and less consistent 
across studies. The observed associations seem not to be restricted to obesity or excessive 
gestational weight gain only, but present across the full range of BMI and gestational weight 
gain.  
CAuSAlITy oR ConFounDInG
It remains unclear whether the associations of maternal obesity during pregnancy with com-
mon childhood outcomes are explained by direct intrauterine mechanisms or confounded 
by environmental, lifestyle or genetic characteristics.11, 12 Most previous observational stud-
ies adjusted their analyses for a variety of pregnancy-related characteristics and maternal 
and offspring socio-demographic, nutrition and lifestyle-related characteristics.11, 12 Despite 
adjustment for potential confounding factors in these observational studies, residual con-
founding may still be a major issue to consider.11, 12 As described previously, several methods 
in epidemiological research can be used to better control for confounding characteristics in 
observational studies.11, 12
Multiple studies have compared the strength of associations of maternal and paternal BMI 
with childhood outcomes as an aid to further disentangle underlying mechanisms.12 Stron-
ger associations for maternal BMI suggest direct intrauterine mechanisms, whereas similar 
or stronger associations for paternal BMI suggest a role for shared genetic or family-based, 
lifestyle-related characteristics.12 Stronger associations of maternal pre-pregnancy BMI with 
birth weight have been reported than for paternal BMI.67 Although studies comparing as-
sociations of maternal and paternal BMI with childhood BMI have shown conflicting results,68 
studies examining these associations with more detailed childhood fat mass measures and 
other cardio-metabolic risk factors have shown that maternal pre-pregnancy BMI tends to 
be more strongly associated with childhood total fat mass, android/gynoid fat mass ratio 
and clustering of cardio-metabolic risk factors than paternal BMI.34, 69 A study among 940 
Swedish children and 873 adolescents showed that higher maternal BMI was more strongly 
associated with offspring cardiorespiratory fitness, after taking offspring fatness into account, 
than paternal BMI.70 No such studies have yet been performed with other childhood respira-
tory outcomes. With regard to childhood cognitive outcomes, few studies that do not show 
strong evidence for a potential intrauterine effect have been performed. A study among 
1,783 Danish parents and their 5-year old children observed similar associations for maternal 
and paternal BMI with childhood IQ.50 A study among 2,379 infants and their parents from 
2 Southern-European birth cohorts showed that although the association for maternal BMI 
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with offspring cognition was stronger than for paternal BMI, the confidence intervals of the 
maternal and paternal effect estimates were not statistically different. These findings suggest 
that maternal pre-pregnancy BMI may, at least partly, influence offspring birth weight and 
childhood cardio-metabolic health through direct intrauterine mechanisms, but this remains 
to be further explored for other childhood health outcomes. A limitation of this statistical 
method is the assumption that a mother and father contribute equally to the shared lifestyle-
related characteristics between parents and their offspring.68 However, the influence of the 
parents on the offspring’s diet and exercise may differ between mother and father.68 
Another approach used to obtain further insight into the role of confounding in these 
observed associations is by a sibling comparison study.11, 12 A sibling comparison study allows 
control for environmental characteristics as well as maternal genotype that are shared among 
siblings.12 Important sibling comparison studies have been performed among children from 
mothers who had high levels of pre-pregnancy weight loss due to biliopancreatic diversion 
bariatric surgery. These studies showed that among children born to mothers before surgery, 
the risk of macrosomia, obesity, reduced insulin sensitivity and suboptimal lipid levels was 
higher than among those children born to mothers after surgery.71 These findings provide 
evidence to suggest that some of the effect of extreme maternal obesity on offspring out-
comes may be through direct intrauterine mechanisms. However, it remains unclear whether 
this effect is also present for less extreme maternal pre-pregnancy BMI levels and a variety 
of childhood health outcomes. Two large sibling comparison studies from the USA showed 
that children born to mothers who gained a large amount of weight during pregnancy had a 
higher birth weight and higher childhood BMI than children born to mothers who gained less 
weight during pregnancy.72, 73 The association with childhood BMI was only partly mediated 
by offspring birth weight.  A sibling comparison study among Swedish men aged 18 years 
showed that among siblings from overweight and obese mothers, higher total gestational 
weight gain was associated with higher offspring BMI.74 However, in the same study popula-
tion, no evidence was found for an association of maternal BMI with offspring BMI among 
siblings.75 Thus far, no sibling comparison studies have focused on childhood respiratory 
outcomes and only few sibling comparison studies focused on childhood cardio-metabolic 
outcomes or cognitive outcomes. A study among 4,908 brother-pairs from Sweden showed 
no associations of maternal gestational weight gain and offspring blood pressure or risk of 
hypertension at 18 years among siblings.76 A study among 333,057 participants from Sweden 
showed that maternal BMI at the first antenatal visit was not associated with autism spectrum 
disorder among siblings, whereas excessive gestational weight gain was associated with the 
risk of autism spectrum disorder within a matched sibling analysis.64 Another study among 
673,632 individuals from Sweden showed that at the population level, maternal pre-pregnan-
cy obesity was associated with an increased risk of offspring ADHD, but not among siblings.77 
Thus, findings from sibling comparison studies among less extreme obese populations sug-
gest that especially gestational weight gain may affect offspring health outcomes through 
direct intrauterine mechanisms, whereas the associations for maternal pre-pregnancy 
BMI with childhood outcomes may be explained by unmeasured confounding factors. An 
important limitation of sibling comparison studies is that besides the major exposures of 
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interest, maternal pre-pregnancy BMI and gestational weight gain, other lifestyle-related 
characteristics may differ between siblings.12
A Mendelian randomization approach uses genetic variants, which are robustly associated 
with the exposure of interest and not affected by confounding, as an instrumental variable 
for a specific exposure.12 A study among 30,487 mothers-offspring pairs from 18 cohort 
studies showed that a genetically higher maternal BMI was associated with a higher birth 
weight, which suggests that genetically higher maternal BMI may be causally related to birth 
weight.78 On the contrary, a study among 4,091 mother-offspring pairs showed no association 
of maternal FTO with childhood fat mass at the age of 9 years, which suggests that maternal 
obesity may not be causally related to childhood adiposity outcomes.69 However, this study 
needs to be interpreted cautionary, as this study may be limited by a relatively small sample 
size. The need for a large sample size to have adequate power for these types of analyses is an 
important limitation of the Mendelian Randomization approach. However, the findings from 
these studies mark the importance for further Mendelian randomization studies with a larger 
sample size and using multiple maternal genetic variants as instruments focused on a variety 
of childhood health outcomes. 
Randomized controlled trials are considered as the golden standard to assess causality.11, 12 
However, with randomized controlled trials, we are only able to test a specific exposure which 
is amenable to intervention. Therefore, previous randomized controlled trials have focused 
on influencing determinants of maternal obesity and excessive weight gain during pregnan-
cy, such as dietary factors and physical activity levels, since directly randomized studies are 
difficult to perform with maternal pre-pregnancy obesity and excessive gestational weight 
gain as major exposures of interest.12 A randomized controlled trial among 574 obese infertile 
women, which provided a 6-month lifestyle intervention program  prior to fertility treatment 
showed a small reduction in maternal pre-pregnancy weight but no effect on rates of healthy 
singleton life born children.79 A meta-analysis among 44 randomized controlled trials focused 
on dietary and physical activity interventions during pregnancy suggested that especially 
dietary interventions during pregnancy, and not physical activity interventions, may lead to 
a small reduction in gestational weight gain and to a slightly lower risk of adverse pregnancy 
outcomes.80 A Cochrane review which included 65 randomized controlled trials suggested 
that interventions during pregnancy focused on diet or exercise, or combined, can reduce 
the risk of excessive gestational weight gain.81 However, the effect of these interventions on 
childhood outcomes remains to be explored. A small randomized controlled trial among 
254 mothers and their children, which provided both dietary advice and exercise to obese 
mothers during pregnancy, showed no difference in their infant BMI or metabolic risk fac-
tors.82 Long-term follow-up of participants in these trials is important as it will provide insight 
into the causality of observed associations as well as the effectiveness of maternal lifestyle 
interventions during pregnancy for improving common health outcomes in offspring.12
Altogether, these epidemiological studies specifically designed to explore the causality for 
the associations of maternal obesity with common childhood health outcomes show incon-
sistent results. Each method has important methodological limitations and combined results 
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from these different approaches will be needed to obtain further insight into the causality of 
these observed associations. 
unDERlyInG MECHAnISMS
The mechanisms underlying the associations of maternal pre-pregnancy obesity or exces-
sive gestational weight gain with offspring health outcomes remain unclear. Maternal 
pre-pregnancy BMI and gestational weight gain are complex traits, which are inversely 
correlated.20 In general, women with a higher pre-pregnancy BMI gain less weight during 
pregnancy as compared to women with a lower pre-pregnancy BMI.8 Most observational 
studies mutually adjusted their analyses for maternal pre-pregnancy BMI and gestational 
weight gain to explore the independent effects of these maternal exposures on offspring 
outcomes.11, 12 However, both maternal pre-pregnancy BMI and gestational weight gain reflect 
multiple components.12 Maternal pre-pregnancy obesity not only reflects maternal fat ac-
cumulation, but also other maternal characteristics, including maternal nutritional status, 
insulin and glucose metabolism and low-grade systemic inflammation.12 Similarly, maternal 
weight gain during pregnancy reflects maternal fat accumulation, but also maternal and 
amniotic fluid expansion and growth of the fetus, placenta and uterus.12 Both maternal pre-
pregnancy obesity and excessive gestational weight gain as well as the correlated maternal 
exposures may lead to programming effects in the offspring through several pathways.12 
Not much is known about the potential programming effects by maternal obesity or ex-
cessive gestational weight gain. The fetal overnutrition hypothesis suggests that increased 
placental transfer of nutrients to the developing fetus in obese mothers and mothers with 
high levels of gestational weight gain, may subsequently affect fetal development, fetal 
fat deposition and the development of the hypothalamic-endocrine system that controls 
appetite and energy metabolism.12 Inflammation and immunological mechanisms due to 
maternal obesity during pregnancy may also affect offspring cardio-metabolic, pulmonary 
and brain development.65, 83, 84 This may predispose individuals to a greater risk of adverse 
health outcomes in later life. Accumulating evidence suggests that epigenetic mechanisms 
may play a key role in these programming mechanisms.85 Thus far, animal studies provide 
support for programming effects of maternal obesity and excessive gestational weight gain 
through epigenetic mechanisms.86 Also, several small human studies using a epigenome-
wide approach showed associations of maternal pre-pregnancy BMI or gestational weight 
gain with DNA methylation in offspring cord blood.87-91 However, the mechanisms proposed 
have not been tested yet in large epidemiological studies. Further mechanistic studies are 
important to obtain a better understanding of the underlying mechanisms. 
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CHAllEnGES FoR FuTuRE EPIDEMIoloGICAl RESEARCH
Although current evidence suggests that maternal obesity during pregnancy adversely affect 
common childhood health outcomes, there remain major issues to be addressed in future 
studies, as previously described.11, 12 
First, despite extensive adjustment for potential confounding factors in most studies and 
the use of more sophisticated study designs in some observational studies, the causality of 
the observed associations remains unclear. Large observational studies with sophisticated 
designs, such as parent-offspring comparison studies, sibling comparison studies and Men-
delian randomization studies are needed for insight into the causality of the observed as-
sociations.11, 12 These studies need to move beyond childhood adiposity as an outcome of 
interest and also focus on a variety of offspring health outcomes, including cardio-metabolic, 
respiratory and cognitive outcomes. Long-term follow-up of participants in trials focused on 
reducing maternal weight throughout pregnancy will also provide further insight into the 
causality of the observed associations.11, 12
Second, the underlying mechanisms of the observed associations of maternal obesity dur-
ing pregnancy with childhood health outcomes need to be further explored.11, 12 Although ani-
mal studies and small human studies have suggested several pathways that may be involved 
in the observed associations, these pathways remain to be studied in large human studies.11, 12 
Identification of potential underlying pathways is complicated, as maternal pre-pregnancy 
obesity and excessive gestational weight gain both reflect several lifestyle-related and bio-
logical components.11, 12 Future studies need to obtain detailed assessments of the maternal 
exposures of interest from the start of pregnancy onwards, such as repeated measurements 
of maternal weight, body composition and metabolic status.11, 12 For the offspring outcomes, 
more detailed measurements of growth, body composition, cardio-metabolic, respiratory 
and cognitive development, such as cardiac structures, endothelial function, lipid spectrums, 
insulin/glucose metabolism, spirometry parameters, fractional exhaled nitric oxide levels, 
bronchial hyper-responsiveness and cranial structures assessed by MRI might also lead to 
further insight into the underlying mechanisms present in the observed associations. Since 
epigenetic mechanisms are one of the major underlying mechanisms of interest, repeated 
offspring blood samples throughout the life course are needed to assess the influence of 
the specific maternal exposures on offspring epigenetic adaptations. Long-term follow-up of 
participants in observational studies is needed to assess the influence on common adverse 
health outcomes throughout the life-course.11, 12
Third, further research focused on optimizing maternal pre-pregnancy BMI and weight gain 
during pregnancy for the prevention of adverse health outcomes in offspring is needed.11, 12 
Further insight needs to be obtained into the optimal amounts of maternal weight gain for 
short- and long-term maternal and offspring health outcomes to further improve the IOM 
recommendations for gestational weight gain.11, 12 By conducting long-term follow-up studies 
of mothers and their children participating in randomized trials focused on reducing mater-
nal weight throughout pregnancy by dietary and physical activity interventions, we will gain 
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insight into the effectiveness of these maternal lifestyle interventions during pregnancy for 
improving a variety of long-term health outcomes in offspring.11, 12
ConCluSIonS
Maternal pre-pregnancy obesity and excessive weight gain during pregnancy are common 
and important modifiable risk factors for adverse fetal outcomes and childhood adiposity, 
cardio-metabolic, respiratory and cognitive related health outcomes. To explore the causal-
ity of these associations, parent offspring comparison studies, sibling comparison studies, 
Mendelian randomization studies and randomized controlled trials are needed. Further 
mechanistic studies, especially in large human populations are needed to obtain insight in 
the underlying mechanisms. Finally, the potential for prevention of common diseases in fu-
ture generations by reducing maternal obesity and excessive weight gain during pregnancy 
needs to be explored. Preventive strategies focused on improving maternal health in the 
preconception period and in pregnancy by optimizing preconception care may improve 
long-term health outcomes in the offspring.
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AbSTRACT
background: Not much is known about the associations of maternal obesity and excessive 
gestational weight gain with body fat in infancy.
objective: To examine the associations of maternal pre-pregnancy body mass index and 
gestational weight gain with infant subcutaneous fat.
Methods: In a population-based prospective cohort study among 845 mothers and their 
infants, we obtained maternal pre-pregnancy body mass index and measured maternal 
weight during pregnancy. At 1.5, 6 and 24 months, we estimated infant total subcutaneous 
fat (sum of biceps, triceps, suprailiacal and subscapular skinfold thicknesses) and central-to-
total subcutaneous fat ratio (sum of suprailiacal and subscapular skinfold thicknesses/total 
subcutaneous fat).
Results: Maternal body mass index was positively associated with higher infant body mass 
index from 6 months onwards. Maternal body mass index was not associated with infant 
subcutaneous fat measures at 1.5 or 6 months. A 1-standard deviation scores (SDS) higher 
maternal body mass index was associated with a 0.09 (95% Confidence Interval 0.01, 0.17) SDS 
higher infant total subcutaneous fat at 24 months, but not with central-to-total subcutane-
ous fat ratio. No associations were present for maternal total or period-specific gestational 
weight gain with infant fat.
Conclusion: Maternal body mass index was positively associated with infant body mass in-
dex and total subcutaneous fat in late infancy. Maternal total and period-specific gestational 
weight gain were not associated with infant body fat mass measures.
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InTRoDuCTIon
Maternal pre-pregnancy obesity and excessive weight gain during pregnancy are associated 
with an increased risk of obesity in childhood.1,2 Body mass index is a suboptimal measure of 
body fat mass and provides no information about body fat distribution.3 Several studies have 
shown that compared to body mass index, central fat distribution is more strongly associated 
with an adverse cardiovascular risk profile.4 Previously, we reported that maternal obesity and 
excessive weight gain especially in early-pregnancy seem to be associated with an adverse 
body fat distribution, such as higher android-to-gynoid fat mass ratio, at 6 years.5,6 We have 
also shown that maternal pre-pregnancy body mass index tended to be more strongly as-
sociated with childhood total and abdominal fat than paternal body mass index, suggesting 
that intrauterine mechanisms might be involved.6 Thus far, previous studies did not assess 
the associations and explore the underlying mechanisms of maternal obesity and excessive 
weight gain during pregnancy with detailed offspring fat mass measures already from early 
infancy onwards, which is a well-known critical period for adiposity development in later 
life.7 Skinfold thickness is a valid measurement of total and regional subcutaneous fat mass in 
infancy.8 We have previously shown that subcutaneous fat mass measured by skinfolds tends 
to track throughout infancy and is positively associated with cholesterol levels at school-age 
children.9,10 
Therefore, we examined in a population-based prospective cohort study among 845 parents 
and their infants, the associations of maternal pre-pregnancy body mass index and weight 
gain in different periods of pregnancy with subcutaneous fat mass measures throughout in-
fancy. We also compared the strength of the associations of maternal and paternal body mass 
index with infant fat mass measures to obtain further insight in the underlying mechanisms. 
METHoDS 
Study design
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from early pregnancy onwards among 9,778 mothers and their children living 
in Rotterdam, the Netherlands.11 The local Medical Ethical Committee approved the study. 
Written informed consent was obtained from parents. Additional detailed assessments of 
growth and development were conducted in a subgroup of Dutch mothers and their children 
from late pregnancy onwards. Of all approached women, 80% agreed to participate. From 
the total of 1,205 mothers and their singleton children participating in the subgroup study, 
1,033 mothers had information about pre-pregnancy body mass index. Missing information 
about pre-pregnancy body mass index was mainly because of later enrolment in the study 
and nonparticipation in the first questionnaire. Body mass index or skinfold thicknesses 
measured at the age of 1.5, 6 or 24 months were available in 845 children (Flow chart is given 
in Supplemental Figure S1). Missing body fat mass measurements during infancy were due 
to loss to follow-up or crying behavior. 
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Parental anthropometrics
As previously described, maternal pre-pregnancy weight was obtained by questionnaire at 
enrolment.11 Maternal height (cm) and paternal height (cm) and weight (kg) were measured 
without shoes and heavy clothing at enrolment. Body mass index (kg/m2) was calculated. 
Maternal and paternal body mass index were categorized into 4 categories (underweight 
(<20 kg/m2), normal weight (20–24.9 kg/m2), overweight (25–29.9 kg/m2), and obese (≥30 kg/
m2)). We measured maternal weight without shoes and heavy clothing at median 12.8 (95% 
range 9.9,17.0), 20.4 (95% range 18.6,22.7) and 30.4 (95% range 28.5,32.5) weeks of gestation. 
In a subgroup of 509 mothers, information about maximum weight during pregnancy was 
assessed by questionnaire 2 months after delivery. Based on the timing of maternal weight 
measurements within our study cohort, we defined early-, mid- and late-pregnancy weight, 
using self-reported and measured maternal weight data, as: at 13 weeks of gestation (median 
12.8, 95% range 9.9,18.9); at 26 weeks of gestation (median 29.9, 95% range 20.4,31.6); and at 
40 weeks of gestation (median 39.0, 95% range 32.6,42.0), respectively. Using this method, 
information about early-, mid- and late-pregnancy weight was available for 762, 824 and 
493 mothers, respectively. Among the subgroup of mothers with maximum weight during 
pregnancy available, we defined excessive gestational weight gain in relation to maternal 
pre-pregnancy body mass index according to the Institute of Medicine (IOM) guidelines.12 
body fat measurements during infancy
We measured weight to the nearest gram in naked infants at the age of 1.5 and 6 months by 
using an electronic infant scale and at 24 months by using a mechanical personal scale (SECA, 
Almere, the Netherlands). Body length at the age of 1.5 and 6 months was measured in supine 
position to the nearest millimeter by using a neonatometer and body height at 24 months 
was measured in standing position by using a Harpenden stadiometer (Holtain Limited, 
Dyfed, UK). Body mass index (kg/m2) was calculated. We measured skinfold thicknesses at the 
ages of 1.5, 6 and 24 months on the left side of the body at the biceps, triceps, suprailiacal and 
subscapular area by using a skinfold caliper (Slim Guide, Creative Health Products).9 We cal-
culated total subcutaneous fat mass from the sum of all four skinfold thicknesses, and central 
subcutaneous fat mass from the sum of suprailiacal and subscapular skinfold thicknesses.13 
Measurements of body fat quantity and distribution require appropriate adjustment for body 
size or total fat mass, respectively, in order to undertake informative comparisons between 
children and within children over time. To create total subcutaneous fat mass independent of 
length or height and central subcutaneous fat mass independent of total subcutaneous fat 
mass, we estimated the optimal adjustment by log-log regression analyses.14 Based on these 
analyses, total subcutaneous fat mass was only weakly correlated with length at 1.5 and 6 
months or height at 24 months, and was not adjusted for it. A central-to-total subcutaneous 
fat mass ratio was calculated as central divided by total subcutaneous fat mass. 
Covariates
Information on maternal and paternal age, educational level and parity was obtained at 
enrolment.11 Information on maternal smoking was assessed by questionnaires during 
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pregnancy. First trimester maternal nutritional information was obtained by food frequency 
questionnaire. Information about pregnancy complications, mode of delivery, child’s sex, 
gestational age and weight at birth was obtained from medical records.15 Information about 
breastfeeding duration and timing of introduction of solid foods was obtained by question-
naires in infancy. 
Statistical analysis
First, we examined differences in subject characteristics between maternal body mass index 
categories with 1-way ANOVA tests and χ2 tests. Next, we examined the associations of ma-
ternal and paternal body mass index with infant subcutaneous fat mass measures at each 
time period using linear regression models. We also used repeated measurement regression 
models to assess the associations of parental pre-pregnancy overweight with the repeatedly 
measured infant fat mass measures. These models take the correlation between repeated 
measurements of the same subject into account, and allow for incomplete outcome data. 
Third, we examined the associations of maternal maximum gestational weight gain and 
excessive gestational weight gain according to the IOM criteria with infant subcutaneous 
fat mass measures using linear regression models. Since maternal weight measurements 
throughout pregnancy are strongly correlated, we performed conditional linear regression 
analyses to assess the independent associations of maternal pre-pregnancy weight and 
early-, mid- and late-pregnancy weight gain with infant subcutaneous fat mass measures. 
We obtained standardized residuals for each weight measurement from the regression of 
maternal weight at a specific time point on prior maternal weight measurements. These 
weight variables are statistically independent from each other, and can be simultaneously 
included in the regression models.16 
Models were adjusted for maternal and childhood socio-demographic and lifestyle-related 
characteristics. Covariates were included based on associations with the exposures and out-
comes of interest in previous studies, or a change in effect estimates >10%. We constructed 
SDS ((observed value−mean)/SD) for parental body mass index and gestational weight gain 
and infant fat mass measures to enable comparison of effect estimates. Since no significant 
interactions between parental body mass index or maternal gestational weight gain and 
child’s sex in the associations with infant subcutaneous fat mass measures were present, 
no further stratified analyses were performed. Missing values in covariates were multiple-
imputed, by using Markov chain Monte Carlo approach. Five imputed datasets were created 
and analyzed together. All statistical analyses were performed using the Statistical Package 
of Social Sciences version 21.0 for Windows (SPSS Inc, Chicago, IL, USA).
RESulTS
Subject characteristics
Characteristics of included mothers, fathers and their children are given in Table 1. Non-
response analyses showed that as compared to mothers who did not participate in the 
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follow-up studies, those who did participate were slightly older, had a higher educational 
level and their children were breastfed for a longer period (p<0.05), but no differences were 
observed regarding maternal and paternal body mass index and maternal weight gain dur-
ing pregnancy (Supplemental Table S1).
Parental body mass index and infant body fat
Table 2 shows the associations of maternal and paternal body mass index with infant 
subcutaneous fat mass measures. We observed no associations of maternal pre-pregnancy 
body mass index with infant body fat mass measures at 1.5 months. A higher maternal 
pre-pregnancy body mass index was associated with higher infant body mass index from 6 
months onwards (difference at 6 and 24 months: 0.09 (95% Confidence Interval (CI) 0.01,0.17) 
SDS, 0.17 (95% CI 0.09,0.26) SDS per 1-SDS higher maternal body mass index, respectively). A 
higher maternal pre-pregnancy body mass index was also associated with higher infant total 
subcutaneous fat mass at 24 months (difference: 0.09 (95% CI 0.01, 0.17) SDS per 1-SDS higher 
maternal body mass index), but not with infant central-to-total subcutaneous fat mass ratio. 
A higher paternal body mass index was only associated with higher infant body mass index 
at 1.5 and 24 months (p-values<0.05). Including both maternal and paternal body mass index 
in the same model did not change the effect estimates for infant fat mass measures at 1.5, 6 
and 24 months.
Supplemental Figure S2 shows that maternal pre-pregnancy overweight was associated 
with higher infant body mass index growth from 6 months onwards, resulting in higher body 
mass index at 24 months (all p-values<0.05). Maternal pre-pregnancy overweight also tended 
to be associated with higher total subcutaneous fat mass and central-to-total subcutaneous 
fat mass ratio at 24 months (difference: 0.09 (95% CI 0.01,0.17) SDS, 0.08 (95% CI -0.01,0.17) 
SDS for maternal pre-pregnancy overweight as compared to maternal pre-pregnancy nor-
mal weight, respectively). No associations of paternal overweight with infant body fat mass 
measures were present.   
Maternal gestational weight gain and infant body fat
Table 3 shows no consistent associations for maternal maximum and excessive gestational 
weight gain with infant body mass index and subcutaneous fat mass measures at 1.5, 6 and 24 
months. Excessive maternal gestational weight gain was only associated with higher infant 
body mass index at 6 months (difference: 0.30 (95% CI 0.11,0.48) SDS for excessive maternal 
weight gain as compared to non-excessive weight gain). No associations were observed for 
maternal weight gain measured until 30 weeks of gestation with infant body fat mass mea-
sures (Supplemental Table S2). In Supplemental Figure S3, early-pregnancy weight gain 
was associated with higher total subcutaneous fat mass at 6 months, but not at older ages. 
No independent associations were observed for maternal mid- and late-pregnancy weight 
gain with infant fat mass measures.
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DISCuSSIon
This study showed that maternal pre-pregnancy body mass index was positively associated 
with infant body mass index and total subcutaneous fat mass from 6 months onwards. Ma-
ternal total and period-specific gestational weight gain were not associated with infant body 
fat mass measures.
Methodological considerations
Strengths of this study were the prospective design with extensive maternal data collection 
from early pregnancy onwards and detailed infant body fat measurements available. Of the 
1,033 mothers and their singleton children with pre-pregnancy body mass index available, 
82% (845) had information on infant body fat measures. The non-response could lead to 
biased effect estimates if the associations of maternal obesity during pregnancy with infant 
body fat were different between participants included and excluded in the analyses. This 
seems unlikely since no differences were observed between participants and non-partici-
pants regarding parental pre-pregnancy body mass index and maternal gestational weight 
gain. A limitation of our study might be the generalizability of our findings to other ethnic 
groups, due to our homogenous ethnic study population. Maternal pre-pregnancy body 
mass index and maximum gestational weight gain were self-reported, which may have led 
to misclassification and underestimation of the reported associations. However, we observed 
similar results when we used maternal weight measured at enrolment (results not shown) and 
weight gain measured until 30 weeks of gestation. Skinfold thickness is a valid measure to 
estimate infants subcutaneous fat mass but provides no information about intra-abdominal 
fat mass.8 However, infants body fat is mainly located subcutaneously in the first two years of 
life.17 Also, inter- and intra-observer measurement error might be larger compared to other 
anthropometric measurements.18,19 
Interpretation of main findings
A higher maternal pre-pregnancy body mass index is associated with higher body mass 
index from early childhood onwards.1,2 Also, maternal pre-pregnancy obesity seems to be 
associated with an adverse offspring body fat pattern, characterized by higher total fat mass 
and abdominal fat mass levels from the age of 2 years onwards.20-22 A study among 325 infants 
showed that maternal pre-pregnancy obesity was positively associated with total fat mass 
already throughout infancy.23 In the current study, we observed that maternal pre-pregnancy 
body mass index was already associated with a higher infant body mass index and total 
subcutaneous fat mass from the age of 6 months onwards. No associations were observed 
for central-to-total subcutaneous fat mass ratio at all ages. Thus, maternal obesity seems to 
influence total body fat mass development already from early infancy onwards. 
By comparing the strength of associations of maternal and paternal body mass index 
with offspring fat mass outcomes, further insight into the underlying mechanisms can be 
obtained. Stronger maternal associations would suggest that intrauterine programming 
effects might be part of the underlying mechanisms, whereas similar or stronger paternal 
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associations suggests that genetics and lifestyle-related characteristics might explain the 
observed associations. Previous studies comparing the strength of associations of parental 
body mass index with infant and childhood body mass index have reported inconsistent 
associations.24-26 We have shown, among 4,871 parents and their 6-year-old children, that 
maternal pre-pregnancy body mass index was more strongly associated with childhood total 
fat mass and android-to-gynoid fat mass ratio, as compared to paternal body mass index.6 
In this current study, we observed more consistent and stronger associations for maternal 
pre-pregnancy body mass index with infant subcutaneous fat mass measures from the age of 
6 months onwards, as compared to the associations of paternal body mass index with infant 
outcomes. At 1.5 months, we observed stronger associations for paternal body mass index 
with infant body mass index as compared to maternal body mass index. Thus, these results 
suggest that intrauterine programming effects may become more apparent at later ages. 
The intrauterine programming effects may involve increased placental transfer of nutrients 
during fetal development. This may subsequently cause permanent adaptations in appetite, 
energy metabolism and neuro-endocrine function in offspring, which predispose individuals 
to a greater risk of obesity in later life.24 These findings could also be explained by a stronger 
influence of maternal lifestyle-related characteristics on child’s lifestyles and subsequent 
body fat mass. However, previous studies have suggested that maternal and paternal diet 
and physical activity are both associated with child’s diet and physical activity, without a 
stronger maternal influence.27,28 Also, since we adjusted our analyses for multiple potential 
confounders the influence of lifestyle-related characteristics on our findings might be limited.
Next to maternal pre-pregnancy obesity, higher maternal total gestational weight gain is 
also associated with a higher childhood body mass index, total fat mass levels and waist 
circumference.29,30 We did not observe consistent associations of maternal total gestational 
weight gain with early infant fat mass measures. It has been suggested that the associations 
of maternal weight gain with offspring fat mass outcomes may depend upon the timing 
of gestational weight gain. A prospective cohort study among 5,154 UK mothers and their 
children  showed that maternal weight gain during early-pregnancy was positively associ-
ated with childhood body mass index and total fat mass.25 In line with these findings, we 
have previously shown that a higher maternal weight gain, especially in early-pregnancy, is 
associated with a higher childhood body mass index, total body fat mass and abdominal fat 
mass levels at the age of 6 years.5 However, these associations were weaker as compared to 
the associations for maternal pre-pregnancy body mass index with these offspring fat mass 
measures. A study among 977 Greek mothers and their children aged 4 years showed that 
maternal weight gain during early-pregnancy was positively associated with childhood body 
mass index, waist circumference and sum of skinfold thickness.31 In the current study, no 
associations were present for maternal early-, mid- and late-pregnancy weight gain during 
pregnancy with early infant fat mass measures. Thus, maternal weight gain during pregnancy 
seems not to influence fat mass development in early infancy, but the effects may become 
more apparent at older offspring ages. 
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ConCluSIonS
A higher maternal pre-pregnancy body mass index is associated with higher infant body 
mass index and total subcutaneous fat mass from the age of 6 months onwards. Maternal 
gestational weight gain was not associated with infant body fat. Further studies are needed 
to obtain insight into the causality of the observed associations, and the underlying biologi-
cal mechanisms.
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SuPPlEMEnTARy MATERIAlS
Figure S1. Flow chart of participants in study
 N = 1,205 
Eligible mothers and their singleton 
children  
N = 172 
Excluded: mothers without information about pre-
pregnancy body mass index available 
N = 1,033 
Mothers and their singleton children 
with pre-pregnancy body mass index 
available 
N = 188 
Excluded: children without postnatal visit at the ages 
of 1.5, 6 and 24 months or without data on body mass 
index and skinfold thicknesses at the ages of 1.5, 6 
and 24 months available 
For maternal pre-pregnancy body mass index analyses: N = 845 
1.5 months  n =741 
6 months  n =748 
24 months  n =711 
 
For paternal body mass index analyses: N = 797 
1.5 months  n =698 
6 months  n =708  
24 months  n =672 
 
For maternal maximum gestational weight gain analyses: N = 509 
1.5 months  n =454 
6 months  n =470 
24 months  n =464 
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Table S1. Comparison of subject characteristics between children included and not included in the analy-
ses1
Characteristics
Participants 
(n=845)
non-participants 
(n=188)
P-value
Maternal characteristics
Age, mean (SD), years 31.8 (4.1) 30.5 (4.5) <0.001
Education (higher education), n (%) 548 (65.2) 103 (55.7) 0.042
Parity (nulliparous), n (%) 522 (61.8) 113 (60.1) 0.671
Body mass index, mean (SD), kg/m2 23.5 (4.1) 23.5 (4.3) 0.855
Maximum gestational weight gain, mean (SD), kg 15.5 (5.7) 14.9 (5.6) 0.424
Excessive gestational weight gain (IOM criteria), n (%) 242 (47.9) 23 (41.1) 0.449
Weight in early-pregnancy, mean (SD), kg 70.8 (12.9) 71.2 (13.2) 0.752
Weight in mid-pregnancy, mean (SD), kg 78.0 (13.3) 78.3 (13.2) 0.832
Weight in late-pregnancy, mean (SD), kg 84.5 (13.5) 83.1 (13.4) 0.462
Total energy intake, mean (SD), kcal 2119 (512) 2142 (518) 0.722
Smoking during pregnancy (yes), n (%) 186 (23.3) 47 (26.3) 0.408
Gestational diabetes, n (%) 9 (1.1) 1 (0.6) 0.528
Gestational hypertensive disorders, n (%) 62 (7.6) 8 (4.5) 0.141
Paternal characteristics
Age, mean (SD), years 33.9 (5.1) 32.9 (5.3) 0.014
Education (higher education), n (%) 472 (64.2) 80 (51.3) 0.010
Body mass index, mean (SD), kg/m2 25.2 (3.2) 25.6 (3.5) 0.142
birth and infant characteristics
Boys, n (%) 439 (52.0) 99 (52.7) 0.861
Gestational age at birth, median (95% range), weeks 40.3 (35.9-42.4) 40.1 (33.7-42.1) 0.278
Birth weight, mean (SD), g 3515 (537) 3478 (601) 0.403
Caesarean delivery, n (%) 119 (14.9) 23 (13.8) 0.705
Breastfeeding duration, mean (SD), months 4.4 (3.9) 3.6 (3.8) 0.030
Introduction of solids foods (before 6 months), n (%) 600 (80.2) 112 (89.6) 0.041
1Values are observed data and represent means (SD), medians (95% range) or numbers of subjects (valid %). Differences 
were tested using Student’s t-tests and Mann-Whitney tests for normally and non-normally distributed variables, respec-
tively and χ2-test for dichotomous variables. SD, standard deviation. IOM criteria, Institute of Medicine criteria.
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Figure S2. Associations of parental pre-pregnancy overweight with infant subcutaneous fat mass mea-
sures1-2
 A. Body mass index 
B. Total subcutaneous fat mass 
C. Central-to-total subcutaneous fat mass ratio 
1Values are regression coeffi  cients (95% confi dence interval) from repeated measurement linear regression models that re-
fl ect diff erences in subcutaneous fat mass measures in standard-deviation scores at 1.5, 6 and 24 months for maternal and 
paternal overweight/obesity as compared to the reference group (maternal and paternal underweight/normal weight). 
Total subcutaneous fat mass = biceps + triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total subcuta-
neous fat mass ratio = (suprailiacal + subscapular skinfold thicknesses)/total subcutaneous fat mass. 
2Maternal model includes maternal age and educational level, parity, maternal total energy intake, smoking habits and 
weight gain until 30 weeks of gestation, gestational diabetes, gestational hypertensive disorders, child’s sex and gesta-
tional age-adjusted birth weight standard-deviation scores, cesarean delivery, breastfeeding duration and timing of intro-
duction of solid foods. Paternal model includes the same potential confounders as maternal model but paternal age and 
educational level instead of maternal age and educational level. 
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Figure S3. Associations of maternal pre-pregnancy weight and early-, mid- and late-pregnancy weight 
with infant subcutaneous fat mass measures from conditional analyses1-2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. Body mass index 
B. Total subcutaneous fat mass 
C. Central-to-total subcutaneous fat mass ratio 
1Values are regression coeffi  cients (95% confi dence interval) from linear regression models that refl ect diff erences in sub-
cutaneous fat mass measures in standard-deviation scores at 1.5, 6 and 24 months per standard-deviation scores change 
in maternal pre-pregnancy weight and per standard-deviation scores change in standardized residual change in mater-
nal early-, mid- and late-pregnancy weight from conditional regression analyses. Total subcutaneous fat mass = biceps 
+ triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total subcutaneous fat mass ratio = (suprailiacal + 
subscapular skinfold thicknesses)/total subcutaneous fat mass.
2Models were adjusted for maternal age and educational level, parity, height at intake, maternal total energy intake, smok-
ing habits during pregnancy, gestational diabetes, gestational hypertensive disorders, child’s sex and gestational age-
adjusted birth weight standard-deviation scores, cesarean delivery, breastfeeding duration and timing of introduction of 
solid foods (for 6 and 24 months outcomes). 
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AbSTRACT
background and aims: It remains unknown whether the effects of prenatal exposures on 
child´s adiposity reflect entirely intrauterine programming. We aimed to assess the effects 
of maternal gestational weight gain, diabetes and smoking on child´s body fat patterns, 
disentangling the direct (through intrauterine programming) and indirect (through birth 
weight) effects. 
Methods and results: We included 4747 singleton 7-year-old children from the Generation 
XXI birth cohort (Porto, Portugal). At birth, maternal and newborn´s characteristics were 
obtained. Anthropometrics were measured at 7 years old and body fat patterns were identi-
fied by principal component analysis. Path analysis was used to quantify direct, indirect and 
total effects of gestational weight gain, diabetes and smoking on body fat patterns. Pattern 
1 was characterized by strong factor loadings with body mass index, fat mass index and 
waist-to-height ratio (fat quantity) and pattern 2 with waist-to-hip ratio, waist-to-thigh ratio, 
and waist-to-weight ratio (fat distribution). The positive total effect of maternal gestational 
weight gain and diabetes on child’s fat quantity was mainly through a direct pathway, re-
sponsible for 91.7% and 83.7% of total effects, respectively (β=0.022; 95% Confidence Interval 
(CI): 0.017, 0.027; β=0.041; 95% CI: -0.011, 0.093). No effects on fat distribution were found. 
Maternal prenatal smoking had a positive direct effect on patterns 1 and 2, explaining 94.9% 
and 76.1% of total effects, respectively.
Conclusion: The effects of maternal gestational weight gain, diabetes and smoking on 
child´s fat quantity seem to be mainly through intrauterine programming. Maternal smoking 
also showed a positive direct effect on child’s fat distribution.
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InTRoDuCTIon
Intrauterine programming has been pointed out, along with genetic predisposition, as a 
major cause of childhood obesity.1 A large body of evidence has focused on adiposity pro-
gramming by maternal under- or over-nutrition, weight gain, diabetes and smoking during 
pregnancy.2 These exposures are likely to affect the development of adipocytes and their 
capacity to expand or contract, the appetite control system and the energy metabolism in 
later life.3 However, it remains unknown whether the observed effects in these previous stud-
ies reflect entirely intrauterine programming. Confounding by lifestyles or genetics and the 
possibility of pathways mediated by other exposures might still be an issue.
Previous studies have addressed the effect of prenatal exposures on the risk of childhood 
obesity with and without adjustment for birth weight.4-7 Since birth weight may be a media-
tor in these associations, the adjustment for birth weight might be inappropriate. First, the 
effect estimate obtained from a model adjusted for birth weight does no longer correspond 
to the total effect. Secondly, the approach of simply adjusting for mediators in the regression 
models is prone to bias and may produce flawed conclusions.8 To our knowledge, no study 
has discussed separately the intrauterine programming effects from those mediated by birth 
weight. Assessing these effects separately will help to get further insight into the paths and 
mechanisms involved and their specific contributions to the associations between prenatal 
exposures and adiposity in later life. 
Most studies looking at the relation between prenatal exposures and later adiposity have 
used proxies and have relied on single measures for defining adiposity, which might have 
limited their ability to detect associations.9 The combination of anthropometric indices ac-
cording to their inter-correlations into robust and uncorrelated patterns of body fat could be 
a more accurate and yet simple approach of evaluating childhood adiposity.
The present study aimed to assess the effects of prenatal exposures (gestational weight 
gain, diabetes and smoking) on body fat patterns of 7-year-old children. A path analysis 
helped to understand whether these effects are mainly explained by a direct (through intra-
uterine programming) or indirect pathway (through birth weight).
METHoDS
Study population
This study included participants from Generation XXI – a population-based birth cohort 
assembled during 2005-2006 at all public maternity units of Porto, Portugal. Of the invited 
mothers, 91.4% accepted to participate, corresponding to 8647 newborns. A detailed descrip-
tion of the cohort methodology was previously reported.10 At the age of 7 years (2012-2014), 
6889 children were re-evaluated (79.7% of the entire cohort), of which 5849 provided data by 
face-to-face interviews. 
For the definition of body fat patterns, of 5849 children who attended the face-to-face inter-
views at 7 years old, we excluded 130 children with missing information on anthropometrics 
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and/or tetra-polar bioelectric impedance, yielding a total of 5719 children (48.5% females). 
Further, we excluded 212 twins and 760 children who lacked data on selected variables of 
interest. The final study sample included 4747 children (48.6% females). The comparison 
between participants (n=4747) and non-participants (excluding twins, n=3604) showed that 
mothers in this study were slightly older [mean (standard deviation, SD)=29.6 (5.30) vs. 28.1 
(5.94) years old] and higher educated [mean (SD)=11.1 (4.27) vs. 9.5 (4.04) years] than mothers 
who were not included in this study. However, the magnitude of the differences was not high 
(Cohen’s effect size values11 of 0.27 and 0.38 for maternal age and education, respectively), 
suggesting that the differences were mostly due to the large sample size rather than due to 
large differences between participants’ characteristics.
Data collection
Baseline evaluation
Data on maternal characteristics were collected in face-to-face interviews, within 72 hours 
after delivery, during the hospital stay. Maternal age and educational level at birth were 
recorded as completed years of aging and schooling. Information on prenatal smoking 
habits was collected and mothers were grouped into never or ever smokers during preg-
nancy. Pre-pregnancy weight was obtained through recall. Maternal height was measured 
by interviewers, and, when not possible, was abstracted from the national identity card. Pre-
pregnancy body mass index (kg/m2, BMI) was calculated. Maternal gestational weight gain 
was calculated as the difference between the final pre-delivery weight, reported by mothers, 
and the pre-pregnancy weight. Personal history of diabetes mellitus was considered present 
when participants reported a medical diagnosis of this condition before the current preg-
nancy. Gestational diabetes was considered present when recorded on obstetrical records 
as a diagnosis during the current pregnancy. Mothers were grouped into never or ever had a 
diagnosis of type 1 or type 2 diabetes mellitus or gestational diabetes. Clinical records were 
reviewed at birth to retrieve data on gestational age and birth weight. Gestational age was 
estimated by ultrasound and, when it was missing, it was estimated based on the last men-
strual period. The z-scores of birth weight for gestational age were calculated according to a 
sex-specific, population-based Canadian reference.12
Re-evaluation at 7 years old
Anthropometrics were obtained by trained personnel with children in underwear and 
barefoot, according to standard procedures. Body weight and height were measured using a 
digital scale (TANITA®) and a wall stadiometer (SECA®), respectively. Waist circumference was 
measured at the umbilicus level, with abdomen relaxed and hip circumference was measured 
at the level of the greatest posterior protuberance of the buttocks. Thigh circumference was 
measured at the position around the mid-thigh and perpendicular to the long axis of the 
thigh, with the leg slightly flexed. All anthropometrics were measured to the nearest 0.1 kg or 
cm. Body mass index was calculated (kg/m2). The waist-to-height, waist-to-hip and waist-to-
thigh ratios were calculated as waist circumference divided by height, hip circumference and 
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thigh circumference, respectively. The relationship between waist circumference and weight 
was assessed using a log-log regression analysis. Log-waist circumference was regressed on 
log-weight. The gradient of the regression line was approximately 0.5, corresponding to the 
value by which weight should be raised in order to calculate a measure uncorrelated with it. 
Waist-to-weight ratio was calculated as waist circumference divided by the square root of 
weight.
Bioelectric impedance analysis was performed using a tetra-polar device (BIA 101 Anni-
versary, Akern, Florence, Italy). Four surface electrodes were placed on the right wrist, ankle, 
hand and foot with the child lying horizontally. Measurements were performed at least 30 
minutes after the last meal. Fat free mass was determined using Schaefer et al. equation13 and 
fat mass was derived accordingly. Fat mass was divided by the squared height to obtain the 
fat mass index,14 in which fat mass was effectively uncorrelated with height, as confirmed by 
a log-log regression analysis. 
Ethics
All phases of the study complied with the Ethical Principles for Medical Research Involving 
Human Subjects expressed in the Declaration of Helsinki. The study was approved by the 
University of Porto Medical School/ S. João Hospital Centre ethics committee and a signed 
informed consent according Helsinki was required for all participants.
Statistical analysis
Principal component analysis was applied to BMI, waist-to-height ratio, waist-to-hip ratio, 
waist-to-thigh ratio, waist-to-weight ratio, and fat mass index to identify uncorrelated pat-
terns of body fat. The number of factors was decided using the Kaiser’s criterion, by which 
factors with an eigenvalue ≥1.0 are retained. Varimax rotation was performed to simplify the 
interpretation of the factor loadings structure. The interpretation of the factors was based on 
those measures with factor loadings higher than 0.30, considering 0.30-0.70 as moderate and 
≥0.70 as strong factor loadings. The scores that were entered in all subsequent analyses were 
calculated using the regression method with standardized scores. Analyses were conducted 
using the R® software version 3.0.1.
Path analysis determines whether data fit well within a prespecified causal model and 
allows the study of direct and indirect effects with multiple independent and dependent 
variables.15 Path analysis was used to quantify direct, indirect (by multiplication of path 
regression coefficients involved) and total effects (by summing direct and indirect effects) of 
prenatal exposures on body fat patterns, taking into consideration the relationships depicted 
in the causal diagram presented as Figure 1. The path analysis used linear regression models 
for continuous outcomes and probit regression models for categorical outcomes and results 
were presented as regression coefficients (β) and corresponding 95% confidence intervals 
(95% CI). The adjustment sets for each regression model are presented in the footnotes of 
Figure 1. Covariates were included in the analyses when they changed the effect estimates 
substantially (>10%): maternal pre-pregnancy body mass index, age and educational level at 
birth. Other covariates such as parity, mode of delivery, child’s sex, breastfeeding duration, 
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physical exercise and fruit/vegetables intake were tested but did not fulfi ll the criterion for 
being considered confounders and therefore were not included in the regression models. 
Models were fi tted, simultaneously for all body fat patterns identifi ed, with Mplus software 
version 5.2 (Muthén & Muthén, Los Angeles, CA, USA). A Comparative Fit Index (CFI) and a 
Tucker-Lewis Index (TLI)≥0.90 and a Root Mean Square Error of Approximation (RMSEA) 
close to zero were used as criteria to support the goodness of fi t.16 No signifi cant interactions 
between prenatal exposures and child’s sex in the associations with body fat patterns were 
found.
Figure 1. Causal diagram for the eff ects of prenatal exposures on body fat patterns identifi ed by principal 
component analysis at 7-year-old children1-2
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1Direct eff ects correspond to the intrauterine programming eff ects (solid arrows) and the indirect eff ects correspond to the 
eff ects mediated by other exposures (dashed arrows).
2Adjustment sets for each regression model:
aadjusted for the other two prenatal exposures, birth weight for gestational age, maternal pre-pregnancy body mass index, 
age and educational level at birth. 
badjusted for the prenatal exposures, maternal pre-pregnancy body mass index, age and educational level at birth.
cadjusted for the other two prenatal exposures, and maternal pre-pregnancy body mass index.
dadjusted for maternal pre-pregnancy body mass index and age at birth.
eadjusted for maternal pre-pregnancy body mass index, age and educational level at birth.
RESulTS
Characteristics of participants are shown in Table 1. Two body fat patterns, similar for both 
sexes, were identifi ed: a pattern 1 characterized by strong factor loadings with BMI, fat mass 
index and waist-to-height ratio (fat quantity) and a pattern 2 characterized by strong factor 
loadings with waist-to-hip ratio, waist-to-thigh ratio and waist-to-weight ratio (fat distribu-
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tion) (Table 2). Both patterns explained 88.3% of the total variance (45.3% was explained by 
pattern 1 and 43.0% by pattern 2).
Table 1. Characteristics of study participants (n=4747)1
Child´s characteristics Mean (SD)
    Birth weight for gestational age, z-scores -0.3 (0.85)
    Body mass index at 7 y, kg/m2 17.1 (2.51)
    Fat mass index at 7 y, kg/m2 3.2 (2.33)
    Waist-to-height ratio at 7 y 0.5 (0.05)
    Waist-to-hip ratio at 7 y 0.9 (0.05)
    Waist-to-thigh ratio at 7 y 1.6 (0.10)
    Waist-to-weight ratio at 7 y, cm/√kg 10.2 (0.48)
Maternal characteristics  
    Age at birth, years 29.6 (5.30)
    Educational level at birth, years 11.1 (4.27)
    Pre-pregnancy body mass index,  kg/m2 23.8 (4.16)
    Gestational weight gain, kg 13.7 (5.77)
n (%)
    Diabetes (type 1 or type 2 diabetes mellitus or gestational diabetes) 327 (6.9)
    Smokers during pregnancy 992 (20.9)
1SD, standard deviation
Table 2. Factor loadings, obtained from principal component analysis, for anthropometric and bioelectric 
impedance measures (n=5719)
Factor loadings
Pattern 1a Pattern 2b
Body mass index, kg/m2 0.980 0.051
Fat mass index, kg/m2 0.937 0.059
Waist-to-height ratio 0.873 0.454
Waist-to-hip ratio 0.277 0.877
Waist-to-thigh ratio -0.044 0.893
Waist-to-weight ratio, cm/√kg 0.202 0.895
Variance explained 45.3% 43.0%
Cumulative variance explained 45.3% 88.3%
aRepresenting fat quantity; bRepresenting fat distribution. 
Figure 1 shows the theoretical causal diagram for the effects of prenatal exposures on 
body fat patterns, in which the direct effects correspond to the programming effects and the 
indirect effects correspond to the effects mediated by other exposures. Figure 1 also shows 
the effect estimates for each path. Table 3 presents the estimates of direct, indirect and total 
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effects of prenatal exposures on the body fat patterns. The overall fit of the model was good: 
CFI=0.993, TLI=0.954 and RMSEA=0.023. Maternal gestational weight gain had a positive 
total effect on pattern 1 (β=0.024; 95% CI: 0.019, 0.028), mainly due to a direct pathway that 
was responsible for 91.7% of the total effect (β=0.022; 95% CI: 0.017, 0.027). We observed a 
positive total effect of borderline statistical significance of maternal diabetes on pattern 1 
(β=0.049; 95% CI: -0.003, 0.101), mainly due to a direct pathway that was responsible for 83.7% 
of the total effect (β=0.041; 95% CI: -0.011, 0.093). The indirect effects through birth weight of 
Table 3. Estimates of direct, indirect and total effects of prenatal exposures on body fat patterns of 7-year-
old children, calculated by path analysis (n=4747)1 
Pattern 1 Pattern 2
β [95% CI]
% of 
total 
effect
β [95% CI]
% of 
total 
effect
Maternal gestational weight gain
Direct effect
0.022
 [0.017,0.027]
91.7% -0.001
 [-0.006,0.004]
25%
Indirect effects
0.002 
[0.001,0.003]
8.3% -0.003 
[-0.004,-0.002]
75%
     Indirect effect through birth weight
0.002 
[0.001,0.003]
100%a -0.003 
 [-0.004,-0.002]
100%a
Total effect
0.024 
[0.019,0.028]
-0.004 
[-0.009,0.001]
Maternal diabetes
Direct effect
0.041 
[-0.011,0.093]
83.7% -0.005 
[-0.066,0.055]
33.3%
Indirect effects
0.008 
[0.004,0.012]
16.3% -0.010 
[-0.015,-0.005]
66.7%
     Indirect effect through birth weight
0.008 
[0.004,0.012]
100%a -0.010 
[-0.015,-0.005]
100%a
Total effect
0.049 
[-0.003,0.101]
-0.015 
[-0.076,0.045]
Maternal smoking during pregnancy
Direct effect
0.169 
[0.104,0.234]
94.9% 0.083 
[0.011,0.155]
76.1%
Indirect effects
0.009 
[-0.006,0.024]
5.1% 0.026 
[0.012,0.040]
23.9%
     Indirect effect through birth weight
-0.024 
[-0.034,-0.014]
—b 0.032 
[0.020,0.043]
—b
Total effect
0.178  
[0.113,0.243]
0.109 
[0.038,0.180]
1β, regression coefficient; CI, confidence interval. Statistically significant results are shown in bold.
aResults expressed in % of indirect effects; 
bResults not expressed in % of indirect effects since effects of opposite direction contribute to the total of indirect effects.
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these prenatal exposures on both patterns were statistically significant but close to 0. After 
excluding the mothers with type 1 and type 2 diabetes mellitus from the analyses, similar 
results were observed for the associations of maternal gestational diabetes with both body 
fat patterns at 7 years old (results not shown). Maternal smoking during pregnancy had a 
positive total effect on both body fat patterns (pattern 1: β=0.178; 95% CI: 0.113, 0.243; pattern 
2: β=0.109; 95% CI: 0.038, 0.180), mostly due to a direct effect that explained 94.9% and 76.1% 
of the total effect on patterns 1 and 2, respectively. A negative indirect effect through birth 
weight on pattern 1 (β=-0.024; 95% CI: -0.034, -0.014) and a positive indirect effect through 
birth weight on pattern 2 (β=0.032; 95% CI: 0.020, 0.043) were also found, i.e., prenatal smok-
ing was negatively associated with birth weight (β=-0.275; 95% CI: -0.333, -0.216) which was 
positively related to pattern 1 (β=0.087; 95% CI: 0.055, 0.120) and negatively related to pattern 
2 (β=-0.115; 95% CI: -0.150, -0.080) (Table 3 and Figure 1). We observed similar results in the 
principal component analysis and path analysis when we used the age- and sex-adjusted BMI 
standard deviation scores based on the World Health Organization Child Growth Standards 
(results not shown).
DISCuSSIon
The effects of maternal weight gain, diabetes and smoking during pregnancy on body fat 
quantity of 7-year-old children seem to be mainly through their intrauterine programing 
effects. These effects on child´s adiposity prevailed over the indirect effects through birth 
weight. Maternal smoking during pregnancy also showed a positive direct effect on body fat 
distribution of children. 
A previous meta-analysis showed that offspring of women with excessive gestational 
weight gain were at an increased risk of obesity, compared with offspring of women with 
adequate gestational weight gain.6 Our study showed that this effect of maternal gestational 
weight gain on child’s body fat quantity is mainly through intrauterine programming effects 
instead of indirect effects through birth weight. Higher maternal weight gain in pregnancy 
might program higher adiposity in the offspring through fetal over-nutrition that has been 
associated with a permanent increase in the capacity of adipocytes to store lipids,17 and with 
excessive appetite postnatally.18 Previous studies found that higher maternal gestational 
weight gain was associated with a central fat distribution in the offspring, mainly assessed 
by waist circumference.19-21 As waist circumference and BMI are strongly correlated,22 these 
associations could be reflecting the well-established positive effect of maternal gestational 
weight gain on fat quantity. In this study, no effects of maternal gestational weight gain on 
body fat distribution were found. 
The effect of exposure to a diabetic intrauterine environment on child´s adiposity has 
raised some controversy. A systematic review has yielded inconclusive results, but overall the 
associations were not statistically significant in 8 studies from a total of 12 included studies.5 
Additionally, a meta-analysis has reported an association between maternal diabetes and 
increased offspring BMI that was no longer significant after adjustment for maternal pre-
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pregnancy BMI.7 In the present study, maternal diabetes tended to be positively associated 
with child’s body fat quantity after taking maternal pre-pregnancy BMI into consideration. 
The intrauterine programming effects prevailed over the indirect effects through birth 
weight. Hyperglycemia is thought to induce excessive appetite postnatally,23 which might 
explain these results. Few studies have addressed the effect of maternal diabetes on child´s 
body fat distribution, reporting, on one hand, a positive association with trunk fat from dual 
energy x-ray absorptiometry (DXA)24 but, on the other hand, no association with visceral or 
subcutaneous abdominal fat obtained by magnetic resonance imaging.25 In this study, no 
effects of maternal diabetes on body fat distribution were found.
A previous meta-analysis has suggested that maternal prenatal smoking leads to offspring 
obesity.4 Thus far, some studies have reported positive associations whereas other studies 
have reported no associations between maternal prenatal smoking and child’s central fat.26, 27 
Our study showed that maternal smoking during pregnancy was associated with higher body 
fat quantity and a central fat distribution in childhood. These effects were mainly through in-
trauterine programming. The mechanisms by which maternal prenatal smoking may program 
child´s adiposity involve an effect of cigarette smoke constituents, such as nicotine, which 
readily cross the placenta towards the fetus leading to permanent changes in the regulation 
of food intake and energy expenditure, such as increased appetite and decreased mobiliza-
tion of fat from adipose tissue later in life.28, 29 Maternal smoking during pregnancy may also 
mimic fetal under-nutrition by reducing blood supply to the fetus via the vasoconstrictive 
effects of nicotine2 or by reducing the mother´s food intake.30 Fetal under-nutrition has 
been associated with a reduced storage capacity of adipocytes, which may favor visceral fat 
deposition in the presence of a positive energy balance postnatally.31 This could be one of the 
mechanisms involved in the higher accumulation of central fat in offspring of smoking moth-
ers in our study. Moreover, fetal under-nutrition has been associated with reduced levels or 
a reduced effect of leptin during the postnatal period, thereby inducing excessive appetite.32 
A process favoring a better metabolic efficiency might also occur to enable fetal survival in a 
limited energy environment, which might lead to an excessive fat storage when enough food 
is available.1 Even though weak, indirect effects through birth weight of maternal prenatal 
smoking on child´s fat quantity and distribution were also observed in our study. Maternal 
smoking during pregnancy seems to lead to a child with low birth weight that subsequently 
maintains this low weight and tends to have a central fat distribution at 7 years old. Smoking 
delays fetus growth due to the high levels of carboxyhemoglobin and other toxic substances 
in blood, the vasoconstrictive effects of nicotine and fetal under-nutrition.2, 3 The maintenance 
of a low weight during childhood by low birth weight newborns could be explained, at least 
in part, by parental child-feeding practices, although this was not addressed in our study. 
However, we have previously shown in 4- and 7-year-old children of the Generation XXI birth 
cohort that a lower BMI leads to a greater parental use of pressure to eat that subsequently 
leads to a lower BMI.33 Yet unknown mechanisms could be involved in the association of birth 
weight with body fat distribution. 
Some limitations and strengths should be considered. Pre-pregnancy weight and final 
pre-delivery weight were both self-reported. Overall, weight tends to be underreported by 
75
Prenatal exposures and body fat in children
women,34 which might have led to an underestimation of pre-pregnancy BMI. The atten-
dance of prenatal visits could have made pregnant women more aware of their weight status, 
minimizing the error of self-reported final pre-delivery weight. Similarly, data on diabetes 
mellitus relied on self-reporting. If misclassification of women occurred, the association 
between maternal diabetes and offspring adiposity could be attenuated. Moreover, treat-
ment of diabetes (based on diet or insulin), by contributing to a better glycemic control, 
may reduce the risk of long-term adverse outcomes for the offspring, thus complicating 
the detection of associations in observational studies like ours. Information on maternal 
smoking habits during pregnancy also relied on self-reporting, without biochemical valida-
tion, which may result in misclassification due to a reluctance to disclose a known adverse 
pregnancy behavior. However, any under-reporting would likely bias results towards the null, 
underestimating the associations. We measured fat mass at 7 years old using BIA which is a 
valid method to assess whole body composition.35 We relied on anthropometrics to assess 
body fat distribution which might have greater measurement error, and be less accurate 
but on the other hand be easier and cheaper to obtain in large epidemiological studies as 
compared to imaging techniques of body composition.36 In this study, we considered that 
the direct effects reflected the intrauterine programming effects. We tried to perform a 
comprehensive analysis, by including the most important paths described to date, and by 
testing several covariates as confounders. However, we cannot exclude the possibility of 
existing other paths not considered in this study and also residual confounding by lifestyles 
or genetics that might have biased our estimates for the intrauterine programming effects. 
This seems unlikely and the bias might be only limited. The major strength of this study is the 
comprehensive assessment of the effects of prenatal exposures, by quantifying their direct 
and indirect effects, on uncorrelated and more robust measures of fat quantity and distribu-
tion in a large population-based sample of 7-year-old children.
ConCluSIon
This study showed that the effects of maternal weight gain, diabetes and smoking during 
pregnancy on body fat quantity of 7-year-old children seem to be mainly through intrauterine 
programming. Maternal smoking during pregnancy also showed a positive direct effect on 
body fat distribution of children. Considering the lasting and lifelong effects of intrauterine 
programming, primary prevention strategies for obesity, as early as during prenatal care, 
are of utmost importance. Although the indirect effects through birth weight seem to be 
weak, this study reinforces the need for careful interpretation of findings adjusted and not 
adjusted for birth weight in studies addressing the associations between prenatal exposures 
and adiposity in later life. 
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AbSTRACT
background: Maternal obesity and excessive gestational weight gain are associated with an 
increased risk of obesity in the offspring. 
objective: To examine the associations of maternal pre-pregnancy body mass index (BMI) 
and gestational weight gain with general, abdominal, pericardial and liver fat measures in 
children aged 10 years.
Design: In a population-based prospective cohort study from early pregnancy onwards 
among 2,354 mothers and their children, we obtained information about maternal pre-
pregnancy BMI and gestational weight gain. We measured offspring BMI, fat mass index 
(total fat mass/height4) by dual-energy X-ray absorptiometry and subcutaneous fat index 
(subcutaneous fat mass/height4), visceral fat index (visceral fat mass/height3), pericardial fat 
index (pericardial fat mass/height3) and liver fat fraction by Magnetic Resonance Imaging 
(MRI) at 10 years. 
Results: A 1-standard deviation score (SDS) higher maternal BMI was associated with higher 
childhood BMI (difference 0.32 (95% Confidence Interval (CI) 0.28, 0.36) SDS), fat mass index 
(difference 0.28 (95% CI 0.24, 0.31) SDS), subcutaneous fat index (difference 0.26 (95% CI 0.22, 
0.30) SDS), visceral fat index (difference 0.24 (95% CI 0.20, 0.28) SDS), pericardial fat index 
(difference 0.12 (95% CI 0.08, 0.16) SDS) and liver fat fraction (difference 0.15 (95% CI 0.11, 0.19) 
SDS). After conditioning each MRI measure of adiposity on BMI at 10 years, higher maternal 
BMI remained associated with higher childhood subcutaneous and visceral fat indices. 
Maximum gestational weight gain was not consistently associated with organ specific fat 
measures. 
Conclusions: Higher maternal BMI, but not gestational weight gain, was associated with 
higher abdominal, pericardial and liver fat measures. The associations with abdominal sub-
cutaneous and visceral fat were independent of BMI. Our results suggest that promoting a 
healthy BMI in women of reproductive age may be of greater importance for childhood organ 
fat than influencing gestational weight gain.
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InTRoDuCTIon
Maternal obesity is associated with several short- and long-term adverse health effects, in-
cluding an increased risk of obesity in the offspring.1-5 It has been hypothesized that maternal 
obesity is related to an increased placental transfer of nutrients to the fetus, which might 
affect the development of adipocytes, the appetite control system, and the energy metabo-
lism.6 However, these associations might also be explained by shared family-based lifestyle or 
genetic factors. Although many studies reported the associations between maternal and off-
spring obesity, it remains unclear whether maternal obesity also affects body fat distribution 
in the offspring. Information about body fat distribution is important since, as compared to 
body mass index (BMI), body fat distribution, and more specifically excess visceral, heart and 
liver fat, may be better indicators of cardiometabolic health.7-9 Previous studies have reported 
that higher maternal BMI is associated with higher abdominal and liver fat in newborns.10, 11 
Maternal pre-pregnancy obesity was also associated with higher visceral fat mass in Greek 
schoolchildren.12 Next to maternal obesity, paternal obesity and excessive gestational weight 
gain may also affect childhood adiposity.13-18 To date, results from studies focused on the 
associations of paternal BMI and gestational weight gain with body fat distribution remain 
scarce and not consistent.16-18
We examined, in a population-based prospective cohort study among 2,354 mothers, 
fathers and their children, the associations of parental pre-pregnancy BMI and gestational 
weight gain with offspring BMI, fat mass index measured by dual-energy X-ray absorptiom-
etry (DXA) and subcutaneous fat index, visceral fat index, pericardial fat index and liver fat 
fraction measured by Magnetic Resonance Imaging (MRI) at 10 years. We explored whether 
any association with organ specific fat measures reflects specific accumulation, or just reflects 
general adiposity.
SubjECTS AnD METHoDS
Study design
This study was embedded in the Generation R Study, a population-based prospective cohort 
study from early pregnancy onwards in Rotterdam, the Netherlands.19 The study was approved 
by the Medical Ethical Committee of the Erasmus MC, Rotterdam (MEC 198.782/2001/31). Writ-
ten informed consent was obtained from parents.19 Pregnant women were enrolled between 
2001 and 2005. Of all the eligible children in the study area, 61% participated at birth in the 
study. In total, 5,706 mothers and their singleton children attended the study visit at 10 years, 
of whom information about pre-pregnancy BMI was available in 4,298 subjects. Further, we 
excluded children without any organ specific fat measures assessed by MRI (n=1,944). Thus, 
the population for analysis was 2,354 mothers and their children (Supplemental Figure S1).
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Parental anthropometrics
Maternal and paternal height and weight were measured at enrolment. Information about 
maternal weight just before pregnancy was obtained by questionnaire. We calculated maternal 
and paternal BMI (kg/m2). In our population for analysis, 56.4% of all women were enrolled 
before a gestational age of 14 weeks. Correlation of pre-pregnancy weight, obtained by ques-
tionnaire, and weight measured at enrolment was 0.96 (p-value<0.01). In this study, maternal 
pre-pregnancy BMI was used and categorized into underweight (<18.5 kg/m2), normal weight 
(18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2), and obesity (≥30.0 kg/m2). For the parental BMI 
comparison analyses, pre-pregnancy maternal and paternal BMI were categorized into normal 
weight (18.5-24.9 kg/m2) and overweight/obesity (≥ 25.0 kg/m2). As previously described, we 
measured maternal weight at early, mid and late pregnancy (median 13.2 weeks of gestation 
(95% range 9.8, 18.9), median 30.1 weeks of gestation (95% range 20.5, 31.4) and median 39.0 
weeks of gestation (95% range 32.8, 42.0), respectively).17 Information about maximum weight 
during pregnancy was assessed by questionnaire 2 months after delivery. Maximum weight 
from questionnaire and weight measured at late pregnancy were strongly correlated (r=0.99, p-
value<0.01). We calculated maximum weight gain during pregnancy as the difference between 
maximum weight and pre-pregnancy weight. Further, we divided maximum weight gain by 
gestational age at birth to obtain the maximum weight gain per week. Maximum gestational 
weight gain was also classified as insufficient, sufficient and excessive weight gain in relation to 
maternal pre-pregnancy BMI according to the Institute of Medicine guidelines.20 
Measures of adiposity at 10 years
We measured child’s height and weight without shoes and heavy clothing and calculated BMI 
(kg/m2). We calculated sex- and age- adjusted standard deviation scores (SDS) of childhood 
BMI based on Dutch reference growth charts (Growth Analyzer 4.0, Dutch Growth Research 
Foundation).21 We measured total body fat mass using a DXA scanner (iDXA, GE-Lunar, 2008, 
Madison, WI, USA, enCORE software v.12.6), according to standard procedures.22 Previous 
studies have validated DXA against computed tomography for body fat assessment.23-25 
Measures of organ fat at 10 years were obtained from MRI scans.19 MRI has been described 
as an accurate and reproducible technique and considered the gold standard for the mea-
surement of intra-abdominal and organ fat deposition.24, 26-28 All children were scanned using 
a 3.0 Tesla MRI (MR 750w, GE Healthcare, Milwaukee, WI, USA) for body fat imaging using 
standard imaging and positioning protocols. They wore light clothing without metal objects 
while undergoing the body scan.29 Abdominal fat scans were acquired in three separate 
acquisitions using a 3-point Dixon technique for fat and water separation (IDEAL sequence). 
The three acquisitions were centralized on the liver, on the umbilicus (abdominal fat scan), 
and on the top of the femur bone (hip scan), respectively. Obtained fat scans were subse-
quently analyzed by the Precision Image Analysis company (PIA, Kirkland, Washington, 
United States). Subcutaneous, visceral, pericardial and liver fat were quantified using the 
sliceOmatic (TomoVision, Magog, Canada) software package. All extraneous structures and 
any image artifacts were removed manually.26 Total subcutaneous and visceral volumes were 
generated by summing the volumes of three scans. Subcutaneous and visceral fat masses 
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were obtained by multiplying the total volumes by the specific gravity of adipose tissue, 0.9 
g/ml. Pericardial fat included both epicardial- and paracardial fat directly attached to the 
pericardium. Pericardial fat volume was quantified using the summation of discs method and 
was subsequently multiplied by the specific gravity of adipose tissue, 0.9 g/ml. Liver fat frac-
tion was determined using the IDEAL IQ sequence.30 Four samples of at least 4 cm2 were taken 
from the central portion of the hepatic volume. Subsequently, the mean signal intensities 
were averaged to generate an overall mean liver fat fraction estimation. 
To create measures of general and organ fat independent of height at 10 years, we esti-
mated the optimal adjustment by log-log regression analyses and subsequently we divided 
total and subcutaneous fat mass by height4 (fat mass index and subcutaneous fat index) and 
visceral and pericardial fat mass by height3 (visceral and pericardial fat indices) (More details 
given in Supplemental Methods).31, 32 
Covariates
Information on maternal and paternal age, educational level, and ethnicity, and maternal 
parity and smoking habits was obtained by questionnaires during pregnancy. Information 
on child’s sex was obtained from medical records. Information on breastfeeding duration 
and timing of introduction of solid foods was obtained by questionnaires in infancy, and 
information on the average television watching time was obtained by questionnaires at the 
age of 10 years.
Statistical analysis
First, we used linear regression models to examine the associations of maternal and paternal 
pre-pregnancy BMI and maximum gestational weight gain, continuously and using clinical cat-
egories, with measures of adiposity (BMI, fat mass index, subcutaneous, visceral and pericardial 
fat indices and liver fat fraction) at 10 years. Second, we examined the independent associations 
of maternal pre-, early, mid, and late pregnancy weight with the childhood outcomes using 
conditional linear regression analyses to account for the correlations between the weight mea-
surements.33 For these models, we obtained standardized residuals for each weight from the 
regression of a maternal weight at a specific time point on prior maternal weights. These vari-
ables correspond to the difference between the actual weight and the expected weight based 
on prior weights and thus are statistically independent from each other and can be included 
simultaneously in the regression models.33 Third, we used conditional regression analyses to 
assess whether the associations of maternal and paternal pre-pregnancy BMI and gestational 
weight gain with measures of organ fat at 10 years were independent of BMI at 10 years. We 
used as outcomes the standardized residuals for each measure of organ fat at 10 years obtained 
from the regression of those outcomes on BMI.33 For all analyses, we used a basic model includ-
ing child´s sex and age at outcome measurements, and a confounder model, which addition-
ally included covariates. We included covariates in the models if they were strongly associated 
with parental anthropometrics and childhood adiposity in our study, or if they changed the 
effect estimates substantially (>10%). We log-transformed the non-normally distributed child-
hood DXA and MRI adiposity measures. We constructed SDS [(observed value - mean)/SD] of 
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the sample distribution for all continuous exposures and DXA and MRI outcomes to enable 
comparisons of effect sizes. We tested for statistical interactions between maternal BMI and 
gestational weight gain, maternal BMI and paternal BMI and between both maternal BMI and 
gestational weight gain with child´s sex, but none of these were consistently significant. Since 
the maximum gestational weight gain was self-reported, sensitivity analyses using weight gain 
measured until late pregnancy were performed. Missing values in covariates (ranging from 0 
to 28%) were multiple-imputed by using Markov chain Monte Carlo approach. Five imputed 
datasets were created and analyzed together. All statistical analyses were performed using the 
Statistical Package of Social Sciences version 21.0 for Windows (SPSS Inc, Chicago, IL, USA).
RESulTS
Subject characteristics
Table 1 shows the subject characteristics. Non-response analyses showed that parents of 
children with MRI follow-up data available were slightly older and had a higher educational 
level, and mothers were more likely to be non-smokers (p-values<0.05). No differences were 
observed for maternal BMI and gestational weight gain and paternal BMI (Supplemental 
Table S1). Supplemental Table S2 shows that the correlation coefficients of BMI and fat mass 
index with subcutaneous and visceral fat indices are moderate to strong and higher than the 
correlation coefficients with pericardial fat index and liver fat fraction. 
Maternal and paternal bMI and childhood organ fat measures
Table 2 shows that a 1-SDS higher maternal BMI was associated with higher childhood BMI 
(difference 0.32 (95% Confidence Interval (CI) 0.28, 0.36) SDS), fat mass index (difference 0.28 
(95% CI 0.24, 0.31) SDS), subcutaneous fat index (difference 0.26 (95% CI 0.22, 0.30) SDS), 
visceral fat index (difference 0.24 (95% CI 0.20, 0.28) SDS), pericardial fat index (difference 
0.12 (95% CI 0.08, 0.16) SDS) and liver fat fraction (difference 0.15 (95% CI 0.11, 0.19) SDS). As 
compared to maternal normal weight, maternal underweight was associated with lower fat 
measures whereas maternal overweight and obesity were associated with higher fat mea-
sures in childhood (p-values<0.05). After conditioning each MRI measure of adiposity on BMI 
at 10 years, higher maternal BMI remained associated with higher childhood subcutaneous 
and visceral fat indices (p-values<0.05). 
Figure 1A shows that, as compared to normal weight parents, those in which only moth-
ers or only fathers were overweight/obese had children with higher levels of all adiposity 
measures at the age of 10 years (p-values<0.05). The associations tended to be stronger when 
only mothers rather than only fathers were overweight/obese. The strongest associations 
were observed for children in which both parents were overweight/obese. After conditioning 
each MRI measure of child’s adiposity on BMI at 10 years (Figure 1b), no significant asso-
ciations were observed for couples in which only mothers or only fathers were overweight/
obese. Those couples in which both parents were overweight/obese had children with higher 
subcutaneous, visceral and pericardial fat indices (p-values<0.05). 
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Table 1. Characteristics of mothers, fathers and their children (n=2,354)1
Characteristics value
Maternal characteristics
Age, mean (SD), years 31.0 (4.8)
Education, n (%)
     Low 160 (6.9)
     Medium 935 (40.5)
     High 1,211 (52.5)
Ethnicity, n (%)
     European 1,532 (65.3)
     Non-European 815 (34.7)
Parity, n (%)
     Nulliparous 1,419 (60.3)
     Multiparous 934 (39.7)
Pre-pregnancy body mass index, median (95% range), kg/m2 22.5 (18.0, 34.9)
Pre-pregnancy body mass index clinical categories, n (%)
     Underweight 97 (4.1)
     Normal weight 1,639 (69.6)
     Overweight 451 (19.2)
     Obesity 167 (7.1)
Maximum gestational weight gain, mean (SD), kg 14.8 (5.8)
Gestational weight gain clinical categories (IOM criteria), n (%)
     Insufficient gestational weight gain 299 (20.5)
     Sufficient gestational weight gain 505 (34.5)
     Excessive gestational weight gain 658 (45.0)
Weight in early pregnancy, mean (SD), kg 69.0 (12.9)
Weight in mid pregnancy, mean (SD), kg 76.0 (12.6)
Weight in late pregnancy, mean (SD), kg 81.6 (12.5)
Smoking during pregnancy, n (%)
     Yes 504 (22.3)
     No 1,757 (77.7)
Paternal characteristics
Age, mean (SD), years 33.6 (5.3)
Education, n (%)
     Low 83 (4.9)
     Medium 652 (38.6)
     High 953 (56.5)
Ethnicity, n (%)
     European 1,383 (74.4)
     Non-European 477 (25.6)
Body mass index, mean (SD), kg/m2 25.3 (3.3)
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Maternal gestational weight gain and childhood organ fat measures
Table 3 shows that a 1-SDS higher maximum weight gain per week was only associated 
with higher childhood BMI (difference 0.08 (95% CI 0.03, 0.13) SDS). Excessive weight gain, 
as compared to sufficient weight gain, was associated with higher childhood BMI, fat mass 
index and subcutaneous and visceral fat indices (p-values<0.05). After conditioning each MRI 
measure of adiposity on BMI at 10 years, no consistent associations were observed. Similar 
results were observed when using maternal weight gain measured until late pregnancy 
(Supplemental Table S5). Figure 2A shows that independent from weights in other periods, 
Table 1. Characteristics of mothers, fathers and their children (n=2,354)1 (continued)
Characteristics value
Body mass index clinical categories, n (%)
     Underweight 9 (0.5)
     Normal weight 945 (50.3)
     Overweight 771 (41.1)
     Obesity 152 (8.1)
birth and infant characteristics
Child’s sex, n (%)
     Boys 1,151 (48.9)
     Girls 1,203 (51.1)
Breastfeeding duration, median (95% range), months 3.5 (0.0, 12.0)
Introduction of solid foods, n (%)
     < 3 months 123 (7.0)
     3-6 months 1,435 (81.7)
     > 6 months 199 (11.3)
Childhood characteristics
Age, mean (SD), years 9.8 (0.3)
Television watching time, n (%)
     < 2 hours/day 1,342 (70.0)
     ≥ 2 hours/day 575 (30.0)
Body mass index, mean (SD), kg/m2 17.5 (2.6)
Total fat mass, median (95% range), g 8,451 (4,549, 21,235)
Subcutaneous fat mass, median (95% range), g 1,297 (603, 5,226)
Visceral fat mass, median (95% range), g 365 (163, 1,004)
Pericardial fat mass, median (95% range), g 10.6 (4.6, 22.6)
Liver fat fraction, median (95% range), % 2.0 (1.2, 5.2)
1Values are observed data and represent means (SD), medians (95% range) or numbers of subjects (valid %). IOM, Institute 
of Medicine; SD, standard deviation.
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higher pre-pregnancy weight was associated with higher levels of all adiposity measures 
(p-values<0.05). Higher early pregnancy weight was associated with higher BMI and fat mass 
index, but not with organ fat measures at 10 years. No associations were observed for mid 
and late pregnancy weight. After conditioning each MRI measure of adiposity on BMI at 10 
years (Figure 2b), higher pre-pregnancy weight remained associated with higher subcutane-
ous and visceral fat indices. No associations were observed for early, mid and late pregnancy 
weight.
Figure 1. Parental body mass index and childhood general and organ fat measures (n=1,795)1
 
 
 
 
 
 
 
 
B. 
A. 
1Estimates are based on multiple imputed data. Model includes child´s sex and age at outcome measurements (except for 
sex- and age-adjusted body mass index SDS), parental age, educational level, and ethnicity, parity, maternal smoking hab-
its during pregnancy, breastfeeding duration, and timing of introduction of solid foods. Results from the basic model are 
given in Supplemental Figure S2. Values in A are regression coeffi  cients (95% Confi dence Intervals) from linear regression 
models that refl ect diff erences in childhood outcomes in SDS for parental body mass index clinical groups as compared 
to the reference group (maternal and paternal normal weight). Values in B are regression coeffi  cients (95% Confi dence 
Intervals) from linear regression models that refl ect diff erences in the standardized residuals of the childhood outcomes 
(obtained by conditional regression analyses on body mass index at 10 years) for parental body mass index clinical groups 
as compared to the reference group (maternal and paternal normal weight). SDS, standard deviation scores.
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Figure 2. Maternal pre-, early, mid, and late pregnancy weight with childhood general and organ fat mea-
sures (n=1,121)1
 A. 
B. 
1Estimates are based on multiple imputed data. Model includes child´s sex and age at outcome measurements (except 
for sex- and age-adjusted body mass index SDS), maternal age, educational level, and ethnicity, parity, height at intake, 
smoking habits during pregnancy, breastfeeding duration, and timing of introduction of solid foods. Results from the 
basic model are given in Supplemental Figure S3. Values in A are regression coeffi  cients (95% Confi dence Intervals) from 
linear regression models that refl ect diff erences in childhood outcomes in SDS per SDS change in maternal pre-pregnancy 
weight and per change in standardized residuals of maternal early, mid, and late pregnancy weight obtained from condi-
tional regression analyses. Values in B are regression coeffi  cients (95% Confi dence Intervals) from linear regression models 
that refl ect diff erences in the standardized residuals of the childhood outcomes (obtained by conditional regression analy-
ses on body mass index at 10 years) per SDS change in maternal pre-pregnancy weight and per change in standardized 
residuals of maternal early, mid, and late pregnancy weight obtained from conditional regression analyses. SDS, standard 
deviation scores.
91
Maternal adiposity and organ fat in children
DISCuSSIon
We observed, in this population-based prospective cohort study, that higher maternal 
pre-pregnancy BMI was associated with higher BMI, fat mass index, subcutaneous, visceral 
and pericardial fat indices and liver fat fraction at 10 years. The associations of maternal BMI 
with offspring subcutaneous and visceral fat indices seemed to be independent of offspring 
BMI. Total and period-specific gestational weight gain were not consistently associated with 
organ fat measures.
Interpretation of main findings
Maternal obesity is a major public health concern.34 A meta-analysis of published studies 
showed an increased risk of overweight in offspring of mothers with overweight and obesity, 
as compared to offspring of mothers with normal weight.5 In the same cohort as the current 
study, we have previously reported that maternal overweight and obesity were strongly 
associated with increased risks of overweight and obesity in the offspring aged 4 and 6 
years.18, 35 In the present study, maternal overweight and obesity were associated with higher 
BMI and fat mass index at 10 years. 
Large cohort studies such as the Framingham Heart Study and the Jackson Heart Study 
have reported that excess visceral and ectopic fat deposition is related to various cardio-
metabolic abnormalities in adults.36-42 In 105 healthy mother-newborn pairs, higher maternal 
BMI was associated with higher infant abdominal fat, independently of weight, and higher 
intrahepatocellular lipid content.10 In another study among 25 newborns, infants born to 
obese mothers with gestational diabetes had higher intrahepatocellular fat compared 
with infants born to normal weight mothers.11 Maternal pre-pregnancy obesity was also 
associated with higher visceral fat mass levels in 1,228 Greek children aged 9-13 years.12 In 
the present study, higher maternal BMI was associated with higher subcutaneous, visceral 
and pericardial fat indices and liver fat fraction at 10 years. The associations of maternal BMI 
with offspring subcutaneous and visceral fat indices seemed to be independent of offspring 
BMI. This means that higher maternal BMI is associated with a specific accumulation of fat in 
abdominal depots that is not a result of general adiposity. We did not observe differences in 
the results when we conditioned on fat mass index instead of BMI. These results are not in 
line with those of our previous study in 6-year-old children suggesting that higher maternal 
pre-pregnancy BMI was not associated with subcutaneous and preperitoneal abdominal fat 
measured by ultrasound, independently of child´s BMI.18 The differences in results may be 
due to different ages or different imaging methods.
Previously, we reported that higher paternal BMI was associated with higher BMI but was 
not associated with subcutaneous and preperitoneal abdominal fat at the age of 6 years, 
independently of child’s BMI.18 In the present study, paternal overweight was associated with 
higher BMI, fat mass index and organ fat measures in children aged 10 years. The associa-
tions observed with MRI adiposity measures were not independent of BMI at 10 years. Our 
results suggest that both maternal and paternal BMI before pregnancy may be risk factors for 
offspring cardiometabolic health by influencing general and organ fat accumulation in later 
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life. Previous studies comparing the associations of maternal and paternal BMI with child-
hood BMI and total fat mass have shown conflicting results.18, 43-46 A recent study using genetic 
variants in a Mendelian randomization approach found little evidence to support strong 
causal intrauterine effects of maternal BMI on offspring adiposity.47 Although we observed a 
tendency for stronger associations of maternal BMI, as compared to paternal BMI, with gen-
eral and abdominal fat measures, the differences between the maternal and paternal effect 
estimates were not statistically significant. These findings may suggest that the associations 
of maternal BMI with offspring adiposity might be explained by shared family-based lifestyle 
and genetic characteristics rather than by intrauterine programming.48
Next to maternal obesity, excessive gestational weight gain also seems to be associated 
with an increased risk of childhood overweight.13-15 In our study, excessive weight gain was as-
sociated with higher BMI and fat mass index. A previous study among 313 mother-child pairs 
reported that higher maternal BMI was associated with higher childhood subcutaneous and 
visceral fat, particularly among mothers with excessive gestational weight gain.16 However, in 
the same cohort as the current study, maternal weight gain in early, mid and late pregnancy 
was not associated with childhood subcutaneous and preperitoneal abdominal fat mass 
levels at 6 years, independently of BMI.17 In our study, total and period-specific weight gain 
was not consistently associated with any MRI adiposity measures. Thus, gestational weight 
gain, contrary to BMI before pregnancy, seems to have a limited influence on offspring organ 
fat in later life.
The mechanisms by which maternal adiposity during pregnancy affects offspring organ fat 
accumulation are not fully known yet. Maternal over-nutrition may affect the development 
of adipocytes and their capacity to expand or contract, the appetite control system and the 
energy metabolism in later life,6 which might lead to increased body fat in the offspring. 
Maternal over-nutrition might also lead to accumulation of fat in the liver and other develop-
ing organs of the fetus, especially during early and mid pregnancy due to the absence of 
adipose tissue.49 The postnatal persistence of increased fat in these depots might be related 
to reduced fatty acid oxidation, changes in lipogenesis and lipoprotein export.49 
Our study shows that higher maternal pre-pregnancy BMI, as opposed to gestational weight 
gain, is related to higher organ fat measures, which have important adverse cardiometabolic 
health consequences. Future preventive strategies focused on promoting a healthy weight 
in women of reproductive age before pregnancy are needed to improve cardiometabolic 
health of the offspring. 
Methodological considerations
Strengths of this study were the large sample size, prospective design and data available 
on multiple maternal weight measurements throughout pregnancy and detailed childhood 
adiposity measures. Of the 4,298 mothers and their singleton children with information on 
pre-pregnancy BMI available, 2,354 had information on MRI adiposity measures at 10 years. 
The non-response could lead to biased effect estimates if the associations of maternal BMI 
and gestational weigh gain with childhood adiposity measures differ between mothers and 
children included and not included in the present analyses. However, this seems unlikely 
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since participants and non-participants did not differ regarding maternal BMI and weight gain 
during pregnancy. We relied on self-reported pre-pregnancy weight and maximum weight 
during pregnancy. Women tend to underestimate their weight on self-report,50 which might 
have led to an underestimation of observed effects for maternal BMI. Since pre-pregnancy 
weight and maximum gestational weight are both self-reported and probably underestimat-
ed, the influence on maximum weight gain is likely to be minimal, which is confirmed by the 
fact that similar results were observed for weight gain measured until late pregnancy. Finally, 
although we adjusted for a large number of potential confounders, residual confounding due 
to lifestyle-related characteristics such as parental and child nutritional intake and physical 
activity might still be present in the observed associations.
ConCluSIonS
Our study suggests that higher maternal BMI, but not gestational weight gain, is associated 
with organ fat accumulation, especially abdominal fat, in the offspring. Our findings empha-
size the importance of promoting a healthy BMI in women who are planning to become 
pregnant rather that influencing weigh gain during pregnancy. 
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SuPPlEMEnTARy MATERIAlS
Figure S1. Selection of study participants
 
 
 
 
 
 
 
 
 
 
 
 
Mothers and singleton children available 
for analysis 
n = 2,354 
 
 
Mothers and singleton children that 
attended the study visit at 10 years 
n = 5,706 
n = 1,944 Excluded: no data on any 
measures of adiposity obtained by 
Magnetic Resonance Imaging at 10 years 
  
 
n = 1,408 Excluded: no data on maternal 
pre-pregnancy body mass index  
Mothers and singleton children with 
information on pre-pregnancy body 
mass index available 
n = 4,298 
Supplemental Methods: Log-log regression analyses
To create measures of adiposity independent of height at 10 years, we estimated the optimal 
adjustment by log-log regression analyses.1 Total fat mass, subcutaneous fat mass, visceral 
fat mass and pericardial fat mass and height were log-transformed, using natural logs. Log-
adiposity measures were regressed on log-height. The regression slope corresponds to the 
power by which height should be raised in order to calculate an index uncorrelated with 
height. Thus, we divided total fat mass by height4, subcutaneous fat mass by height4, visceral 
fat mass by height3, and pericardial fat mass by height3.
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 Table S1. Comparison of subject characteristics between participants and non-participants.1
Characteristics
Participants
(n=2,354)
non-participants
(n=1,944)
P-value
Maternal characteristics
Age, mean (SD), years 31.0 (4.8) 30.6 (5.1) 0.01
Education (higher education), n (%) 1211 (52.5) 887 (46.9) <0.01
Ethnicity (European), n (%) 1532 (65.3) 1256 (64.7) 0.72
Parity (nulliparous), n (%) 1419 (60.3) 1123 (57.9) 0.10
Pre-pregnancy body mass index, median (95% range), kg/m2 22.5 (18.0, 34.9) 22.6 (18.2, 34.2) 0.90
Obesity, n (%) 167 (7.1) 164 (8.4) 0.22
Maximum gestational weight gain, mean (SD), kg 14.8 (5.8) 14.9 (5.5) 0.62
Excessive gestational weight gain (IOM criteria), n (%) 658 (45.0) 416 (42.9) 0.16
Weight in early pregnancy, mean (SD), kg 69.0 (12.9) 68.7 (12.0) 0.47
Weight in mid pregnancy, mean (SD), kg 76.0 (12.6) 75.5 (12.5) 0.17
Weight in late pregnancy, mean (SD), kg 81.6 (12.5) 80.1 (11.8) 0.01
Smoking during pregnancy (yes), n (%) 504 (22.3) 473 (25.5) 0.02
Paternal characteristics
Age, mean (SD), years 33.6 (5.3) 33.1 (5.7) 0.02
Education (higher education), n (%) 953 (56.5) 713 (52.5) 0.02
Ethnicity (European), n (%) 1383 (74.4) 1089 (72.9) 0.36
Body mass index, mean (SD), kg/m2 25.3 (3.3) 25.2 (3.4) 0.33
birth and infant characteristics
Boys, n (%) 1151 (48.9) 986 (50.7) 0.23
Breastfeeding duration, median (95% range), months 3.5 (0.0, 12.0) 3.5 (0.0, 12.0) 0.58
Introduction of solid foods (> 6 months), n (%) 199 (11.3) 99 (9.8) 0.44
Childhood characteristics
Age, mean (SD), years 9.8 (0.3) 9.8 (0.4) 0.02
Television watching time (≥ 2 hours/day), n (%) 575 (30.0) 477 (32.8) 0.09
Body mass index, mean (SD), kg/m2 17.5 (2.6) 17.7 (2.9) 0.04
Total fat mass, median (95% range), g 8,451 (4,549, 21,235) 8,557 (4,505, 23,454) 0.26
1Values are observed data and represent means (SD), medians (95% range) or numbers of subjects (valid %). Differences 
were tested using Student’s t-tests and Mann-Whitney tests for normally and non-normally distributed variables, respec-
tively and χ2-test for dichotomous variables. IOM, Institute of Medicine; SD, standard deviation.
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 Table S2. Correlation coefficients between all measures of adiposity at 10 years (n=2,354)1
Measures of adiposity
Body mass 
index
Fat mass 
index
Subcutaneous 
fat index
Visceral fat 
index
Pericardial 
fat index
Liver fat 
fraction
Body mass index 1 0.81* 0.77* 0.58* 0.31* 0.38*
Fat mass index 0.81* 1 0.95* 0.69* 0.33* 0.42*
Subcutaneous fat index 0.77* 0.95* 1 0.74* 0.35* 0.45*
Visceral fat index 0.58* 0.69* 0.74* 1 0.47* 0.39*
Pericardial fat index 0.31* 0.33* 0.35* 0.47* 1 0.18*
Liver fat fraction 0.38* 0.42* 0.45* 0.39* 0.18* 1
1Values are Spearman correlation coefficients. *P-value<0.01
 Table S3. Maternal body mass index and childhood general and organ fat measures1
Measures of adiposity at 10 years in SDS
body mass 
index
(n=2,354)
Fat mass 
index
(n=2,339)
Subcutaneous 
fat index
(n=2,049)
visceral fat 
index
(n=2,052)
Pericardial 
fat index
(n=2,123)
liver fat 
fraction
(n=2,319)
BMI (kg/m2 in SDS)
0.35 
(0.31, 0.39)*
0.32 
(0.28, 0.36)*
0.30  
(0.26, 0.34)*
0.25 
(0.21, 0.29)*
0.12 
(0.08, 0.16)*
0.18 
(0.14, 0.22)*
Underweight
(<18.5 kg/m2)
-0.44 
(-0.64, -0.24)*
-0.27 
(-0.45, -0.08)*
-0.25 
(-0.44, -0.05)**
-0.35 
(-0.56, -0.15)*
-0.27 
(-0.48, -0.06)**
-0.15 
(-0.36, 0.05)
Normal weight
(18.5 – 24.9 kg/m2)
Reference Reference Reference Reference Reference Reference
Overweight
(25.0 – 29.9 kg/m2)
0.53
(0.43, 0.63)*
0.48 
(0.38, 0.57)*
0.47 
(0.37, 0.57)*
0.36 
(0.26, 0.47)*
0.15 
(0.04, 0.26)*
0.25 
(0.15, 0.35)*
Obesity
(≥30.0 kg/m2)
0.99 
(0.83, 1.14)*
0.95 
(0.81, 1.10)*
0.89 
(0.73, 1.05)*
0.72 
(0.55, 0.88)*
0.42 
(0.25, 0.60)*
0.53 
(0.37, 0.69)*
1Values are regression coefficients (95% Confidence Intervals) from linear regression models that reflect differences in 
childhood outcomes in SDS per SDS change in maternal pre-pregnancy body mass index or for body mass index clinical 
groups as compared to the reference group (normal weight). Model includes child´s sex and age at outcome measure-
ments (except for sex- and age-adjusted body mass index SDS). **P-value<0.05, *P-value<0.01. SDS, standard deviation 
scores.
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Figure S2. Parental body mass index and childhood general and organ fat measures (n=1,795)1
 
1Values are regression coeffi  cients (95% Confi dence Intervals) from linear regression models that refl ect diff erences in 
childhood outcomes in SDS for parental body mass index clinical groups as compared to the reference group (maternal 
and paternal normal weight). Model includes child´s sex and age at outcome measurements (except for sex- and age-
adjusted body mass index SDS). SDS, standard deviation scores.
 Table S4. Maternal gestational weight gain and childhood general and organ fat measures1
Measures of adiposity at 10 years in SDS
body mass 
index
(n=1,462)
Fat mass
 index
(n=1,451)
Subcutaneous 
fat index
(n=1,287)
visceral fat 
index
(n=1,288)
Pericardial 
fat index
(n=1,336)
liver fat 
fraction
(n=1,444)
Maximum weight gain per 
week (kg in SDS)
0.02 
(-0.03, 0.07)
-0.03 
(-0.08, 0.01)
-0.04 
(-0.09, 0.01)
0.00 
(-0.05, 0.06)
0.01 
(-0.04, 0.07)
-0.02 
(-0.07, 0.03)
Insuffi  cient weight gain
-0.06 
(-0.21, 0.08)
0.06 
(-0.07, 0.19)
0.04 
(-0.10, 0.17)
0.00 
(-0.15, 0.15)
0.04 
(-0.11, 0.19)
0.08 
(-0.06, 0.22)
Suffi  cient weight gain Reference Reference Reference Reference Reference Reference
Excessive weight gain
0.21 
(0.10, 0.33)*
0.18 
(0.07, 0.29)*
0.15 
(0.04, 0.26)**
0.20 
(0.08, 0.32)*
0.11
 (-0.01, 0.23)
0.10
 (-0.02, 0.21)
1Values are regression coeffi  cients (95% Confi dence Intervals) from linear regression models that refl ect diff erences in 
childhood outcomes in SDS per SDS change in maternal maximum weight gain per week or for IOM weight gain clini-
cal groups as compared to the reference group (suffi  cient weight gain). Model includes child´s sex and age at outcome 
measurements (except for sex- and age-adjusted body mass index SDS). **P-value<0.05, *P-value<0.01. SDS, standard 
deviation scores.
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 Table S5. Maternal weight gain until late pregnancy and childhood general and organ fat measures1
Measures of adiposity at 10 years in SDS2
body mass 
index
(n=1,316)
Fat mass 
index
(n=1,306)
Subcutaneous 
fat index
(n=1,157)
visceral fat 
index
(n=1,158)
Pericardial 
fat index
(n=1,207)
liver fat 
fraction
(n=1,301)
Weight gain until late 
pregnancy per week (kg in 
SDS)
0.08 
(0.03, 0.13)*
0.02 
(-0.03, 0.07)
0.01 
(-0.04, 0.06)
0.04 
(-0.02, 0.09)
0.02 
(-0.04, 0.08)
0.00 
(-0.05, 0.06)
Insufficient weight gain
-0.13 
(-0.28, 0.02)
-0.05 
(-0.19, 0.08)
-0.02 
(-0.16, 0.12)
-0.04 
(-0.19, 0.12)
0.06 
(-0.11, 0.22)
0.04 
(-0.11, 0.18)
Sufficient weight gain Reference Reference Reference Reference Reference Reference
Excessive weight gain
0.18 
(0.06, 0.30)*
0.14 
(0.03, 0.25)**
0.14 
(0.02, 0.25)**
0.19 
(0.06, 0.31)*
0.12 
(-0.01, 0.25)
0.07 
(-0.05, 0.19)
MRI measures of adiposity at 10 years in SDS 
conditional on body mass index3
Subcutaneous 
fat index
(n=1,157)
visceral fat 
index
(n=1,158)
Pericardial 
fat index
(n=1,207)
liver fat 
fraction
(n=1,301)
Weight gain until late 
pregnancy per week (kg in 
SDS)
-0.09 
(-0.14, -0.04)*
-0.01 
(-0.07, 0.05)
0.00 
(-0.06, 0.06)
-0.03 
(-0.08, 0.02)
Insufficient weight gain
0.13 
(0.00, 0.27)
0.06 
(-0.10, 0.21)
0.11 
(-0.06, 0.27)
0.10 
(-0.05, 0.25)
Sufficient weight gain Reference Reference Reference Reference
Excessive weight gain
0.01 
(-0.10, 0.12)
0.11 
(-0.01, 0.24)
0.07 
(-0.06, 0.20)
0.01 
(-0.11, 0.13)
1Estimates are based on multiple imputed data. Model includes child´s sex and age at outcome measurements (except 
for sex- and age-adjusted body mass index SDS), maternal age, educational level, ethnicity, parity, smoking habits during 
pregnancy, and child’s breastfeeding duration, timing of introduction of solid foods and television watching time. Models 
for weight gain until late pregnancy per week were additionally adjusted for pre-pregnancy body mass index. **P-val-
ue<0.05, *P-value<0.01. 2Values are regression coefficients (95% Confidence Intervals) from linear regression models that 
reflect differences in childhood outcomes in SDS per SDS change in maternal weight gain until late pregnancy per week 
or for IOM weight gain clinical groups as compared to the reference group (sufficient weight gain). 3Values are regression 
coefficients (95% Confidence Intervals) from linear regression models that reflect differences in the standardized residuals 
of the childhood outcomes (obtained by conditional regression analyses on body mass index at 10 years) per SDS change 
in maternal weight gain until late pregnancy per week or for IOM weight gain clinical groups as compared to the reference 
group (sufficient weight gain). SDS, standard deviation scores.
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Figure S3. Maternal pre-, early, mid, and late pregnancy weight with childhood general and organ fat mea-
sures (n=1,121)1
 
1Values are regression coeffi  cients (95% Confi dence Intervals) from linear regression models that refl ect diff erences in 
childhood outcomes in SDS per SDS change in maternal pre-pregnancy weight and per change in standardized residuals 
of maternal early, mid, and late pregnancy weight obtained from conditional regression analyses. Model includes child´s 
sex and age at outcome measurements (except for sex- and age-adjusted body mass index SDS). SDS, standard deviation 
scores.
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AbSTRACT
background: We compared the accuracy of body fat patterns and single measures in assess-
ing body fat and clarified the use of indices based on waist circumference as measures of 
adiposity in children. 
Methods: This study included 2531 7-year-old children from the Generation XXI birth cohort 
(Porto, Portugal). Anthropometrics were obtained by trained personnel and body fat patterns 
were identified by principal component analysis. Whole-body dual energy X-ray absorptiom-
etry (DXA) scans were performed. Pearson´s correlation coefficients of the scores obtained by 
principal component analysis and the single measures with DXA-fat mass index and -central 
fat were obtained.
Results: Principal component analysis identified two body fat patterns, similar by sex and 
explaining 88.3% of total variance. Pattern 1 (body mass index, fat mass index from tetra-polar 
bioelectric impedance and waist-to-height ratio) showed stronger correlations with DXA-fat 
mass index (r=0.85, p<0.001) and pattern 2 (waist-to-hip, waist-to-thigh and waist-to-weight 
ratios) showed stronger correlations with DXA-central fat (r=0.35, p<0.001). As compared to 
single measures, body fat patterns showed similar correlations with DXA-derived measures.
Conclusions: As compared to single anthropometric indices, body fat patterns seem to add 
little value for estimating body fat in children. Waist-to-height ratio seems to be a proxy for 
total fat, while waist-to-hip, waist-to-thigh and waist-to-weight ratios seem to be proxies 
for central fat. Further studies should address the predictive ability of waist-to-weight ratio 
to identify children at risk of developing cardiometabolic disease, as this was the first time 
describing its potential usefulness.
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InTRoDuCTIon
Epidemiologic studies on childhood obesity often use proxies and single measures for its 
definition, which might have limited their ability to detect associations.1 The combination 
of anthropometric indices into robust body fat patterns could be a more accurate and yet 
simple approach of evaluating childhood obesity. However, no study has addressed whether 
body fat patterns are more accurate than single measures for assessing body fat in children. 
Another drawback of most previous studies is related to the use of waist circumference as 
proxy for central fat. Waist circumference has been more strongly correlated with body mass 
index (BMI) and total body fat than with abdominal visceral fat and thus should be considered 
a marker of total fat, rather than of central fat.2, 3 This evidence raises doubts about the use of 
indices based on waist circumference, such as waist-to-height ratio, as proxies for central fat, 
but no study has addressed this to date. 
We aimed to compare the accuracy of body fat patterns and single measures for assessing 
body fat and to clarify the use of indices based on waist circumference as measures of adipos-
ity in children.
METHoDS
This study included participants from the population-based birth cohort Generation XXI that 
was assembled during 2005-2006 at all public maternity units of Porto, Portugal.4 Of 5849 
children who attended the face-to-face interviews at 7 years old, 5719 children had anthro-
pometrics and tetra-polar bioelectric impedance available. A sub-sample of 2531 children 
had whole-body dual energy X-ray absorptiometry (DXA) measurements (47.6% females). 
As compared to children without DXA measurements (n=3188), those children with DXA 
measurements (n=2531) were slightly younger [mean (standard deviation, SD)=6.7 (0.49) vs. 
6.9 (0.36) years old] and had a lower BMI [mean (SD)=16.9 (2.45) vs. 17.1 (2.55) kg/m2]. Although 
these differences were statistically significant, the magnitude of the differences was small. No 
differences were observed for child’s sex and for the other anthropometric indices. All phases 
of the study complied with the Ethical Principles for Medical Research Involving Human 
Subjects expressed in the Declaration of Helsinki. The study was approved by the University 
of Porto Medical School/ S. João Hospital Centre Ethics Committee and a signed informed 
consent according Helsinki was required for all participants.
Anthropometrics were obtained by trained personnel with children in underwear and 
barefoot, according to standard procedures.5 Body weight was measured to the nearest 0.1 
kg using a digital scale (TANITA®) and height was measured to the nearest 0.1 cm using a wall 
stadiometer (SECA®). Waist circumference was measured at the umbilicus level, with abdo-
men relaxed and hip circumference at the level of the greatest posterior protuberance of the 
buttocks; both were measured to the nearest 0.1 cm, with the child in a standing position, 
arms at the sides and feet positioned together. Thigh circumference was measured to the 
nearest 0.1cm around the mid-thigh and perpendicular to the long axis of the thigh, with 
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the leg slightly flexed. The inter-observer variability in anthropometric measurements was 
assessed comparing a subset of measurements made by each interviewer. The inter-observer 
variability adjusted for child’s age was close to zero for all anthropometrics, showing no dif-
ferences between interviewers. 
Body mass index was calculated as the value of weight (kg) over the squared height (m). 
Waist-to-height ratio, waist-to-hip ratio and waist-to-thigh ratio were calculated as waist 
circumference divided by height, hip and thigh circumferences, respectively. The relationship 
between waist circumference and weight was assessed using a log-log regression analysis, 
which gave a slope of 0.5, corresponding to the value by which weight should be raised in 
order to calculate a measure uncorrelated with it. Waist-to-weight ratio was calculated, for 
the first time in the literature, as waist circumference/weight0.5.
Tetra-polar bioelectric impedance analysis was performed (BIA 101 Anniversary, Akern, 
Florence, Italy). Fat free mass was determined using Schaefer et al. equation and fat mass was 
derived accordingly.6 Fat mass/height2 was calculated to obtain the fat mass index (BIA-FMI), 
in which fat mass was effectively uncorrelated with height.
Whole-body DXA scans were performed (QDR 4500A; Hologic, Bedford, MA, USA). Fat 
mass/height4 was calculated and was effectively uncorrelated with height. Central fat was 
assessed as trunk fat. Fat mass obtained from bioelectric impedance and DXA was compared. 
Pearson´s correlation coefficient was strong (r=0.89, p<0.001) and an intraclass correlation 
coefficient using an absolute agreement definition of 58.7% was obtained through a two-way 
mixed effects model, showing reasonable accuracy of bioelectric impedance analysis. 
Principal component analysis was applied to BMI, waist-to-height ratio, waist-to-hip ratio, 
waist-to-thigh ratio, waist-to-weight ratio, and BIA-FMI. Factors with eigenvalues ≥1.0 were 
retained and varimax rotation was performed. Factor loadings>0.30 were used in the inter-
pretation of factors. The scores were calculated using the regression method with standard-
ized scores. Pearson´s correlation coefficients of the scores obtained by principal component 
analysis and the single measures with DXA-FMI and -central fat were obtained. Analyses were 
conducted using R® version 3.0.1 and SPSS 21.0 (SPSS Inc. 2004, Chicago, IL, USA).
RESulTS
Characteristics of participants are shown in Table 1. Two independent body fat patterns, 
which explained 88.3% of total variance, were identified: a pattern 1 characterized by BMI, 
BIA-FMI and waist-to-height ratio and a pattern 2 characterized by waist-to-hip, waist-to-
thigh and waist-to-weight ratios (Table 2). No sex differences in the body fat patterns were 
observed (data not shown). Pattern 1 (Fat quantity) presented a stronger correlation with 
DXA-FMI (r=0.85, p<0.001) while pattern 2 (Fat distribution) presented a stronger correlation 
with DXA-central fat (r=0.35, p<0.001) (Table 3). The magnitude of the correlations with DXA-
derived measures was similar for body fat patterns and single measures. Waist-to-height 
ratio presented a stronger correlation with DXA-FMI (r=0.82, p<0.001) while waist-to-thigh 
ratio presented a stronger correlation with DXA-central fat (r=0.30, p<0.001). Waist-to-hip 
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and waist-to-weight ratios were similarly correlated with both DXA-derived measures. No sex 
differences in the associations of body fat patterns and single measures with DXA-derived 
measures were observed (data not shown). 
Table 1. Characteristics of study participants (n=2531)1
Child´s characteristics Mean (SD)
    Age, years 6.7 (0.49)
    Body mass index, kg/m2 16.9 (2.45)
    BIA-fat mass index, kg/m2 3.1 (2.27)
    Waist-to-height ratio  0.5 (0.05)
    Waist-to-hip ratio 0.9 (0.04)
    Waist-to-thigh ratio 1.6 (0.10)
    Waist-to-weight ratio, cm/√kg 10.2 (0.47)
    DXA-fat mass index, kg/m4 3.7 (1.32)
    DXA-central fat, kg 3.3 (1.71)
1BIA, bioelectric impedance analysis; DXA, dual energy X-ray absorptiometry; SD, standard deviation.
Table 2. Factor loadings, obtained from principal component analysis, for anthropometric and bioelectric 
impedance measures (n=5719)1
Factor loadings
Pattern 1 Pattern 2 
Body mass index, kg/m2 0.98 0.05
BIA-fat mass index, kg/m2 0.94 0.06
Waist-to-height ratio 0.87 0.45
Waist-to-hip ratio 0.28 0.88
Waist-to-thigh ratio -0.04 0.89
Waist-to-weight ratio, cm/√kg 0.20 0.90
Variance explained 45.3% 43.0%
Cumulative variance explained 45.3% 88.3%
1BIA, bioelectric impedance analysis.
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Table 3. Pearson´s correlation coefficients of body fat patterns and single measures with DXA-derived mea-
sures in children (n=2531)1
DXA-fat mass index, kg/m4 DXA-central fat, kga
Pattern 1 - Fat quantity 0.85 (p<0.001) 0 (p=0.879)
Pattern 2 - Fat distribution 0.10 (p<0.001) 0.35 (p<0.001)
Body mass index, kg/m2 0.83 (p<0.001) 0.08 (p<0.001)
BIA-fat mass index, kg/m2 0.80 (p<0.001) -0.02 (p=0.305)
Waist-to-height ratio 0.82 (p<0.001) 0.28 (p<0.001)
Waist-to-hip ratio 0.27 (p<0.001) 0.31 (p<0.001)
Waist-to-thigh ratio 0.02 (p=0.462) 0.30 (p<0.001)
Waist-to-weight ratio, cm/√kg 0.35 (p<0.001) 0.33 (p<0.001)
1BIA, bioelectric impedance analysis; DXA, dual energy X-ray absorptiometry.
aadjusted for total fat mass.
DISCuSSIon
Pattern 1 combines well-known measures of total adiposity (BMI and BIA-FMI) and pattern 
2 combines measures of regional adiposity (waist-to-hip ratio and waist-to-thigh ratio) and 
seem to represent fat quantity and distribution, respectively. This is corroborated by the stron-
ger correlations between pattern 1 and DXA-FMI and between pattern 2 and DXA-central fat. 
Nonetheless, both body fat patterns showed similar correlations with DXA-derived measures 
as compared to single measures. Body fat patterns seem to add little value for estimating 
body fat in children. Fat distribution, either using patterns or single measures, seems to be 
poorer measured as compared to fat quantity.
Anthropometric indices based on waist circumference may represent both fat quantity 
and distribution, which may raise controversial findings in population-based settings. In our 
study, waist-to-height ratio was stronger correlated with DXA-FMI while waist-to-thigh ratio 
was stronger correlated with DXA-central fat and thus seem to be proxies for total and central 
fat, respectively. Although waist-to-hip ratio and waist-to-weight ratio were similarly corre-
lated with both DXA-derived measures, their correlations with DXA-FMI were much weaker as 
compared to BMI, BIA-FMI and waist-to-height ratio while their correlations with DXA-central 
fat were similar as compared to waist-to-thigh ratio and thus might be reasonable proxies 
for central fat. Waist-to-thigh ratio seems to be the measure of central fat less correlated with 
total fat. Waist circumference showed similar findings as compared to waist-to-height ratio 
(data not shown).
Measurements of waist circumference require adjustment for body height or weight if 
comparisons between individuals, or within individuals over time, are to be meaningful. 
Previous studies showed that shorter subjects had a higher cardiometabolic risk than taller 
subjects with similar waist circumference, which contributed to the definition of waist-to-
height ratio as another proxy for central adiposity.7 The correction of waist circumference for 
111
Anthropometric indices in children
height allows that a single cut-off level may be used in different ethnic, age and sex groups8 
while waist circumference requires sex- and population-specific cut-off levels to account for 
the effect of height on metabolic risk within different populations.9 However, adjustment 
of waist circumference for height seems not enough to distinguish children according to 
their fat distribution. Two hypothetical children of identical height might have different waist 
circumference due to different body weights. Thus, waist-to-height ratio remains influenced 
by body weight and, like waist circumference, is a better index of total adiposity rather 
than of central adiposity, as corroborated by our findings. Previous studies have discussed 
whether waist circumference adjusted for BMI is a better predictor of visceral fat in adults as 
compared to waist circumference and have reported contradictory results.10, 11 In our sample 
of 7-year-old children, height explains 3.9% while weight explains 83.4% of the variance of 
waist circumference, and thus adjustment for weight seems to be appropriate in order to 
obtain an accurate measure of central adiposity. Waist circumference can be adjusted for 
weight as waist circumference/weightp, where p is the appropriate power by which to raise 
weight in order to obtain an index uncorrelated with it. As compared to waist-to-hip ratio 
and waist-to-thigh ratio, the other measures of fat distribution in our study, waist-to-weight 
ratio might be easier to obtain and less likely to measurement error in most age groups. This 
was the first time suggesting waist-to-weight ratio as a proxy for central fat, and thus further 
studies are needed to address its predictive ability to identify children at risk of developing 
cardiometabolic disease. 
Some strengths and limitations should be considered. Major strengths of this study are the 
population-based design with detailed childhood body fat measurements available. We re-
lied on anthropometric measurements, which might have greater measurement error and be 
less accurate, but on the other hand be easier and cheaper to obtain in large epidemiological 
studies as compared to imaging techniques of body composition.12 In this study, we have also 
used DXA, which is an imaging technique that quantifies total and regional body fat content 
with high precision.12 Of the 5719 children with anthropometrics and tetra-polar bioelectric 
impedance available, 2531 children had DXA measurements. However, the non-response is 
unlikely to lead to biased effect estimates since children with and without DXA measure-
ments did not differ regarding sex, age and the anthropometric indices.
In conclusion, this study suggests that body fat patterns, as compared to single anthropo-
metric indices, add little value for estimating body fat quantity and distribution in children. 
Waist-to-height ratio seems to be a proxy for total fat (and not for central fat, as suggested 
in previous studies), while waist-to-hip, waist-to-thigh and waist-to-weight ratios seem to be 
proxies for central fat. Waist-to-weight ratio is a promising proxy for abdominal fat distribu-
tion, with population-based advantages over other measures, that warrants further research.
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Subcutaneous fat mass in infancy and 
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AbSTRACT
background: Skinfold thickness enables the measurement of overall and regional sub-
cutaneous fatness in infancy and may be associated with total and abdominal body fat in 
later childhood. We examined the associations of subcutaneous fat in infancy with total and 
abdominal fat at school-age.
Methods: In a population-based prospective cohort study among 821 children, we calcu-
lated total subcutaneous fat (sum of biceps, triceps, suprailiacal and subscapular skinfold 
thicknesses) and central-to-total subcutaneous fat ratio (sum of suprailiacal and subscapular 
skinfold thicknesses/total subcutaneous fat) at 1.5 and 24 months. At 6 years, we measured 
fat mass index (total fat/height3), central-to-total fat ratio (trunk fat/total fat) and android-to-
gynoid fat ratio (android fat/gynoid fat) by dual-energy X-ray absorptiometry and preperito-
neal fat mass area by abdominal ultrasound. 
Results: Central-to-total subcutaneous fat ratio at 1.5 months was positively associated with 
fat mass index and central-to-total fat ratio at 6 years, whereas both total and central-to-total 
subcutaneous fat ratio at 24 months were positively associated with all childhood adiposity 
measures. A 1-standard-deviation scores higher total subcutaneous fat at 24 months was 
associated with an increased risk of childhood overweight (Odds Ratio 1.70 [95% Confidence 
Interval 1.36, 2.12]). These associations were weaker than those for body mass index and 
stronger among girls than boys.    
Conclusions: Subcutaneous fat in infancy is positively associated with total and abdominal 
fat at school-age. Our results also suggest that skinfold thicknesses add little value to esti-
mate later body fat, as compared to body mass index.  
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InTRoDuCTIon
Infancy seems to be a critical period for the development of obesity.1 An accumulating body 
of evidence has suggested that nutrition and growth in infancy are related to the risk of 
obesity in later life.2, 3 Also, infant growth patterns seem to be related not only to body mass 
index, but also to an adverse body fat distribution.4, 5 Several studies have shown that com-
pared to body mass index, body fat distribution plays a greater role in the development of 
obesity-related complications, such as cardiovascular disease and type 2 diabetes.6 Although 
previous studies have suggested that central fat mass tracks moderately from mid-childhood 
into adulthood,7-10 it is not known whether body fat distribution measures in infancy are as-
sociated with similar measures in later childhood.
Skinfold thickness is a valid measurement of subcutaneous fat mass that enables assess-
ment of overall and regional fatness in infancy.11 Previously, we reported the tracking of sub-
cutaneous fat mass measured by skinfold thickness during the first 2 years of life.12 Assessing 
the associations of these specific fat mass measures during infancy with fat mass measures 
during childhood helps to further understand the stability of body fat across childhood. Also, 
skinfold thickness measurements in infancy may be associated with an adverse body fat pat-
tern in later childhood. 
Therefore, we examined, in a population-based prospective cohort study among 821 chil-
dren, the associations of infant subcutaneous fat mass measures with total and abdominal fat 
mass measures and with the risk of overweight at school-age. 
METHoDS
Study design
This study was embedded in the Generation R Study, a population-based prospective cohort 
study from early pregnancy onwards among 9778 mothers and their children living in Rot-
terdam, the Netherlands.13 The study was approved by the local Medical Ethical Committee. 
Written informed consent was obtained from all mothers. Additional detailed assessments of 
fetal and postnatal growth and development were conducted in a subgroup of Dutch moth-
ers and their children from late pregnancy onwards. Of all approached women, 80% agreed 
to participate. Of the total of 1205 singleton children participating in the subgroup study, 
965 children had body mass index or skinfold thicknesses measured at the age of 1.5 or 24 
months. Of the group of 965 children, 821 children had follow-up measurements at the age of 
6 years (Flow chart is given in Supplemental Figure S1). 
body fat measurements during infancy
We measured weight to the nearest gram in naked infants at the age of 1.5 months by using an 
electronic infant scale and at 24 months by using a mechanical personal scale (SECA, Almere, 
the Netherlands). Body length at the age of 1.5 months was measured in supine position to 
the nearest millimeter by using a neonatometer and body height at 24 months was measured 
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in standing position by using a Harpenden stadiometer (Holtain Limited, Dyfed, UK). Body 
mass index (kg/m2) was calculated.
We measured skinfold thicknesses at the ages of 1.5 and 24 months on the left side of the 
body at the biceps, triceps, suprailiacal and subscapular area by using a skinfold caliper (Slim 
Guide, Creative Health Products) according to standard procedures.12 We calculated total 
subcutaneous fat mass from the sum of all four skinfold thicknesses, and central subcutane-
ous fat mass from the sum of suprailiacal and subscapular skinfold thicknesses.14, 15 To create 
total subcutaneous fat mass independent of length or height and central subcutaneous fat 
mass independent of total subcutaneous fat mass, we estimated the optimal adjustment by 
log-log regression analyses.16 Details of these regressions are given in the Supplemental 
Methods. Total subcutaneous fat mass was only weakly correlated with length or height, and 
was not adjusted for it whereas a central-to-total subcutaneous fat mass ratio was calculated 
as central divided by total subcutaneous fat mass.  
body fat measurements at school-age
Measurements were performed in a dedicated research center by a well-trained staff.4 We 
measured height to the nearest millimeter by using a Harpenden stadiometer (Holtain 
Limited, Dyfed, UK) and weight to the nearest gram by using a mechanical personal scale 
(SECA, Almere, the Netherlands) in standing position without shoes and heavy clothing. We 
calculated body mass index (kg/m2), and defined overweight and obesity as described by 
Cole et al.17 
We measured total and regional body fat mass using a DXA scanner (iDXA, GE-Lunar, 2008, 
Madison, WI, USA, enCORE software v.12.6), according to standard procedures.4 Previous 
studies have validated DXA against computed tomography for body fat assessment.18-20 We 
divided total fat mass by height3 in order to obtain a fat mass index uncorrelated with height, 
as confirmed by a log-log regression analysis.16, 21 We assessed central fat mass as fat mass of 
the trunk, and divided by total fat mass in order to obtain a central-to-total fat mass ratio 
effectively uncorrelated with total fat mass. We calculated the ratio of android and gynoid 
fat mass, which reflects the relation between fat mass in the abdomen (android) and hip 
(gynoid) regions. 
Abdominal preperitoneal fat mass, as a proxy for visceral fat mass, was measured by ab-
dominal ultrasound (GE LOGIQ E9, Milwaukee, WI, USA), as described previously.22 Briefly, a 
linear (L12-5 MHz) transducer was placed perpendicular to the skin surface on the median 
upper abdomen.23 We scanned longitudinally from the xiphoid process to the navel along 
the midline (linea alba). Preperitoneal fat mass area was measured as the area of 2 cm length 
along the midline starting from the reference point in direction of the navel. 
Covariates
Information on maternal age, educational level, parity, pre-pregnancy weight and smoking 
habits during pregnancy was assessed using self-reported questionnaires during pregnancy. 
We measured maternal height at enrolment, and calculated pre-pregnancy body mass index 
(kg/m2). Information about child’s sex, gestational age and weight at birth was obtained from 
119
Body fat in infants and children
medical records. Information about breastfeeding duration, timing of introduction of solid 
foods and average television watching time at 6 years old was obtained by questionnaires. 
Statistical analysis 
We examined differences between boys and girls for maternal and child’s characteristics with 
Student’s t-tests and Mann-Whitney tests for normally and non-normally distributed variables, 
respectively and with χ2-test for dichotomous variables. We used Pearson’s or Spearman’s 
rank correlation coefficients to estimate correlations of subcutaneous fat mass measures at 
1.5 or 24 months with total and abdominal fat mass measures at 6 years. We assessed the 
associations of infant subcutaneous fat mass measures with childhood total and abdominal 
fat mass measures using linear regression models and with the risk of childhood overweight 
using logistic regression models. These regression models were adjusted for maternal age, 
educational level, parity, pre-pregnancy body mass index and smoking habits during preg-
nancy, and child’s gestational age-adjusted birth weight SDS, breastfeeding duration, timing 
of introduction of solid foods, and TV watching time. We included covariates in the models 
when they changed the effect estimates substantially (>10%), or when they were strongly 
associated with body fat mass in our or previous studies. Since we observed statistically 
significant interactions between infant subcutaneous fat mass measures and child’s sex in 
the association with childhood total and abdominal fat mass measures, we performed all 
analyses for the total group and for boys and girls separately. No significant interactions 
were observed with body mass index categories at 1.5 or 24 months. We constructed SDS 
[(observed value - mean)/SD] for all continuous body fat measures at each age to take into 
account the expected changes in body composition and fat distribution across ages and also 
to enable comparisons in effect size for different exposure and outcome measures. Missing 
values in covariates (ranging from 0 to 15%) were multiple-imputed, by using Markov chain 
Monte Carlo approach. Five imputed datasets were created and analyzed together. We per-
formed statistical analyses using the Statistical Package of Social Sciences version 21.0 for 
Windows (SPSS Inc, Chicago, IL, USA).
RESulTS
Subject characteristics
Tables 1 and 2 show the subject characteristics. Boys had higher body mass index, whereas 
girls had higher central-to-total subcutaneous fat mass ratio at 1.5 months and a higher 
total subcutaneous fat mass and central-to-total subcutaneous fat mass ratio at 24 months 
(p<0.05). At 6 years, girls had higher fat mass index, central-to-total fat mass ratio, and ab-
dominal preperitoneal fat mass area than boys (p<0.05). Supplemental Table S2 gives all 
subcutaneous fat mass measures at 1.5 and 24 months. Non-response analyses showed that 
as compared to children who did not participate in the follow-up studies, those who did 
participate were born with a higher weight and gestational age at birth and were breastfed 
for a longer period (p<0.05). (Supplemental Table S3).
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Table 1. Characteristics of study participants1
Total group 
(n = 821)
boys (n = 412) Girls (n = 409) P-value
Maternal characteristics
  Age (years), mean (SD) 32.0 (3.9) 31.8 (3.9) 32.1 (3.8) 0.346
  Highest completed education, n (%)
     Primary school 10 (1.2) 3 (0.7) 7 (1.7) 0.428
     Secondary school 265 (32.3) 135 (32.8) 130 (31.8)
     Higher education 546 (66.5) 274 (66.5) 272 (66.5)
  Parity, n (%) primiparae 522 (63.6) 262 (63.6) 260 (63.6) 0.995
  Pre-pregnancy body mass index (kg/m2), mean (SD) 23.5 (4.0) 23.4 (4.0) 23.7 (4.0) 0.208
  Smoking habits during pregnancy, n (%) yes 175 (21.3) 87 (21.1) 88 (21.5) 0.776
Child’s characteristics
  Sex, % 412 (50.2) 409 (49.8)
  Birth weight (g), mean (SD) 3533 (522) 3588 (503) 3477 (536) 0.002
   Gestational age at birth (weeks), median (95% 
range)
40.3 (36.3-42.4) 40.3 (36.5-42.4) 40.3 (36.0-42.4) 0.710
  Breastfeeding duration (months), mean (SD) 4.8 (3.8) 4.7 (3.7) 4.9 (3.9) 0.442
  Introduction of solid foods, n (%)
     <3 months 47 (5.7) 23 (5.6) 24 (5.9) 0.885
     3 to 6 months 631 (76.9) 316 (76.7) 315 (77.0)
     >6 months 143 (17.4) 73 (17.7) 70 (17.1)
  TV watching time, n (%)  ≥ 2 hours/day 76 (9.3) 45 (10.9) 31 (7.6) 0.131
1Values are expressed as means (SD), medians (95% range) or numbers of subjects (%). The values represent the pooled 
results after multiple imputation. Observed data are given in Supplemental Table S1. SD, standard deviation.
Table 2. Body fat at 1.5 and 24 months by skinfold thicknesses and at 6 years old by dual-energy X-ray 
absorptiometry and abdominal ultrasound1
Total group boys Girls P-value
1.5 months n = 742 n = 372 n = 370
    Age (months), mean (SD) 1.6 (0.4) 1.6 (0.4) 1.6 (0.5) 0.340
    Body mass index (kg/m2), mean (SD) 15.1 (1.4) 15.3 (1.5) 15.0 (1.3) 0.001
    Total subcutaneous fat mass (mm), mean (SD) 23.9 (7.1) 23.8 (7.0) 24.0 (7.1) 0.705
     Central-to-total subcutaneous fat mass ratio, mean 
(SD)
0.50 (0.05) 0.49 (0.05) 0.51 (0.05) <0.001
24 months n = 746 n = 381 n = 365
    Age (months), mean (SD) 25.2 (1.1) 25.3 (1.1) 25.2 (1.1) 0.408
    Body mass index (kg/m2), mean (SD) 15.9 (1.3) 16.0 (1.3) 15.9 (1.3) 0.145
    Total subcutaneous fat mass (mm), mean (SD) 27.4 (7.5) 26.7 (7.2) 28.1 (7.7) 0.012
     Central-to-total subcutaneous fat mass ratio, mean 
(SD)
0.43 (0.06) 0.42 (0.06) 0.44 (0.06) 0.001
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body fat from infancy to childhood
The crude correlations of infant subcutaneous fat mass measures at 1.5 or 24 months with 
total and abdominal fat mass measures at 6 years old for the total group and by sex are 
shown in Supplemental Tables S4 and S5, respectively.  
A 1-standard-deviation scores (SDS) higher body mass index at 1.5 months was only associ-
ated with a 0.16 [95% Confidence Interval (CI) 0.09, 0.24] SDS increase in body mass index at 
6 years (Table 3). A 1-SDS higher central-to-total subcutaneous fat mass ratio at 1.5 months 
was associated with a 0.12 [95% CI 0.05, 0.19] SDS increase in fat mass index and a 0.11 [95% 
CI 0.04, 0.18] SDS increase in central-to-total fat mass ratio at 6 years. No other associations 
of fat mass at 1.5 months with fat outcomes at 6 years were observed. Also, no sex differences 
were observed. 
A 1-SDS higher body mass index at 24 months was associated with an increase of 0.48 [95% 
CI 0.42, 0.54] SDS in body mass index, 0.33 [95% CI 0.26, 0.40] SDS in fat mass index, 0.18 [95% 
CI 0.11, 0.26] SDS in central-to-total fat mass ratio, and 0.16 [95% CI 0.08, 0.23] SDS in android-
to-gynoid fat mass ratio (Table 4). A 1-SDS higher total subcutaneous fat mass at 24 months 
was associated with an increase of 0.30 [95% CI 0.23, 0.37] SDS in body mass index, 0.36 [95% 
CI 0.29, 0.43] SDS in fat mass index, 0.28 [95% CI 0.20, 0.35] SDS in central-to-total fat mass 
ratio, 0.23 [95% CI 0.16, 0.31] SDS in android-to-gynoid fat mass ratio and 0.19 [95% CI 0.12, 
0.26] SDS in preperitoneal fat mass area. The associations of central-to-total subcutaneous fat 
mass ratio at 24 months with fat mass measures at 6 years were also significant but weaker. 
The associations tended to be stronger among girls than among boys. 
Table 2. Body fat at 1.5 and 24 months by skinfold thicknesses and at 6 years old by dual-energy X-ray ab-
sorptiometry and abdominal ultrasound1 (continued)
Total group boys Girls P-value
6 years 
    Age (years), mean (SD)
n = 821 n = 412 n = 409
6.0 (0.3) 6.0 (0.3) 6.0 (0.2) 0.450
    Body mass index (kg/m2), mean (SD) 15.9 (1.4) 15.9 (1.3) 15.9 (1.5) 0.955
    Overweight and obese (IOTF), n (%) 88 (10.7) 34 (8.3) 54 (13.2) 0.023
    Fat mass index (kg/m3), mean (SD) 3.2 (0.8) 2.9 (0.7) 3.4 (0.9) <0.001
    Central-to-total fat mass ratio, mean (SD) 0.33 (0.04) 0.32 (0.03) 0.34 (0.04) <0.001
    Android-to-gynoid fat mass ratio, mean (SD) 0.24 (0.05) 0.24 (0.05) 0.25 (0.06) 0.089
    Preperitoneal fat mass area (cm²),  median (95% 
range)
0.4 (0.2-0.9) 0.3 (0.2-0.7) 0.4 (0.2-1.0) <0.001
1Values are expressed as means (SD), medians (95% range) or numbers of subjects (valid %). Body mass index = weight/
height2. Total subcutaneous fat mass = biceps + triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total 
subcutaneous fat mass ratio = (suprailiacal + subscapular skinfold thicknesses)/total subcutaneous fat mass. Fat mass in-
dex = total fat mass/height3. Central-to-total fat mass ratio = trunk fat mass/total fat mass. Android-to-gynoid fat mass ratio 
= android fat mass/gynoid fat mass. IOTF, International Obesity Task Force. SD, standard deviation. 
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Infant body fat and risk of childhood overweight 
A 1-SDS higher body mass index at 1.5 months was associated with an increased risk of over-
weight at 6 years (Odds Ratio (OR) 1.40 [95% CI 1.08, 1.81]) (Figure 1), whereas a 1-SDS higher 
central-to-total subcutaneous fat mass ratio at 1.5 months was associated with an increased 
risk of overweight at 6 years among girls only (OR 1.61 [95% CI 1.09, 2.38]). A 1-SDS higher body 
Table 3. Associations of subcutaneous fat mass measures at 1.5 months with total and abdominal fat mass 
at 6 years old1-3
Fat mass measures at 1.5 
months
Fat mass measures at 6 years in standard-deviation scores
 Difference [95% Confidence Interval]
body mass 
index
Fat mass 
index
Central-to-
total fat mass 
ratio
Android-to- 
gynoid fat mass 
ratio
Preperitoneal 
fat mass area
Total group
Body mass index 
0.16
[0.09,0.24]**
0.05
[-0.03,0.12]
-0.03
[-0.11,0.05]
0.04
[-0.04,0.12]
0.05
[-0.03,0.13]
Total subcutaneous fat mass 
0.06
[-0.02,0.13]
0.05
[-0.02,0.13]
0.01
[-0.07,0.09]
0.01
[-0.07,0.09]
0.05
[-0.02,0.12]
Central-to-total  subcutaneous  
fat mass ratio 
0.04
[-0.02,0.12]
0.12
[0.05,0.19]**
0.11
[0.04,0.18]**
0.07
[0.00,0.14]
0.07
[-0.01,0.14]
boys
Body mass index 
0.25
[0.14,0.36]**
0.21
[0.09,0.33]**
0.10
[-0.02,0.22]
0.13
[0.02,0.25]*
0.20
[0.07,0.33]**
Total  subcutaneous fat mass 
0.12
[0.01,0.23]*
0.07
[-0.04,0.19]
0.09
[-0.03,0.20]
0.03
[-0.08,0.14]
0.14
[0.02,0.26]*
Central-to-total  subcutaneous  
fat mass ratio 
0.03
[-0.08,0.13]
0.07
[-0.03,0.18]
0.06
[-0.05,0.16]
0.07
[-0.04,0.17]
0.01
[-0.11,0.13]
Girls
Body mass index 
0.08
[-0.02,0.18]
0.02
[-0.08,0.12]
-0.06
[-0.16,0.05]
-0.03
[-0.14,0.08]
0.02
[-0.09,0.12]
Total  subcutaneous  fat mass 
-0.01
[-0.11,0.09]
0.01
[-0.10,0.11]
-0.08
[-0.19,0.03]
-0.02
[-0.13,0.09]
-0.03
[-0.13,0.06]
Central-to-total  subcutaneous  
fat mass ratio 
0.08
[-0.01,0.18]
0.10
[0.01,0.20]*
0.09
[-0.01,0.19]
0.06
[-0.04,0.17]
0.06
[-0.03,0.16]
1Values are standardized regression coefficients [95% confidence interval] and represent the difference in standard-devia-
tion scores for fat mass measures at 6 years per 1-standard-deviation scores increase in body mass index and subcutaneous 
fat mass measures at 1.5 months. Body mass index = weight/height2. Total subcutaneous fat mass = biceps + triceps + 
suprailiacal + subscapular skinfold thicknesses. Central-to-total subcutaneous fat mass ratio = (suprailiacal + subscapular 
skinfold thicknesses)/total subcutaneous fat mass. Fat mass index = total fat mass/height3. Central-to-total fat mass ratio = 
trunk fat mass/total fat mass. Android-to-gynoid fat mass ratio = android fat mass/gynoid fat mass.  
2Models are adjusted for maternal age, educational level, parity, pre-pregnancy body mass index, smoking habits during 
pregnancy, and child’s gestational age-adjusted birth weight standard-deviation scores, breastfeeding duration, timing of 
introduction of solid foods, and TV watching time. 
3P-value for interaction of child´s sex with fat mass measures at 1.5 months >0.05. 
*P-value<0.05; **P-value<0.01.
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mass index and total subcutaneous fat mass at 24 months were associated with increased 
risks of childhood overweight (OR 2.76 [95% CI 2.07, 3.69] and OR 1.70 [95% CI 1.36, 2.12]), 
respectively). We did not observe associations for central-to-total subcutaneous fat mass 
ratio at 24 months with the risk of childhood overweight. Stronger associations were present 
among girls than among boys.
Table 4. Associations of subcutaneous fat mass measures at 24 months with total and abdominal fat mass 
at 6 years old1-2
Fat mass measures at 24 
months
Fat mass measures at 6 years in standard-deviation scores
Difference [95% Confidence Interval]
body mass 
index
Fat mass 
index
Central-to-total 
fat mass ratio
Android-to- 
gynoid fat mass 
ratio
Preperitoneal 
fat mass area
Total group
Body mass index 
0.48
[0.42,0.54]**†
0.33
[0.26,0.40]**†
0.18
[0.11,0.26]**†
0.16
[0.08,0.23]**†
0.07
[0.00,0.14]†
Total  subcutaneous fat mass 
0.30
[0.23,0.37]**
0.36
[0.29,0.43]**†
0.28
[0.20,0.35]**
0.23
[0.16,0.31]**†
0.19
[0.12,0.26]**
Central-to-total  subcutaneous 
fat mass ratio 
0.09
[0.01,0.16]*†
0.14
[0.06,0.22]**†
0.12
[0.04,0.20]**†
0.10
[0.03,0.18]**†
0.10
[0.02,0.17]*
boys
Body mass index 
0.46
[0.36,0.55]**
0.35
[0.25,0.45]**
0.20
[0.09,0.30]**
0.10
[-0.01,0.21]
0.01
[-0.12,0.13]
Total  subcutaneous fat mass 
0.26
[0.15,0.36]**
0.33
[0.22,0.43]**
0.22
[0.11,0.32]**
0.12
[0.01,0.23]*
0.14
[0.01,0.27]*
Central-to-total  subcutaneous 
fat mass ratio 
-0.01
[-0.12,0.10]
-0.02
[-0.13,0.10]
0.00
[-0.11,0.11]
0.01
[-0.10,0.12]
0.11
[-0.02,0.24]
Girls
Body mass index 
0.50
[0.41,0.59]**
0.43
[0.33,0.52]**
0.25
[0.14,0.36]**
0.22
[0.11,0.32]**
0.15
[0.05,0.25]**
Total  subcutaneous fat mass 
0.34
[0.24,0.44]**
0.38
[0.28,0.47]**
0.30
[0.20,0.41]**
0.31
[0.20,0.41]**
0.21
[0.12,0.29]**
Central-to-total  subcutaneous 
fat mass ratio 
0.15
[0.05,0.26]**
0.18
[0.07,0.28]**
0.14
[0.04,0.25]**
0.14
[0.03,0.25]*
0.05
[-0.05,0.15]
1Values are standardized regression coefficients [95% confidence interval] and represent the difference in standard-devi-
ation scores for fat mass measures at 6 years per 1-standard-deviation scores increase in body mass index and subcutane-
ous fat mass measures at 24 months. Body mass index = weight/height2. Total subcutaneous fat mass = biceps + triceps + 
suprailiacal + subscapular skinfold thicknesses. Central-to-total subcutaneous fat mass ratio = (suprailiacal + subscapular 
skinfold thicknesses)/total subcutaneous fat mass. Fat mass index = total fat mass/height3. Central-to-total fat mass ratio = 
trunk fat mass/total fat mass. Android-to-gynoid fat mass ratio = android fat mass/gynoid fat mass.  
2Models are adjusted for maternal age, educational level, parity, pre-pregnancy body mass index, smoking habits during 
pregnancy, and child’s gestational age-adjusted birth weight standard-deviation scores, breastfeeding duration, timing of 
introduction of solid foods, and TV watching time. 
†P-value for interaction of child´s sex with fat mass measures at 24 months ≤0.05. 
*P-value<0.05;  **P-value<0.01.
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Figure 1. Associations of subcutaneous fat mass measures at 1.5 or 24 months with risk of overweight at 
6 years old1-3
 
1Values are odds ratios (95% Confidence Interval) on a logarithmic scale and represent the risk of overweight at 6 years per 
1-standard-deviation scores increase in body mass index and subcutaneous fat mass measures at 1.5 or 24 months. Body 
mass index = weight/height2. Total subcutaneous fat mass = biceps + triceps + suprailiacal + subscapular skinfold thick-
nesses. Central-to-total subcutaneous fat mass ratio = (suprailiacal + subscapular skinfold thicknesses)/total subcutaneous 
fat mass. SDS, standard-deviation scores.
2Models are adjusted for maternal age, educational level, parity, pre-pregnancy body mass index, smoking habits during 
pregnancy, and child’s gestational age-adjusted birth weight standard-deviation scores, breastfeeding duration, timing of 
introduction of solid foods, and TV watching time.
3P-value for interaction of child´s sex with total subcutaneous fat mass and central-to-total subcutaneous fat mass ratio at 
1.5 months ≤0.05. P-value for interaction of child´s sex with body mass index at 24 months <0.05. 
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CoMMEnT
We observed that infant subcutaneous fat mass measures, calculated from skinfold thick-
ness, are associated with total and abdominal fat mass at school-age. The effect estimates 
were stronger for body mass index and total subcutaneous fat mass than for central-to-total 
subcutaneous fat mass ratio, and for girls compared to boys. Also, the effect estimates were 
stronger for 24 months than for 1.5 months fat mass measures.
Interpretation of main findings 
Body mass index tends to track from infancy onwards. A previous review among 21 stud-
ies has shown that large body size (weight or body mass index) in 0- to 4-year-old children 
was related to large body size at primary school age.24 A meta-regression analysis among 48 
cohort studies has shown a high degree of tracking for body mass index among children until 
10 years of age. The tracking estimates gradually decreased over follow-up time and were 
not influenced by body mass index at first measurement or sex.25 In our study, we observed a 
moderate tracking of body mass index from infancy to childhood. Stronger associations were 
observed from 24 months onwards than from 1.5 months onwards, in line with the stronger 
tracking reported in the meta-regression for shorter follow-up periods. We did not observe 
differences in results when we used ponderal index (weight/height3) at 1.5 months (data not 
shown). We observed slightly stronger effect estimates among girls compared to boys. 
Body mass index provides limited information about body fat distribution. Android-to-gy-
noid fat mass ratio as well as preperitoneal fat mass have previously been associated with an 
adverse cardiovascular risk profile in childhood and adulthood, independently of body mass 
index.26, 27 Previous studies have suggested that total and central fat mass track moderately 
from childhood into adulthood,7-10, 28-30 although with a lower tracking as compared to body 
mass index. Since we used different body fat mass measures in infancy and at school-age, 
we could not directly estimate tracking coefficients. However, we observed that total subcu-
taneous fat mass at 24 months was positively associated with fat mass index at school-age, 
suggesting tracking of total fat mass from infancy into school-age. Higher total and central-
to-total subcutaneous fat mass ratio in infancy were associated with higher central-to-total 
and android-to-gynoid fat mass ratios measured by DXA and preperitoneal fat mass area 
measured by abdominal ultrasound at 6 years old. Our results suggest that besides higher 
body mass index, higher total subcutaneous fat mass and central-to-total subcutaneous fat 
mass ratio in infancy relate to an adverse body fat profile at school-age.
We observed stronger effect estimates for infant total subcutaneous fat mass than for 
central-to-total subcutaneous fat mass ratio, in the associations with similar measures 
at school-age, though both showed weaker effect estimates compared to the tracking of 
body mass index from infancy to childhood. The latter may be explained by the differences 
in methodology to assess the fat mass components in infancy and childhood. In infancy, 
skinfold thickness measurements reflect the subcutaneous depots only, whereas in child-
hood DXA comprise both subcutaneous and intra-abdominal depots.11 However, during 
the first 4 months of life approximately 90% of body fat is located subcutaneously,31 and 
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preperitoneal fat mass seems to increase only from the second year of life onwards.32 Finally, 
skinfold thickness measurements may be more liable to measurement error than body mass 
index,33, 34 which may also lead to an underestimation of the effect estimates for subcutaneous 
fat measures from infancy onwards. We also observed stronger effect estimates among girls 
than boys. Sex-specific adiposity differences have been attributed to sex hormones. During 
infancy, testosterone concentrations increase during the first week of life before decreas-
ing around 6 months of life among boys, whereas oestrogen increases shortly after birth 
and remains raised until 2-3 years among girls.35 The stronger associations that we observed 
among girls may be partly a result of a more stable body fat development during infancy 
driven by less hormonal fluctuations. Further studies are needed to explore the mechanisms 
underlying the observed sex differences in body fat development. The stronger associations 
observed for 24 months than for 1.5 months could be due to the shorter interval between 24 
months and 6 years old, as previously reported for body mass index.25 Also, 1.5 months might 
be more reflective of fetal growth patterns which seemed to be less associated, as compared 
to postnatal growth, with later abdominal adiposity in our previous study.5
Whether skinfold thickness measurements during infancy are useful in clinical practice is 
not known. Our results suggest that compared to body mass index, subcutaneous fat mass 
measures in infancy add little value to estimate total or abdominal fat mass at school-age. 
Given the challenges of obtaining precise and reliable skinfold thickness measurements, the 
additional clinical value of skinfold thicknesses compared to body mass index may be only 
limited.
Methodological considerations
Major strengths of this study are the population-based prospective design with detailed 
infant and childhood body fat measurements available. Of the 965 singleton children with 
information on body fat mass measures at the age of 1.5 or 24 months, 85% (821) participated 
in the adiposity follow-up study at 6 years old. The non-response could lead to biased ef-
fect estimates if the associations of interest would differ between children included and not 
included in the analyses. Children included in the analyses were born with a higher weight 
and gestational age and were breastfed for a longer period compared to those not included. 
It is difficult to speculate if these differences might have influenced our effect estimates. 
However, this seems unlikely since children that did not participate in the follow-up studies 
did not differ from those who did participate regarding infant body mass index and subcu-
taneous fat mass measures. Our sample was ethnically homogeneous, which may limit the 
generalizability of our results to other ethnic groups.25 We used skinfold thickness which is 
a valid measurement of subcutaneous fat in children but in extremely overweight children 
the measurement error is larger.15 The inter- and intra-observer measurement error is also 
larger as compared to other anthropometric measurements.33, 34 We did not have available 
skinfold thickness measurements from the lower limbs such as thigh or calf, which could 
have improved our estimates of subcutaneous fat mass. We obtained detailed measures of 
adiposity at school-age by using DXA that quantifies body fat content with high precision and 
abdominal ultrasound which is a valid method to assess abdominal preperitoneal fat mass 
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area.23 Finally, although we adjusted for a large number of potential confounders, residual 
confounding in the observed associations might still occur, as in any observational study.
ConCluSIon
Subcutaneous fat mass measures in infancy are positively associated with total and abdomi-
nal fat mass at school-age. The effect estimates were stronger for body mass index and total 
subcutaneous fat mass than for central-to-total subcutaneous fat mass ratio, and for girls 
compared to boys. Our results suggest that skinfold thickness measurements in infancy add 
little value to estimate body fat in later childhood, as compared to body mass index.  
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SuPPlEMEnTARy MATERIAlS
Figure S1. Flow chart of participants in study
 N = 1205 
Eligible children  
 
N = 240 
Excluded: no postnatal visit at the ages of 1.5 
and 24 months or missing data on body mass 
index and skinfold thicknesses at the ages of 
1.5 and 24 months  
 
N = 965 
Children with body mass index or 
skinfold thicknesses measured at 
the age of 1.5 or 24 months 
 
N = 144 
Excluded: no visit at 6 years of age or missing 
data on body mass index, dual-energy X-ray 
absorptiometry and abdominal ultrasound at 6 
years of age 
 
N = 821 
Children with required data available 
1.5 months                    n = 742 
24 months                     n = 746 
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Supplemental Methods:  Log-log regression analyses
Measurements of body fat quantity and distribution require appropriate adjustment for body 
size or total fat mass, respectively, in order to undertake informative comparisons between 
children and within children over time. The relationships between total subcutaneous fat 
mass and length or height, and between central subcutaneous fat mass and total subcutane-
ous fat mass were assessed using log-log regression analyses. Total and central subcutaneous 
fat mass measures as well as length or height were all log-transformed. Log-total subcuta-
neous fat mass was regressed on log-length or height. The regression slope corresponds 
to the power P by which length or height should be raised in order to calculate an index 
uncorrelated with length or height (total subcutaneous fat mass/length or heightP). A similar 
calculation was undertaken for log-central and -total subcutaneous fat mass.1
REFEREnCES
 1.  Wells JC, Cole TJ, ALSPAC study team. Adjustment of fat-free mass and fat mass for height in children 
aged 8 y. Int J Obes Relat Metab Disord. 2002;26:947-952.
Table S1. Characteristics of study participants1
Total group 
(n = 821)
boys (n = 412) Girls (n = 409) P-value
Maternal characteristics
  Age (years), mean (SD) 32.0 (3.9) 31.8 (3.9) 32.1 (3.8) 0.346
  Highest completed education, n (%)
     Primary school 10 (1.2) 3 (0.7) 7 (1.7) 0.429
     Secondary school 265 (32.4) 135 (32.9) 130 (31.9)
     Higher education 542 (66.3) 272 (66.3) 270 (66.3)
  Parity, n (%) primiparae 522 (63.6) 262 (63.6) 260 (63.6) 0.995
  Pre-pregnancy body mass index (kg/m2), mean (SD) 23.6 (4.2) 23.4 (4.2) 23.8 (4.2) 0.159
  Smoking habits during pregnancy, n (%) yes 157 (21.1) 76 (20.7) 81 (21.5) 0.781
Child’s characteristics
  Sex, % 50.2 49.8
  Birth weight (g), mean (SD) 3533 (522) 3588 (503) 3477 (536) 0.002
  Gestational age at birth (weeks), median (95% 
range)
40.3 (36.3-42.4) 40.3 (36.5-42.4) 40.3 (36.0-42.4) 0.710
  Breastfeeding duration (months), mean (SD) 4.6 (3.9) 4.5 (3.8) 4.8 (4.0) 0.394
  Introduction of solid foods, n (%)
     <3 months 41 (5.4) 20 (5.2) 21 (5.6) 0.857
     3 to 6 months 578 (76.7) 290 (76.1) 288 (77.2)
     >6 months 135 (17.9) 71 (18.6) 64 (17.2)
  TV watching time, n (%) ≥ 2 hours/day 65 (8.7) 38 (10.2) 27 (7.3) 0.153
1Values are observed data and represent means (SD), medians (95% range) or numbers of subjects (valid %). Of the total 
group, data were missing on maternal highest completed education (n = 4), pre-pregnancy body mass index (n = 121), 
smoking habits during pregnancy (n = 78), and child’s breastfeeding duration (n = 117), timing of introduction of solid 
foods (n = 67) and TV watching time (n = 77). SD, standard deviation.
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Table S2. Subcutaneous fat mass (mm)1
Total group boys Girls P-value
1.5 months n = 742 n = 372 n = 370
    Triceps 6.6 (2.2) 6.6 (2.1) 6.6 (2.3) 0.746
    Biceps 5.4 (2.0) 5.5 (2.0) 5.4 (2.1) 0.318
  Suprailiacal 5.7 (2.0) 5.6 (2.0) 5.8 (2.1) 0.111
  Subscapular 6.2 (1.8) 6.1 (1.8) 6.2 (1.8) 0.222
24 months n = 746 n = 381 n = 365
    Triceps 8.9 (2.9) 8.9 (3.0) 8.9 (2.8) 0.722
    Biceps 6.8 (2.4) 6.6 (2.3) 7.0 (2.4) 0.059
  Suprailiacal 5.6 (2.2) 5.3 (2.0) 6.0 (2.3) <0.001
  Subscapular 6.1 (1.9) 5.8 (1.7) 6.3 (2.0) <0.001
1Values are means (standard deviation).
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Table S3. Comparison of maternal and child’s characteristics between children included and not included 
in the analyses1
Participants
 (n = 821)
non-participants
(n = 144)
P-value
Maternal characteristics
  Age (years), mean (SD) 32.0 (3.9) 30.8 (4.9) 0.008
  Highest completed education, n (%)
     Primary school 10 (1.2) 8 (5.6) <0.001
     Secondary school 265 (32.4) 58 (40.8)
     Higher education 542 (66.3) 76 (53.5)
  Parity, n (%) primiparae 522 (63.6) 74 (51.4) 0.005
  Pre-pregnancy body mass index (kg/m2), mean (SD) 23.6 (4.2) 22.9 (3.4) 0.082
  Smoking habits during pregnancy, n (%) yes 157 (21.1) 47 (34.6) 0.001
Child’s characteristics
  Sex, % male 50.2 58.3 0.071
  Birth weight (g), mean (SD) 3533 (522) 3402 (611) 0.017
  Gestational age at birth (weeks), median (95% range) 40.3 (36.3-42.4) 39.9 (34.9-42.5) 0.001
  Breastfeeding duration (months), mean (SD) 4.6 (3.9) 3.3 (3.6) 0.001
  Introduction of solid foods, n (%)
     <3 months 41 (5.4) 7 (6.8) 0.322
     3 to 6 months 578 (76.7) 72 (69.9)
     >6 months 135 (17.9) 24 (23.3)
  TV watching time, n (%) ≥ 2 hours/day 65 (8.7) 4 (7.0) 0.656
1.5 months 
   Body mass index (kg/m2), mean (SD) 15.1 (1.4) 15.2 (1.3) 0.553
   Total subcutaneous fat mass (mm), mean (SD) 23.9 (7.1) 24.9 (9.2) 0.267
   Central-to-total subcutaneous fat mass ratio, mean (SD) 0.50 (0.05) 0.50 (0.04) 0.304
24 months 
   Body mass index (kg/m2), mean (SD) 15.9 (1.3) 15.9 (1.2) 0.660
   Total subcutaneous fat mass (mm), mean (SD) 27.4 (7.5) 27.0 (5.8) 0.712
   Central-to-total subcutaneous fat mass ratio, mean (SD) 0.43 (0.06) 0.44 (0.07) 0.161
1Values are observed data and represent means (SD), medians (95% range) or numbers of subjects (valid %). Differences 
were tested using Student’s t-tests and Mann-Whitney tests for normally and non-normally distributed variables, respec-
tively and χ2-test for dichotomous variables. SD, standard deviation.
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Table S4. Correlation coefficients between body fat mass measures at 1.5 months and 6 years old1
Fat mass measures 
at 1.5 months
Fat mass measures at 6 years
Pearson correlation coefficients
Spearman correlation 
coefficients
body mass 
index
Fat mass index
Central-to-
total fat mass 
ratio
Android-to- 
gynoid fat 
mass ratio
Preperitoneal fat 
mass area
Total group
Body mass index 0.22** 0.08* -0.01 0.05 0.08*
Total subcutaneous 
fat mass
0.08* 0.05 0.01 0.03 0.05
Central-to-total  
subcutaneous fat 
mass ratio
0.06 0.12** 0.11** 0.07 0.07
boys
Body mass index 0.29** 0.17** 0.06 0.12* 0.18**
Total  subcutaneous 
fat mass
0.14** 0.07 0.06 0.06 0.08
Central-to-total 
subcutaneous fat 
mass ratio
0.05 0.09 0.07 0.08 0.01
Girls
Body mass index 0.16** 0.09 -0.01 0.01 0.08
Total  subcutaneous 
fat mass
0.02 0.03 -0.05 0.01 0.01
Central-to-total 
subcutaneous fat 
mass ratio
0.07 0.07 0.07 0.05 0.04
1Values are correlation coefficients between body fat mass measures standard-deviation scores using Pearson r tests for 
normally distributed variables and Spearman’s rho tests for skewed variables. Body mass index = weight/height2. Total 
subcutaneous fat mass = biceps + triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total subcutaneous 
fat mass ratio = (suprailiacal + subscapular skinfold thicknesses)/total subcutaneous fat mass. Fat mass index = total fat 
mass/height3. Central-to-total fat mass ratio = trunk fat mass/total fat mass. Android-to-gynoid fat mass ratio = android 
fat mass/gynoid fat mass.  
*P-value<0.05;  **P-value<0.01.
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Table S5. Correlation coefficients between body fat mass measures at 24 months and 6 years old1
Fat mass measures 
at 24 months
Fat mass measures at 6 years     
Pearson correlation coefficients
Spearman correlation 
coefficients  
body mass 
index
Fat mass index
Central-to-
total fat mass 
ratio
Android-to- 
gynoid fat 
mass ratio
Preperitoneal fat 
mass area
Total group
Body mass index 0.52** 0.36** 0.18** 0.17** 0.11**
Total  subcutaneous 
fat mass 
0.32** 0.37** 0.28** 0.24** 0.25**
Central-to-total  
subcutaneous fat 
mass ratio 
0.11** 0.17** 0.14** 0.12** 0.13**
boys
Body mass index 0.47** 0.33** 0.14** 0.08 0.06
Total  subcutaneous 
fat mass 
0.26** 0.32** 0.20** 0.11 0.18**
Central-to-total 
subcutaneous fat 
mass ratio 
-0.01 0.00 0.01 0.03 0.13*
Girls
Body mass index 0.57** 0.48** 0.28** 0.25** 0.21**
Total  subcutaneous 
fat mass 
0.36** 0.39** 0.32** 0.32** 0.30**
Central-to-total  
subcutaneous fat 
mass ratio 
0.21** 0.23** 0.18** 0.18** 0.08
1Values are correlation coefficients between body fat mass measures standard-deviation scores using Pearson r tests for 
normally distributed variables and Spearman’s rho tests for skewed variables. Body mass index = weight/height2. Total 
subcutaneous fat mass = biceps + triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total subcutaneous 
fat mass ratio = (suprailiacal + subscapular skinfold thicknesses)/total subcutaneous fat mass. Fat mass index = total fat 
mass/height3. Central-to-total fat mass ratio = trunk fat mass/total fat mass. Android-to-gynoid fat mass ratio = android 
fat mass/gynoid fat mass.  
*P-value<0.05;  **P-value<0.01.
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AbSTRACT
objective: To examine the associations of infant subcutaneous fat with cardiovascular risk 
factors at school-age.
Methods: In a population-based prospective cohort study among 808 children, total sub-
cutaneous fat (sum of biceps, triceps, suprailiacal and subscapular skinfold thicknesses) and 
central-to-total subcutaneous fat ratio (sum of suprailiacal and subscapular skinfold thick-
nesses/total subcutaneous fat) at 1.5 and 24 months were estimated. At 6 years, body mass 
index, blood pressure, cholesterol, triglycerides, and insulin levels were measured.
Results: Infant subcutaneous fat measures were not associated with childhood blood 
pressure, triglycerides or insulin levels. A 1-standard-deviation score (SDS) higher total sub-
cutaneous fat at 1.5 months was, independently of body mass index, associated with lower 
low-density lipoprotein (LDL)-cholesterol levels at 6 years. In contrast, a 1-SDS higher total 
subcutaneous fat at 24 months was associated with higher total-cholesterol (difference 0.13 
(95% Confidence Interval (CI) 0.03, 0.23) SDS) and LDL-cholesterol levels (difference 0.12 (95% 
CI 0.02, 0.21) SDS) at 6 years. There were no associations of central-to-total subcutaneous fat 
ratio with childhood cholesterol levels.
Conclusions: These results suggest that infant total subcutaneous fat is weakly associated 
with cholesterol levels at school-age. Further studies are needed to assess the long-term 
cardiometabolic consequences of infant body fat.
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InTRoDuCTIon
Early infant and childhood growth rates are associated with cardiovascular disease risk in 
later life.1 Results from longitudinal studies suggest that rapid weight gain in infancy or gain 
in body mass index in childhood are associated with an adverse cardiovascular risk profile in 
adulthood.2-4 Weight or body mass index are suboptimal measures of fat mass development 
and provide no information about body fat distribution.5 Several studies have shown that as 
compared to body mass index, body fat distribution plays a greater role in the development 
of risk factors for cardiovascular disease.6 We have previously reported in a cross-sectional 
study among 6-year-old children that both general and abdominal fat mass measures are 
associated with cardiovascular risk factors, independently of body mass index.7 Also, previous 
studies have shown that high total subcutaneous fat mass measured by the sum of skinfold 
thicknesses is associated with high blood pressure, an unfavorable blood lipids profile and 
high glucose and insulin levels in childhood.8-12 Currently, it is not known whether, next to 
rapid weight gain, total and regional subcutaneous fat mass development in infancy is as-
sociated with cardiovascular risk factors in later life. Assessing the contribution of fatness 
in infancy to later cardiovascular risk status is particularly relevant to identify early critical 
periods of fat development that influence the risk for cardiovascular disease. 
Therefore, we examined, in a population-based prospective cohort study among 808 
children, the associations of infant subcutaneous fat mass measures with cardiovascular 
risk factors at school-age. We used skinfold thickness measurements at 1.5 and 24 months 
to estimate total subcutaneous fat mass and central-to-total subcutaneous fat mass ratio. 
Cardiovascular risk factors of interest include blood pressure, total-, high-density lipoprotein 
(HDL)-, and low-density lipoprotein (LDL)-cholesterol levels, triglycerides levels and insulin 
levels at 6 years.
METHoDS
Study design
This study was embedded in the Generation R Study, a population-based prospective cohort 
study from early pregnancy onwards among 9,778 mothers and their children living in Rot-
terdam, the Netherlands.13, 14 The study protocol was approved by the local Medical Ethical 
Committee. Written informed consent was obtained from all mothers. Additional detailed 
assessments of fetal and postnatal growth and development were conducted in a subgroup 
of Dutch mothers and their children from late pregnancy onwards. Of all approached 
women, 80% agreed to participate. Of the total of 1,205 singleton children participating in 
the subgroup study, 965 children had body mass index or skinfold thicknesses measured at 
the age of 1.5 or 24 months. Of these children, 808 children had cardiovascular risk factors 
measurements at the age of 6 years (Flow chart is given in Supplemental Figure S1). Missing 
measurements were due to loss to follow-up, crying behavior or non-consent for venous 
puncture at 6 years old.
CHAPTER 3.3
140
body fat measurements during infancy 
We measured weight to the nearest gram in naked infants at the age of 1.5 months by using an 
electronic infant scale and at 24 months by using a mechanical personal scale (SECA, Almere, 
the Netherlands). Body length at the age of 1.5 months was measured in supine position to 
the nearest millimeter by using a neonatometer and body height at 24 months was measured 
in standing position by using a Harpenden stadiometer (Holtain Limited, Dyfed, UK). Body 
mass index (kg/m2) was calculated.
We measured skinfold thicknesses at the ages of 1.5 and 24 months on the left side of 
the body at the biceps, triceps, suprailiacal and subscapular area by using a skinfold caliper 
(Slim Guide, Creative Health Products) according to standard procedures described in detail 
previously.15 We calculated total subcutaneous fat mass from the sum of all four skinfold 
thicknesses, and central subcutaneous fat mass from the sum of suprailiacal and subscapular 
skinfold thicknesses.16 Measurements of body fat quantity and distribution require appropri-
ate adjustment for body size or total fat mass, respectively, in order to undertake informative 
comparisons between children and within children over time. To create total subcutaneous 
fat mass independent of length or height and central subcutaneous fat mass independent 
of total subcutaneous fat mass, we estimated the optimal adjustment by log-log regression 
analyses.17 Details of these regressions are given in the Supplemental Methods. Based on 
these analyses, total subcutaneous fat mass was only weakly correlated with length at 1.5 
months or height at 24 months, and was not adjusted for height whereas a central-to-total 
subcutaneous fat mass ratio was calculated as central divided by total subcutaneous fat mass. 
Cardiovascular risk factors at school-age 
Blood pressure was measured at the right brachial artery four times with one-minute intervals, 
using the validated automatic sphygmanometer Datascope Accutor Plus (Paramus, NJ).18 We 
calculated the mean value for systolic and diastolic blood pressure using the last three blood 
pressure measurements of each participant. Thirty-minutes fasting blood samples were 
collected to measure total-, HDL-, and LDL-cholesterol, triglycerides, and insulin concentra-
tions, using Cobas 8000 analyzer (Roche, Almere, the Netherlands). Quality control samples 
demonstrated intra- and interassay coefficients of variation ranging from 0.77 to 1.39%, and 
0.87 to 2.40%, respectively. 
Covariates
Information on maternal age, educational level, parity, pre-pregnancy weight and smoking 
habits during pregnancy was assessed using self-reported questionnaires during pregnancy. 
We measured maternal height at enrollment and calculated pre-pregnancy body mass index 
(kg/m2). First trimester maternal nutritional information was obtained by food frequency 
questionnaire.19 Gestational weight gain was calculated as the difference between maternal 
weight measured at 30 weeks of gestation and pre-pregnancy weight. Information about 
gestational diabetes and gestational hypertensive disorders, child’s sex, gestational age and 
weight at birth was obtained from medical records. Information about breastfeeding dura-
tion, timing of introduction of solid foods and average TV watching time at 6 years old was 
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obtained by questionnaires. At the age of 6 years, we measured child’s height and weight in 
standing position without shoes and heavy clothing, and calculated body mass index (kg/
m2).
Statistical analysis
We assessed the associations of body mass index, total subcutaneous fat mass and central-to-
total subcutaneous fat mass ratio at 1.5 and 24 months and the change between these ages, 
with cardiovascular risk factors (blood pressure, total-, HDL-, and LDL-cholesterol, triglycer-
ides and insulin levels) at school-age using linear regression models. The regression models 
were adjusted for maternal age, educational level, parity, pre-pregnancy body mass index, 
maternal total energy intake, smoking habits and total weight gain during pregnancy, gesta-
tional diabetes, gestational hypertensive disorders, and child’s sex, gestational age-adjusted 
birth weight standard-deviation scores (SDS), breastfeeding duration, timing of introduction 
of solid foods, and TV watching time. We included covariates in the models when they were 
strongly associated with body fat mass and cardiovascular risk factors in our or previous 
studies, or when they changed the effect estimates substantially (>10%). Additionally, we 
adjusted these models for childhood body mass index to assess whether any association 
of infant fat mass measures with childhood cardiovascular risk factors was independent of 
body mass index at 6 years. For the models with body mass index as main exposure, we 
constructed a conditional body mass index variable at 6 years that was statistically indepen-
dent of body mass index at 1.5 and 24 months, allowing simultaneous inclusion in multiple 
regression models.20 Details of these models are given in the Supplemental Methods. For the 
models with subcutaneous fat mass measures as exposures, body mass index at 6 years was 
simultaneously included in the regression models since no collinearity was observed. We did 
not observe significant interactions between infant fat mass measures and sex, breastfeeding 
groups (never, ever) and body mass index categories at 1.5 or 24 months in the associations 
with childhood cardiovascular risk factors. For all analyses, we log-transformed not normally 
distributed cardiovascular risk factors (triglycerides and insulin levels). We constructed SDS 
[(observed value - mean)/SD] of the sample distribution for all variables to enable com-
parisons in effect size. Missing values in covariates were multiple-imputed, by using Markov 
chain Monte Carlo approach. Five imputed datasets were created and analyzed together. We 
performed statistical analyses using the Statistical Package of Social Sciences version 21.0 for 
Windows (SPSS Inc, Chicago, IL, USA).
RESulTS
Subject characteristics
Tables 1 and 2 show the subject characteristics. Of all participating children, 50.1% were boys, 
the mean (SD) birth weight was 3535 (517) g and the median (95% range) gestational age at 
birth was 40.3 (36.4-42.4) weeks. 
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Table 1. Characteristics of study participants1
Total group 
(n = 808)
Maternal characteristics
  Age (years), mean (SD) 32.0 (3.8)
  Highest completed education, n (%)
     Primary school 10 (1.2)
     Secondary school 261 (32.5)
     Higher education 533 (66.3)
  Parity, n (%) nulliparous 512 (63.4)
  Pre-pregnancy body mass index (kg/m2), mean (SD) 23.6 (4.2)
  Total energy intake (kcal), mean (SD) 2131 (499)
  Total weight gain during pregnancy (kg), mean (SD) 10.2 (4.6)
  Smoking habits during pregnancy, n (%)
     No 575 (78.7)
     Yes 156 (21.3)
  Gestational diabetes, n (%) 9 (1.1)
  Gestational hypertensive disorders, n (%) 64 (8.1)
Child’s characteristics
  Boys, n (%) 405 (50.1)
  Birth weight (g), mean (SD) 3535 (517)
  Gestational age at birth (weeks), median (95% range ) 40.3 (36.4-42.4)
  Breastfeeding duration (months), mean (SD) 4.7 (3.9)
  Introduction of solid foods, n (%)
     <3 months 41 (5.5)
      3 to 6 months 569 (76.6)
     >6 months 133 (17.9)
  TV watching time, n (%)
     < 2 hours/day 668 (91.3)
     ≥ 2 hours/day 64 (8.7)
   Body mass index at 6 years (kg/m2), mean (SD) 15.9 (1.4)
   Overweight and obesity at 6 years (IOTF criteria), n (%) 87 (10.8)
1Values are observed data and represent means (SD), medians (95% range) or numbers of subjects (valid %). IOTF, Interna-
tional Obesity Task Force; SD, standard deviation.
Non-response analyses showed that as compared to mothers who did not participate in 
the follow-up studies, those who did participate were slightly older, had a higher educational 
level and pre-pregnancy body mass index and were more likely to be nulliparous and non-
smokers (p<0.05). Their children were born with a higher weight and gestational age at birth 
and were breastfed for a longer period (p<0.05) (Supplemental Table S1).
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Table 2. Body fat at 1.5 and 24 months by skinfold thicknesses and cardiovascular risk factors at 6 years old1 
Total group
(n = 808)
Fat mass measures at 1.5 months n = 731
    Age (months), mean (SD) 1.6 (0.4)
    Body mass index (kg/m2), mean (SD) 15.2 (1.4)
    Total subcutaneous fat mass (mm), mean (SD) 23.9 (7.0)
    Central-to-total subcutaneous fat mass ratio, mean (SD) 0.50 (0.05)
Fat mass measures at 24 months n = 735
    Age (months), mean (SD) 25.2 (1.1)
    Body mass index (kg/m2), mean (SD) 16.0 (1.3)
    Total subcutaneous fat mass (mm), mean (SD) 27.4 (7.5)
    Central-to-total subcutaneous fat mass ratio, mean (SD) 0.43 (0.06)
Cardiovascular risk factors at 6 years n = 808
    Age (years), mean (SD) 6.0 (0.3)
    Systolic blood pressure (mm/Hg), mean (SD) 102.4 (7.9)
    Diastolic blood pressure (mm/Hg), mean (SD) 60.2 (6.4)
    Total-cholesterol (mmol/l), mean (SD) 4.2 (0.6)
    HDL-cholesterol (mmol/l), mean (SD) 1.3 (0.3)
    LDL-cholesterol (mmol/l), mean (SD) 2.3 (0.6)
    Triglycerides (mmol/l), median (95% range) 1.0 (0.4-2.2)
    Insulin (U/I), median (95% range) 116 (18-384)
1Values are expressed as means (SD) or medians (95% range). Body mass index = weight/height2. Total subcutaneous fat 
mass = biceps + triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total subcutaneous fat mass ratio = 
(suprailiacal + subscapular skinfold thicknesses)/total subcutaneous fat mass. HDL-cholesterol, high-density lipoprotein-
cholesterol; LDL-cholesterol, low-density lipoprotein-cholesterol; SD, standard deviation.
Infant body fat and cardiovascular risk factors at school-age
Table 3 shows that, after adjustment for potential confounders, body mass index at 1.5 and 
24 months or its change over infancy was not associated with cardiovascular risk factors at 
school-age. Similarly, total subcutaneous fat mass and central-to-total subcutaneous fat 
mass ratio at 1.5 and 24 months or its change over infancy were not associated with child-
hood blood pressure and triglycerides or insulin levels. A 1-SDS higher total subcutaneous 
fat mass at 1.5 months was associated with lower LDL-cholesterol levels at the age of 6 years 
(difference -0.10 (95% Confidence Interval (CI) -0.20, -0.01) SDS), whereas 1-SDS higher total 
subcutaneous fat mass at 24 months was associated with higher childhood total- and LDL-
cholesterol levels (differences 0.15 (95% CI 0.05, 0.24) SDS and 0.14 (95% CI 0.04, 0.23) SDS, 
respectively). Also, 1-SDS increase in total subcutaneous fat mass from 1.5 to 24 months was 
associated with higher childhood total- and LDL-cholesterol levels (differences 0.10 (95% CI 
0.03, 0.18) SDS and 0.11 (95% CI 0.04, 0.19) SDS, respectively). These results were not materially 
affected by additional adjustment for childhood body mass index (Table 3). Results from the 
unadjusted analyses are given in Supplemental Table S2. 
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DISCuSSIon
We observed in this population-based prospective cohort study that infant subcutaneous fat 
mass measures at 1.5 and 24 months were not associated with childhood blood pressure and 
triglycerides or insulin levels, but were weakly associated with childhood cholesterol levels at 
6 years, independently of body mass index.
Methodological considerations
Major strengths of this study are the population-based prospective design with detailed 
infant body fat and childhood cardiovascular risk factors measurements available. Some 
methodological issues need to be considered. Of the 965 singleton children with information 
on body fat mass measures at the age of 1.5 or 24 months, 84% (808) participated in the 
adiposity and cardiovascular follow-up study at 6 years old. The non-response could lead 
to biased effect estimates if the associations of infant subcutaneous fat mass with cardio-
vascular risk factors at school-age differ between children included and not included in the 
present analyses. However, this seems unlikely since children that did not participate in the 
follow-up studies did not differ from those who did participate regarding body mass index 
and subcutaneous fat mass measures at 1.5 and 24 months. Our study group was ethnically 
homogeneous (Dutch only), which may limit the generalizability of our results to other ethnic 
groups.21 We used skinfold thickness as a measure of subcutaneous fat mass and therefore we 
were not able to measure intra-abdominal depots. However, during the first months of life 
approximately 90% of body fat is located subcutaneously22 and preperitoneal fat mass seems 
to increase only from the second year of life onwards.23 Previous studies have shown that 
skinfold thickness is a valid measurement of fat mass in children, but in extremely overweight 
children the measurement error is larger.24 The inter- and intra-observer measurement error 
is also larger as compared to other anthropometric measurements.25, 26 The use of thirty-
minutes fasting blood samples may have resulted in misclassification and thus may have 
led to underestimation of the observed associations. However, it has been shown in adults 
that non-fasting blood lipid levels can accurately predict increased risks of cardiovascular 
events in later life.27 Finally, we adjusted for a large number of potential confounders but 
residual confounding in the observed associations might still occur, as in any observational 
study. For example, in our study, we were unable to adjust our results for detailed nutritional 
information during infancy and at school-age.
Interpretation of main findings
A high body mass index is an important risk factor for an adverse cardiovascular risk profile 
in late childhood.7, 12, 28 Also, a high body mass index gain during childhood has been associ-
ated with cardiovascular risk in adolescence and adulthood.3, 29 Few studies have assessed 
the relation of body mass index and cardiovascular risk in preschool children and have found 
weak or no associations with blood lipid and insulin levels.30-32 Rapid weight gain in the first 
3 months of life has been associated with increased adiposity and an unfavorable cardiovas-
cular profile in later life.2 However, it remains unknown whether gain in body mass index or 
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ponderal index in infancy predisposes individuals to cardiovascular risk. A study among 4,601 
UK subjects has shown that changes in ponderal index from 0 to 2 years were not associated 
with cardiovascular risk factors in adolescence.29 In the present study, we observed no as-
sociations of body mass index at the ages of 1.5 and 24 months or its change in this period 
with cardiovascular risk factors at school-age. Also, we did not observe differences in results 
when we used ponderal index calculated as weight/height3 at 1.5 months (data not shown).33
Body mass index may not be an accurate measure of total fat mass and provides no infor-
mation on body fat distribution.5 An accumulating body of evidence has suggested that body 
fat distribution is more strongly associated with cardiovascular disease and type 2 diabetes 
than body mass index.6 We have previously reported in a cross-sectional study among 6-year-
old children that high fat mass percentage and android-to-gynoid fat mass ratio measured by 
dual-energy X-ray absorptiometry were associated with adverse levels of cardiovascular risk 
factors, independently of body mass index. The associations of these more detailed body fat 
mass measures with blood lipid levels tended to be stronger than the associations for body 
mass index.7 
Previous studies have also shown that high total and central subcutaneous fat mass mea-
sures, estimated from skinfold thicknesses, are associated with an adverse cardiovascular 
risk profile, namely high blood pressure, an unfavorable blood lipids profile and high insulin 
levels, in late childhood.8-10, 12, 34 Another study has shown that an increase in total subcutane-
ous fat mass from 8 to 18 years old was associated with an increase in total-cholesterol, LDL-
cholesterol and triglycerides levels and a decrease in HDL-cholesterol levels.11 Few studies 
have assessed the associations of subcutaneous fat mass measures with cardiovascular risk 
in preschool children.31, 35 Those studies have found that total subcutaneous fat mass was 
positively but weakly related to fasting insulin in children aged 2 to 3 years31 while no associa-
tion was found with blood lipid levels in children aged 4 years.35 It is not known whether total 
and regional subcutaneous fat mass in infancy is associated with cardiovascular risk factors in 
later life. We observed no associations of infant subcutaneous fat mass measures with child-
hood blood pressure and triglycerides or insulin levels. At 1.5 months, total subcutaneous 
fat mass was inversely associated with LDL-cholesterol at the age of 6 years old. We cannot 
explain this finding. Child’s dietary intake and physical activity may have confounded this 
association, since we had only available information about breastfeeding, age at introduction 
of solid foods and TV watching time at 6 years. At 24 months, total subcutaneous fat mass, but 
not central-to-total subcutaneous fat mass ratio, was positively but also weakly associated 
with childhood total- and LDL-cholesterol, independently of body mass index at 6 years old. 
LDL-cholesterol is an important determinant of cardiovascular risk and a causal agent in the 
atherothrombotic process.36 
In line with the previous cross-sectional studies performed among preschool children,31, 35 
our study suggests that subcutaneous fat mass measures in infancy seem to be poor indica-
tors of cardiovascular risk profile in later childhood. These findings may be partially explained 
by the fact that fat mass measures in infancy represent the accumulation of fat mass over a 
short period of time, which may not be long enough to influence cardiovascular risk profile. 
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Further studies are needed to assess the long-term cardiovascular consequences of infant 
total and regional fat mass measures.
ConCluSIon
Our results suggest that infant subcutaneous fat mass measures do not affect childhood 
blood pressure and triglycerides or insulin levels, and are weakly associated with childhood 
total- and LDL-cholesterol levels at 6 years, independently of body mass index.
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SuPPlEMEnTARy MATERIAlS
Figure S1. Flow chart of participants in study
 N = 1,205 
Eligible children  
 
N = 240 
Excluded: no postnatal visit at the ages of 1.5 
and 24 months or missing data on body mass 
index and skinfold thicknesses at the ages of 
1.5 and 24 months  
 
N = 965  
Children with body mass index or 
skinfold thicknesses measured at 
the age of 1.5 or 24 months 
 
N = 157 
Excluded: no visit at 6 years of age or missing 
data on cardiovascular risk factors at 6 years 
of age 
 
N = 808 
Children with required data 
available 
1.5 months                    n = 731 
24 months                     n = 735  
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Supplemental Methods 
log-log regression analyses
The relationships between total subcutaneous fat mass and length or height, and between 
central subcutaneous fat mass and total subcutaneous fat mass were assessed using log-log 
regression analyses. Total and central subcutaneous fat mass measures as well as length or 
height were all log-transformed. Log-total subcutaneous fat mass was regressed on log-
length or height. The regression slope corresponds to the power P by which length or height 
should be raised in order to calculate an index uncorrelated with length or height (total sub-
cutaneous fat mass/length or heightP). A similar calculation was undertaken for log-central 
and -total subcutaneous fat mass.1
Conditional analysis
We performed conditional analysis to enable inclusion of body mass index measures at 
different ages in the same linear regression model, without problems regarding the correla-
tions between the measures. First, we calculated the expected body mass index at the age 
of 6 years based on body mass index at 1.5 or 24 months by performing a linear regression 
model of body mass index at 1.5 or 24 months regressed on body mass index at 6 years. The 
standardized residuals obtained from these regression models correspond to the difference 
between the expected and the actual body mass index at 6 years and thus are entirely uncor-
related with body mass index at 1.5 or 24 months. Then, we added the standardized residuals 
to the models in order to assess the associations of infant body mass index with childhood 
cardiovascular risk factors, independently of body mass index at 6 years.2 
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Table S1. Comparison of maternal and child’s characteristics between children included and not included 
in the analyses1
Participants
 (n = 808)
non-participants
(n = 157)
P-value
Maternal characteristics
  Age (years), mean (SD) 32.0 (3.8) 30.9 (4.9) 0.008
  Highest completed education, n (%)
     Primary school 10 (1.2) 8 (5.2) <0.001
     Secondary school 261 (32.5) 62 (40.0)
     Higher education 533 (66.3) 85 (54.8)
  Parity, n (%) nulliparous 512 (63.4) 84 (53.5) 0.020
  Pre-pregnancy body mass index (kg/m2), mean (SD) 23.6 (4.2) 22.8 (3.4) 0.040
  Total energy intake (kcal), mean (SD) 2131 (499) 2091 (533) 0.391
  Total weight gain during pregnancy (kg), mean (SD) 10.2 (4.6) 10.4 (4.7) 0.477
  Smoking habits during pregnancy, n (%)
     No 575 (78.7) 100 (67.6) 0.004
     Yes 156 (21.3) 48 (32.4)
  Gestational diabetes, n (%) 9 (1.1) 2 (0.5) 0.318
  Gestational hypertensive disorders, n (%) 64 (8.1) 19 (5.0) 0.056
Child’s characteristics
  Boys, n (%) 405 (50.1) 91 (58.0) 0.072
  Birth weight (g), mean (SD) 3535 (517) 3403 (624) 0.014
  Gestational age at birth (weeks), median (95% range) 40.3 (36.4-42.4) 39.9 (34.8-42.4) 0.003
  Breastfeeding duration (months), mean (SD) 4.7 (3.9) 3.3 (3.5) <0.001
  Introduction of solid foods, n (%)
     <3 months 41 (5.5) 7 (6.1) 0.417
      3 to 6 months 569 (76.6) 81 (71.1)
     >6 months 133 (17.9) 26 (22.8)
  TV watching time, n (%)
     < 2 hours/day 668 (91.3) 64 (92.8) 0.672
     ≥ 2 hours/day 64 (8.7) 5 (7.2)
1.5 months 
    Body mass index (kg/m2), mean (SD) 15.2 (1.4) 15.2 (1.3) 0.989
    Total subcutaneous fat mass (mm), mean (SD) 23.9 (7.0) 24.9 (9.1) 0.235
    Central-to-total subcutaneous fat mass ratio, mean (SD) 0.50 (0.05) 0.50 (0.04) 0.297
24 months
    Body mass index (kg/m2), mean (SD) 16.0 (1.3) 15.9 (1.2) 0.504
    Total subcutaneous fat mass (mm), mean (SD) 27.4 (7.5) 26.8 (6.0) 0.488
    Central-to-total subcutaneous fat mass ratio, mean (SD) 0.43 (0.06) 0.44 (0.07) 0.123
1Values are observed data and represent means (SD), medians (95% range) or numbers of subjects (valid %). Differences 
were tested using Student’s t-tests and Mann-Whitney tests for normally and non-normally distributed variables, respec-
tively and χ2-test for dichotomous variables. SD, standard deviation.
153
Infant fat and childhood cardiovascular risk
Table S2. Associations of infant subcutaneous fat mass measures with cardiovascular risk factors at 6 years 
old1-2
Cardiovascular risk factors at 6 years in standard-deviation scores
 Difference (95% Confidence Interval)
Fat mass measures
Systolic 
blood 
pressure
Diastolic 
blood 
pressure
Total-
cholesterol
HDl-
cholesterol
lDl-
cholesterol
Triglycerides Insulin
1.5 months
Body mass index 
0.03
(-0.04,0.11)
-0.01
(-0.08,0.06)
0.02
(-0.07, 0.11)
0.03
(-0.06,0.12)
-0.01
(-0.10,0.08)
0.01
(-0.08,0.10)
-0.01
(-0.10,0.08)
Total  subcutaneous 
fat mass 
0.03
(-0.04,0.11)
-0.02
(-0.10,0.05)
-0.05
(-0.14,0.05)
0.02
(-0.08,0.11)
-0.10
(-0.19,-0.01)*
-0.02
(-0.11,0.08)
0.05
(-0.04,0.15)
Central-to-total 
subcutaneous fat 
mass ratio 
-0.01
(-0.09,0.06)
-0.03
(-0.10,0.05)
0.06
(-0.03,0.15)
0.02
(-0.06,0.12)
0.02
(-0.06,0.12)
0.09
(-0.01,0.18)
0.02
(-0.07,0.11)
24 months
Body mass index 
-0.03
(-0.10,0.05)
-0.06
(-0.14,0.02)
-0.05
(-0.15,0.04)
-0.10
(-0.19,-0.01)*
0.00
(-0.10,0.09)
-0.01
(-0.10,0.09)
-0.06
(-0.15,0.04)
Total subcutaneous 
fat mass 
0.01
(-0.07,0.08)
0.02
(-0.06,0.09)
0.14
(0.05,0.24)**
0.01
(-0.08,0.10)
0.13
(0.04,0.22)**
0.03
(-0.06,0.12)
0.03
(-0.06,0.13)
Central-to-total 
subcutaneous fat 
mass ratio 
0.04
(-0.04,0.11)
0.04
(-0.04,0.11)
0.05
(-0.04,0.15)
-0.10
(-0.19,-0.01)*
0.10
(0.01,0.20)*
0.04
(-0.06,0.14)
-0.01
(-0.11,0.09)
Change from 1.5 to 
24 months
Body mass index 
-0.05
(-0.11,0.02)
-0.04
(-0.11,0.02)
-0.05
(-0.13,0.03)
-0.06
(-0.14,0.02)
-0.01
(-0.10,0.07)
-0.02
(-0.10,0.06)
-0.01
(-0.10,0.07)
Total  subcutaneous 
fat mass 
-0.01
(-0.06,0.05)
0.02
(-0.04,0.08)
0.10
(0.03,0.17)**
0.00
(-0.07,0.07)
0.10
(0.03,0.18)**
0.03
(-0.04,0.11)
0.01
(-0.06,0.09)
Central-to-total 
subcutaneous fat 
mass ratio 
0.02
(-0.04,0.08)
0.04
(-0.02,0.10)
-0.04
(-0.12,0.03)
-0.06
(-0.13,0.01)
0.02
(-0.06,0.10)
-0.04
(-0.12,0.03)
-0.01
(-0.09,0.06)
1Values are standardized regression coefficients (95% confidence interval) and represent the difference in standard-de-
viation scores for cardiovascular risk factors at 6 years per 1-standard-deviation scores increase in body mass index and 
subcutaneous fat mass measures. Body mass index = weight/height2. Total subcutaneous fat mass = biceps + triceps + 
suprailiacal + subscapular skinfold thicknesses. Central-to-total subcutaneous fat mass ratio = (suprailiacal + subscapular 
skinfold thicknesses)/total subcutaneous fat mass. HDL-cholesterol, high-density lipoprotein-cholesterol; LDL-cholesterol, 
low-density lipoprotein-cholesterol.
2Unadjusted model.
*P-value<0.05; **P-value<0.01.
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InTRoDuCTIon
Obesity is a major public health problem in adulthood,1 and leads to increased risks of cardio-
metabolic diseases, musculoskeletal, respiratory and psychological disorders, and cancers.2,3 
Likewise, obesity is reaching alarming levels in women of reproductive age, infants and 
children,4,5 which also has major public health implications.
Obesity at the start of pregnancy and excessive gestational weight gain may have short- 
and long-term consequences for both mother and child, such as an increased risk of preg-
nancy complications and childhood obesity.6-13 A maternal obesogenic environment during 
pregnancy leads to fetal over-nutrition that might cause permanent changes in the develop-
ment of adipocytes and in the appetite control system, resulting in larger susceptibility to 
develop obesity later in life.14 Infancy, and especially nutrition and growth during this period, 
also seems to be critical for the development of obesity and cardiometabolic diseases.15-19 
Assessing the influence of maternal pre-pregnancy body mass index, gestational weight gain 
and infant growth and adiposity on detailed offspring fat measures and cardiovascular risk 
factors, already from early infancy onwards, is important to obtain a better understanding of 
the influence of maternal and infant adiposity on health outcomes in later life.
The general aim of this thesis was to clarify the adiposity and cardiovascular health related 
consequences of maternal and infant adiposity. This chapter provides a general discussion 
of the main findings of the studies in this thesis, discusses general methodological issues 
and provides suggestions for future research and implications for clinical practice and policy.
InTERPRETATIon oF MAIn FInDInGS
Maternal adiposity during pregnancy
Pre-pregnancy body mass index
A meta-analysis of observational studies showed that maternal pre-pregnancy overweight 
and obesity were associated with a 2-fold and a 3-fold higher risk of offspring overweight/
obesity, respectively.10 Similarly, maternal overweight and obesity have been strongly associ-
ated with increased risks of overweight and obesity in children aged 4 and 6 years within 
the Generation R Study cohort.20,21 Thus far, not much is known about the associations of 
maternal obesity with offspring adiposity status throughout infancy, which is a critical period 
for adiposity development in later life. In line with previous meta-analysis and single studies 
at older ages, we showed that higher maternal pre-pregnancy body mass index was associ-
ated with higher body mass index from 6 months onwards in infants from the Generation R 
Study. Body fat is mainly located subcutaneously in the first two years of life.22,23 Thus, skinfold 
thickness, which is a valid measure to estimate subcutaneous fat mass,24 might be particularly 
relevant in infancy. Also, information on total and regional subcutaneous fat mass can be ob-
tained from these measurements, enabling the study of different locations of fat at younger 
ages. We showed that maternal pre-pregnancy body mass index was positively associated 
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with total subcutaneous fat mass but not with central-to-total subcutaneous fat mass ratio at 
24 months. No associations were observed with subcutaneous fat mass measures at 1.5 and 6 
months. Thus, results from this thesis showed that maternal pre-pregnancy obesity seems to 
influence total body fat mass development already from early infancy onwards.
As compared to total or subcutaneous fat, excess visceral, heart and liver fat has been de-
scribed as better indicators of cardiometabolic risk.25-27 In 105 healthy mother-newborn pairs, 
higher maternal body mass index was associated with higher infant abdominal fat, indepen-
dently of weight, and higher intrahepatocellular lipid content.28 In another study among 25 
newborns, infants born to obese mothers with gestational diabetes had higher intrahepato-
cellular fat compared with infants born to normal weight mothers.29 Maternal pre-pregnancy 
obesity was also associated with higher visceral fat mass levels in 1,228 Greek children aged 
9-13 years.30 These studies have important limitations, such as their small sample size and the 
lack of properly control for confounding by general adiposity in these associations. The fat 
that is accumulated in a specific location is influenced by the general adiposity status. Thus, to 
assess the risk factors for accumulation in specific depots, it is important to control for the ef-
fect of general adiposity. A previous study in 6-year-old children from the Generation R Study 
reported that maternal pre-pregnancy body mass index was not associated with subcutane-
ous and preperitoneal abdominal fat measured by ultrasound, independently of child´s body 
mass index.21 Contrarily, we showed that higher maternal body mass index was associated 
with higher subcutaneous, visceral, pericardial and liver fat assessed by magnetic resonance 
imaging in 10-year-old children from the Generation R Study. The associations of maternal 
body mass index with offspring subcutaneous and visceral fat seemed to be independent of 
offspring body mass index, suggesting that higher maternal body mass index is associated 
with a specific accumulation of fat in abdominal depots that is not a result of general adipos-
ity. The different results reported in the studies using data from 6- and 10-year-old children 
from the Generation R Study might be related to the use of different methods for measuring 
subcutaneous and visceral fat mass. Ultrasound has been shown to be a reliable method to 
differentiate between the abdominal preperitoneal and subcutaneous fat compartments but 
showed poorer accuracy and reproducibility as compared to magnetic resonance imaging 
that has been described as a gold standard technique.31 Besides this, lower amounts of fat 
in these specific depots at younger ages might lead to lower variability, and might have, at 
least partly, contributed to the absence of effect in the sample of 6-year-old children. Results 
from this thesis showed that higher maternal body mass index is associated with organ fat 
accumulation, especially abdominal fat, in 10-year-old children.
Gestational weight gain
Excessive gestational weight gain has been associated with an increased risk of childhood 
overweight and obesity.11-13 In a study among 948 mothers and their children from the South-
ampton Women’s Survey, higher maternal total gestational weight gain was associated with 
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higher neonatal total fat mass and higher total fat mass at 6 years but not at 4 years.32 In a study 
among 1,044 mother-child pairs from Project Viva, higher weight gain during pregnancy was 
associated with higher sum of subscapular and triceps skinfold thickness.33 In a retrospective 
cohort study in Germany of 6,837 mother-child pairs, excessive gestational weight gain was as-
sociated with higher risk of abdominal adiposity measured using waist circumference.34 In 313 
mother-child pairs, higher maternal body mass index was associated with higher childhood 
subcutaneous and visceral fat, particularly among mothers with excessive gestational weight 
gain.35 It has been suggested that the associations of maternal weight gain with offspring 
fat mass outcomes may depend upon the timing of gestational weight gain. A prospective 
cohort study among 5,154 UK mothers and their children showed that maternal weight gain 
during early-pregnancy was positively associated with childhood total fat mass.36 A study 
among 977 Greek mothers and their children aged 4 years showed that maternal weight gain 
during early-pregnancy was positively associated with childhood sum of skinfold thickness 
and waist circumference.37 In 5,908 mothers and their 6-year-old children from the Genera-
tion R Study, maternal weight gain in early-, mid- and late-pregnancy was not associated with 
childhood subcutaneous and preperitoneal abdominal fat mass levels, independently of 
body mass index.38 We showed with results from this thesis that maternal total and period-
specific gestational weight gain were not consistently associated with body mass index, total 
subcutaneous fat mass and central-to-total subcutaneous fat mass ratio in infants aged 1.5, 6 
and 24 months from the Generation R Study. Higher maternal total gestational weight gain 
seems to be associated with higher body fat quantity assessed by using a body fat pattern 
combining body mass index, fat mass index and waist-to-height ratio in children aged 7 years 
from the Generation XXI. However, no associations were observed with body fat distribution 
assessed by using a body fat pattern combining waist-to-hip, waist-to-thigh and waist-to-
weight ratios. Similarly, higher weight gain during pregnancy, especially in early-pregnancy, 
was associated with higher body mass index but no consistent associations were observed 
with subcutaneous, visceral, pericardial and liver fat, independently of body mass index in 
children aged 10 years from the Generation R Study. Results from this thesis showed that the 
effects of maternal weight gain during pregnancy on fat mass development seem to become 
more apparent at older offspring ages and seem to be restricted to the general adiposity 
and not to the accumulation in specific depots. The absence of effect, or less clear effect 
as compared to maternal pre-pregnancy body mass index, might be explained by the fact 
that gestational weight gain reflects maternal nutritional status but also other components 
such as the fetus, amniotic fluid, placenta, uterine and mammary tissue expansion, increased 
blood volume, and extracellular fluid.39 
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Underlying mechanisms
It remains unclear whether the associations of maternal adiposity during pregnancy with in-
fant and childhood adiposity are explained by direct intrauterine mechanisms or confounded 
by environmental, lifestyle or genetic characteristics. To help disentangling the underlying 
mechanisms, previous studies have compared the strength of associations of maternal and 
paternal body mass index with infant and childhood adiposity measures. Although studies 
comparing associations of maternal and paternal body mass index with childhood body 
mass index have shown conflicting results,40 other studies have shown that maternal pre-
pregnancy body mass index tends to be more strongly associated with childhood total fat 
mass than paternal body mass index.21,41 In this thesis, we showed stronger associations for 
paternal body mass index with infant body mass index at 1.5 months but stronger associa-
tions for maternal pre-pregnancy body mass index with infant body mass index and total 
subcutaneous fat mass from the age of 6 months onwards. These results suggest that intra-
uterine programming effects may become more apparent at later ages. We also showed a 
tendency for stronger associations of maternal pre-pregnancy body mass index with general 
and abdominal fat at 10 years. Even though there is a tendency in this thesis for stronger 
associations of maternal body mass index with infant and childhood adiposity measures, 
the confidence intervals of the maternal and paternal effect estimates were not statistically 
different and thus no clear conclusions can be drawn. In this thesis, we also showed, by using 
a path analysis, that the positive although small effect of gestational weight gain on child´s 
body fat quantity seemed to be mainly through intrauterine programming effects instead of 
indirect effects through birth weight.
The mechanisms by which maternal adiposity during pregnancy might affect offspring´s 
general, abdominal and organ fat accumulation are not fully known yet. A maternal obe-
Main findings
• Higher maternal body mass index was associated with higher body mass index 
and total subcutaneous fat mass from 6 months onwards, but not with central-to-
total subcutaneous fat mass ratio in infancy. 
• Higher maternal body mass index was associated with higher abdominal, 
pericardial and liver fat measures at 10 years. The associations with abdominal 
subcutaneous and visceral fat were independent of body mass index.
• Maternal total and period-specific gestational weight gain were not associated 
with body mass index and subcutaneous fat mass measures in infancy.
• Maternal gestational weight gain was positively associated with body fat quantity 
but not with body fat distribution at 7 years.
• Maternal total and period-specific gestational weight gain were not consistently 
associated with subcutaneous, visceral, pericardial and liver fat measures, inde-
pendently of body mass index at 10 years.
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sogenic environment during pregnancy leads to higher maternal plasma concentrations of 
glucose, amino acids and free fatty acids that are transferred to the developing fetus. Fetal 
over-nutrition has been associated with a permanent increase in the capacity of adipocytes 
to store lipids.42 Moreover, intrauterine exposure to a high-fat diet43,44 and/or to hypergly-
cemia45 is thought to induce excessive appetite postnatally due to a dysregulation in the 
expression of appetite-regulating genes and a reduced sensitivity of central hypothalamic 
neuropeptides to peripheral satiety signals (specifically leptin and insulin). Maternal over-
nutrition might also lead to accumulation of fat in the liver and other developing organs of 
the fetus, especially during early- and mid-pregnancy due to the absence of adipose tissue.46 
The postnatal persistence of increased fat in these depots might be related to reduced fatty 
acid oxidation, changes in lipogenesis and lipoprotein export.46
Infant adiposity 
Infant adiposity and childhood adiposity
Body mass index tends to track from infancy onwards.47,48 Although total and central fat mass 
track moderately from childhood into adulthood,49-55 the stability of these measures already 
from early infancy onwards is not known. We showed a moderate tracking of body mass 
index from 1.5 and 24 months to 6 years in children from the Generation R Study. Also, total 
subcutaneous fat mass at 24 months was positively associated with fat mass index at 6 years, 
suggesting tracking of total fat mass from infancy into school-age. Higher total subcutane-
ous fat mass and central-to-total subcutaneous fat mass ratio in infancy were associated with 
higher central-to-total and android-to-gynoid fat mass ratios measured by dual energy X-ray 
absorptiometry and preperitoneal fat mass area measured by abdominal ultrasound at 6 
years old.  We observed stronger effect estimates for infant total subcutaneous fat mass than 
for central-to-total subcutaneous fat mass ratio, in the associations with similar measures at 
school-age, although both showed weaker effect estimates compared with the tracking of 
body mass index from infancy to childhood. Stronger effect estimates were observed among 
girls than boys which might be explained by a more stable body fat development, driven by 
less hormonal fluctuations, during infancy in girls.56 Also, the effect estimates were stronger 
for 24 months than for 1.5 months fat mass measures, which might be due to the shorter 
interval between 24 months and 6 years old. Also, 1.5 months might be more reflective of 
fetal growth patterns which seemed to be less predictive, as compared to postnatal growth, 
of later abdominal adiposity.57 Thus, results from this thesis showed that body mass index and 
subcutaneous fat mass measures in infancy are positively associated with body mass index, 
total and abdominal fat mass at school-age. Compared with body mass index, subcutaneous 
fat mass measures in infancy add little value to estimate adiposity in childhood. 
Infant adiposity and childhood cardiovascular risk factors
Rapid weight gain in the first 3 months of life has been associated with increased adiposity 
and an unfavorable cardiovascular profile in later life.19 However, it remains unknown whether 
gain in body mass index or ponderal index (weight/height3) in infancy predisposes individuals 
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to cardiovascular risk. A study among 4,601 UK subjects has shown that changes in ponderal 
index from 0 to 2 years were not associated with cardiovascular risk factors in adolescence.58 
Similarly, we observed no associations of body mass index at the ages of 1.5 and 24 months or 
its change in this period with cardiovascular risk factors at 6 years. Previous studies have also 
shown that high total and central subcutaneous fat mass measures, estimated from skinfold 
thicknesses, are associated with an adverse cardiovascular risk profile in childhood.59-65 Cur-
rently, it is not known whether total and central subcutaneous fat mass measures in infancy 
are associated with cardiovascular risk factors in later life. We observed no associations of 
infant subcutaneous fat mass measures with childhood blood pressure and triglycerides or 
insulin levels in children from the Generation R Study. At 1.5 months, total subcutaneous fat 
mass was inversely associated with low-density lipoprotein (LDL)-cholesterol at 6 years old. 
Residual confounding by children´s dietary intake and physical activity might have contrib-
uted to this finding, since we had only available information about breastfeeding, age at 
introduction of solid foods and TV watching time at 6 years. At 24 months, total subcutane-
ous fat mass, but not central-to-total subcutaneous fat mass ratio, was positively but weakly 
associated with childhood total- and LDL-cholesterol, independently of body mass index at 6 
years old. Results from this thesis suggest that body mass index and subcutaneous fat mass 
measures in infancy seem to be poor indicators of cardiovascular risk profile in later child-
hood. These findings may be partially explained by the fact that fat mass measures in infancy 
represent the accumulation of fat mass over a short period of time, which may not be long 
enough to influence cardiovascular risk profile.
Main findings
• Infant body mass index and subcutaneous fat mass measures were positively 
associated with body mass index, total and abdominal fat mass at school-age.
• Infant body mass index and subcutaneous fat mass measures were not as-
sociated with childhood blood pressure and triglycerides or insulin levels. Total 
subcutaneous fat mass was weakly associated with cholesterol levels at 6 years, 
independently of body mass index.
METHoDoloGICAl ConSIDERATIonS
Strengths and limitations for each study are described in Chapter 2 and Chapter 3 of this 
thesis. In the following paragraphs, general methodological considerations regarding selec-
tion bias, information bias, confounding and causality are discussed.
Selection bias
Selection bias is a bias in the estimated association or effect of an exposure on an outcome 
that arises from the procedures used to select individuals into the study or the analysis.66 
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It is present when the association between exposure and outcome in study participants is 
different as compared to that in eligible non-participants. Selection bias may occur due to 
selective non-response at baseline or selective loss to follow-up. 
Generation XXI
Of the invited mothers, 91% accepted to participate. When compared to the mothers from 
the catchment area, delivering in 2005 and 2006, cohort participants were slightly younger 
but similar in marital status. The prevalence of caesarean section was slightly higher than 
the prevalence in Portugal in 2004. The cohort had a similar gender proportion but higher 
proportion of multiple fetuses as compared to the national percentages. When compared 
to the Portuguese deliveries in 2005 and 2006, the cohort presented a higher proportion of 
preterm and low birth weight newborns, probably because all the maternities enrolled had 
highly differentiated perinatal support.
In this thesis, we used data from the 7-year-old re-evaluation, in which 80% of the entire 
cohort participated. Mothers participating in follow-up studies were slightly older and higher 
educated, although the magnitude of the differences was small.
Generation R Study
The participation rate at birth was 61%. As compared to the general population in Rotterdam, 
women from the Generation R Study were less likely to be from ethnic minority groups and 
of lower socioeconomic status. Also, participating women were less likely to develop gesta-
tional hypertensive disorders and have children born preterm or with low birth weight. 
In this thesis, we used data from the subgroup of Dutch mothers and their children partici-
pating in additional detailed assessments of growth and development from late pregnancy 
onwards, in which the loss to follow-up at 1.5, 6 and 24 months and 6 years old was low. 
We also used data from the follow-up at the age of 10 years, in which 76% of the original 
cohort participated in the study. A lower percentage of children participated in the magnetic 
resonance imaging measurements of abdominal and organ fat at 10 years, which was mainly 
due to non-consent. Compared to the baseline characteristics, mothers who did visit the 
research center in the follow-up evaluations were older, more frequently of Dutch nationality 
and higher educated.67
Generation XXI might have included mothers that were more likely to have children born 
preterm or with low birth weight. It is difficult to speculate whether this could have biased 
our effect estimates. On the other hand, the selective non-response at baseline in the 
Generation R Study suggests a selection towards a more affluent and healthy population, 
which may have led to lower prevalence rates of maternal, infant and childhood adiposity 
and cardiovascular risk factors, and subsequently reduced statistical power. Also, it may af-
fect the generalizability of our findings to less healthy and affluent populations. However, 
several studies have shown that in cohort studies associations are not strongly influenced by 
selective non-participation at baseline, and therefore it seems unlikely that the results of this 
thesis are biased due to the selection procedures.68,69
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Similarly, the selective loss to follow-up in both cohorts suggests a selection towards a 
healthier population. Although difficult to speculate if this might have biased our effect es-
timates, this seems unlikely since participants did not differ from non-participants regarding 
the exposures of interest, such as maternal pre-pregnancy body mass index.
Information bias
Information bias is a bias in an estimate arising from measurement errors or misclassifica-
tion.66 In this thesis, we relied on anthropometric measurements, such as body mass index, 
indices based on waist circumference and skinfold thicknesses, which might have greater 
measurement error and be less accurate, but on the other hand be easier and cheaper to 
obtain in large epidemiological studies as compared to imaging techniques of body com-
position.24,70,71 High accuracy and reproducibility have been reported for dual energy X-ray 
absorptiometry, abdominal ultrasound and magnetic resonance imaging that were also used 
in this thesis.24,31,72-74 
Misclassification can be non-differential or differential. Non-differential misclassification 
occurs when the determinant status is not related to the outcome status, and vice-versa and 
generally leads to an underestimation of the effect estimates. Differential misclassification 
occurs when the determinant status is related to the outcome status, and vice-versa and 
generally leads to biased results, which can be either overestimated or underestimated. In 
this thesis, differential misclassification is unlikely. Exposure data used in our studies were 
collected longitudinally and before assessment of the outcomes, the data collectors were 
blinded to the exposure status when assessing the outcomes and parents as well as data 
collectors were unaware of the specific research questions under study. However, non-
differential misclassification might have occurred. In the studies included in this thesis, 
information on maternal pre-pregnancy weight and maximum gestational weight was 
self-reported. Women tend to underestimate their weight on self-report,75 which might have 
led to an underestimation of observed effects for maternal pre-pregnancy body mass index. 
Since pre-pregnancy weight and maximum gestational weight are both self-reported and 
probably underestimated, the influence on maximum weight gain is likely to be minimal. 
The attendance of prenatal visits could also have made pregnant women more aware of their 
weight status, minimizing the error of self-reported final pre-delivery weight. The bias in 
the results for maternal pre-pregnancy body mass index and maximum gestational weight 
gain seems also unlikely since similar results were observed when using maternal weight 
measured at enrolment and weight gain measured until late-pregnancy. The use of thirty-
minutes fasting blood samples may have resulted in misclassification and thus may have led 
to underestimation of the observed associations. However, it has been shown in adults that 
non-fasting blood lipid levels can accurately predict increased risks of cardiovascular events 
in later life.76
Confounding
Confounding occurs when all or part of the effect between an exposure and an outcome is 
in fact explained by other variables that affect the outcome but are not themselves affected 
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by the exposure.66 To take account for confounding, we adjusted all analyses for multiple po-
tential confounders. We selected covariates based on their associations with the exposures 
and outcomes of interest in our or previous studies or a change in effect estimate of more 
than 10%. In this thesis, adjustment for potential confounders only moderately affected the 
effect estimates, which suggests that the observed associations are possibly true associa-
tions between the exposures and the outcomes. Although information about many potential 
confounders was available in the studies included in this thesis, residual confounding might 
still be present. Also, information about several confounders was self-reported and misclassi-
fication might have occurred, contributing to residual confounding and an overestimation of 
the observed effect estimates. To help understanding whether the associations of maternal 
obesity with infant and childhood adiposity are explained by direct intrauterine mechanisms 
or confounded by environmental, lifestyle or genetic characteristics, we compared the asso-
ciations of both maternal and paternal body mass index. A similar effect size for the maternal 
and paternal association would suggest that the association of maternal obesity with infant 
and childhood adiposity is explained by unmeasured environmental factors, rather than 
direct intrauterine mechanisms. A limitation of this approach is the assumption that both 
parents contribute equally to the shared lifestyle-related characteristics between parents 
and their offspring. We also performed a comprehensive path analysis to help understanding 
whether the effects of prenatal exposures (gestational weight gain, diabetes and smoking) 
on child´s body fat are mainly explained by a direct (through intrauterine programming) or 
indirect pathway (through birth weight). Although we included the most important paths 
described to date, and tested several covariates as confounders, we cannot exclude the pos-
sibility of existing other paths not considered in this thesis and also residual confounding by 
lifestyles or genetics that might have biased our estimates for the intrauterine programming 
effects. 
Causality
The causality of the associations observed in this thesis remains to be established. The Brad-
ford Hill criteria, that can be useful for providing evidence of a causal relationship between 
an exposure and an outcome, include strength, consistency, specificity, temporality, dose-
response relationship, biological plausibility, coherence, experiment and analogy.66 Overall, 
our associations may be relatively small. Although stronger associations are more likely to be 
causal, weak relationships may also be causal. The main findings of this thesis were consistent 
with previous studies, our studies were longitudinal supporting the temporality between ex-
posures and outcomes, several potential biological mechanisms for these associations have 
been described, and our findings were coherent with animal studies. Although not explored 
in all studies presented in this thesis, we did observe some dose-response effects between 
maternal body mass index and general and organ fat at 10 years. The specificity, experiment 
and analogy criteria were not addressed in this thesis. Although this thesis was not designed 
to fully clarify the causality of these associations, our observational studies seem to provide 
some evidence for causal relationships based on the Bradford Hill criteria.
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FuTuRE RESEARCH
Although findings from this thesis suggest that maternal adiposity during pregnancy and 
infant adiposity adversely affect infant and childhood adiposity and cardiovascular health, 
the following major issues remain to be addressed in future studies.
Causality
We performed an extensive adjustment for potential confounding factors, used parental body 
mass index comparison analyses and path analyses and found some evidence for causality in 
our studies based on the Bradford Hill criteria. However, the causality of the associations for 
maternal adiposity during pregnancy observed in this thesis remains unclear. Randomized 
controlled trials, sibling comparison studies, and Mendelian randomization studies can be 
used to obtain further insight into the causality of the associations.
Randomized controlled trials are the gold standard study design to establish causality. 
Previous randomized controlled trials focused on controlling obesity in pregnant women 
or reducing the risk of excessive gestational weight gain by improving diet and physical 
activity showed small reductions in maternal pre-pregnancy weight and gestational weight 
gain.77-79 The effect of these interventions on infant and childhood outcomes remains to be 
explored. A small randomized controlled trial that provided dietary advice and exercise to 
obese pregnant women showed no differences in their infant body mass index or metabolic 
risk factors.80 Long-term follow-up of participants in these randomized controlled trials might 
provide a unique opportunity to examine whether maternal obesity and excessive gesta-
tional weight gain are causally related to childhood adiposity status and cardiovascular risk. 
It will also provide insight into the effectiveness of these interventions for improving health 
outcomes in the offspring. Many randomized controlled trials have started their interven-
tions from the second trimester onwards.79,81 Considering the findings of this thesis that sug-
gest that promoting a healthy maternal pre-pregnancy body mass index might be of greater 
importance than influencing gestational weight gain, randomized controlled trials focused 
on the preconception or early pregnancy period are needed.
Sibling comparison studies allow control for environmental characteristics as well as 
maternal genotype that are shared among siblings. However, besides major exposures of 
interest, other lifestyle-related characteristics may also differ between siblings, limiting the 
potential of this study design to assess causality.82 Mendelian randomization studies use ge-
netic variants, known to be robustly associated with the exposure of interest and not affected 
by confounding, to examine whether the exposure is causally related to the outcome.83 
Mendelian randomization studies with large sample sizes to have adequate statistical power, 
using multiple maternal genetic variants as instruments and focused on childhood outcomes 
are needed.
Assessment of exposures and outcomes
In this thesis, information on self-reported maternal pre-pregnancy body mass index, 
measured early-, mid-, and late-pregnancy weight and self-reported maximum gestational 
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weight was available. Studies with measured pre-pregnancy weight and maximum gesta-
tional weight might reduce the risk for misclassification and bias. Studies with serial repeated 
maternal weight measurements during pregnancy are also needed to allow a more thorough 
identification of critical time points for adiposity and cardiovascular development. Gesta-
tional weight gain reflects multiple components, which might complicate the interpretation 
of the associations. Studies disentangling the different components of gestational weight 
gain might provide further insight into the underlying mechanisms. Infant and childhood 
outcomes studied in this thesis included total, abdominal and organ fat, blood pressure, lipids 
and insulin levels. We used magnetic resonance imaging that is a gold standard technique for 
measuring intra-abdominal and ectopic fat deposition.31,72-74 However, we only have magnetic 
resonance imaging measurements available at 10 years. Future studies should measure these 
body fat compartments, which have important adverse metabolic consequences, at younger 
ages to obtain further insight into its development and related risk factors and health con-
sequences. Additional measurements of childhood cardiovascular development might also 
provide further insight into the underlying mechanisms linking early life exposures to cardio-
vascular events in later life. Measures of endothelial function, intima media thickness, insulin/
glucose metabolism and coronary circulation imaging in children might be of interest to gain 
more knowledge about the cardiovascular development. To obtain further insight into the 
underlying mechanisms for the associations addressed in this thesis, large population-based 
studies focused on epigenetics and metabolomics are needed. Further research needs to 
explore whether and which critical periods are involved in these associations.
IMPlICATIonS FoR ClInICAl PRACTICE AnD PolICy
Maternal adiposity during pregnancy and infant adiposity might influence the adiposity sta-
tus and cardiovascular profile in later life. The observed effect estimates were small to moder-
ate, but are of interest from a developmental perspective since obesity and cardiovascular 
risk factors tend to track into adulthood. Also, even subclinical differences in cardiovascular 
risk factors during childhood are related to the development of cardiovascular disease in 
later life. Thus, prevention of maternal adiposity during pregnancy and infant adiposity is 
important to reduce the burden of obesity and cardiovascular disease throughout the life 
course and in future generations.
Preventive strategies or interventions focused on the preconception period or during preg-
nancy should be implemented. Women might be more motivated to make lifestyle changes 
in preconception period and pregnancy and might also keep these new lifestyle habits after 
pregnancy, highlighting the potential for health gains. In particular, based on our findings, 
promoting a healthy body mass index in women when entering pregnancy might be of 
greater importance than influencing gestational weight gain. So, it is essential to promote 
knowledge about the importance of a healthy weight in women of reproductive age. General 
practitioners, gynecologists, and other health professionals should inform and advise young 
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women. Also, specific health care programs aiming to encourage healthy eating and physical 
activity for overweight or obese mothers-to-be should be conducted.
Information about the benefits of an adequate body composition during infancy should 
also be provided to families together with proper recommendations for breastfeeding, 
introduction of solid foods and other environmental and behavioral factors that might 
impact the health of the child later in life. Since the education sector plays a critical role in 
providing nutrition and health education, increasing the opportunities for physical activity 
and promoting healthy school environments is of utmost importance in preventing obesity 
in childhood.5
ConCluSIon
Findings from this thesis suggest that maternal adiposity during pregnancy and infant 
adiposity are associated with infant and childhood adiposity and cardiovascular health out-
comes. The observed associations are relatively small, but may be important for the burden 
of obesity and cardiovascular disease on a population level.
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Summary
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Chapter 1 provides the background, hypothesis, aims and design for this thesis. Obesity is in-
creasing in prevalence worldwide and has large clinical implications in childhood and adulthood. 
An accumulating body of evidence suggests that obesity and cardiometabolic diseases in child-
hood and adulthood at least partly originate in fetal or early postnatal life. Adverse exposures, 
acting during fetal and early postnatal development, lead to permanent adaptations in the 
structure, physiology and function of various organ systems. In particular, maternal adiposity 
during pregnancy might lead to a higher risk of obesity in the offspring through intrauterine 
programming mechanisms. A maternal obesogenic environment during pregnancy leads to 
fetal over-nutrition and might cause permanent changes in the development of adipocytes, 
and in the appetite control system. Infant growth patterns, such as rapid postnatal weight gain, 
seem also to be critical for the development of obesity and cardiovascular diseases in later life. 
Assessing the influence of maternal adiposity during pregnancy and infant growth and adiposity 
on detailed offspring fat measures and cardiovascular risk factors is important to obtain a better 
understanding of the influence of mother´s and infant´s health on health outcomes in later life. 
Therefore, the general aim of this thesis was to assess the adiposity and cardiovascular health 
related consequences of maternal and infant adiposity. The studies presented in this thesis used 
data from the Generation XXI, a population-based birth cohort in Porto, Portugal and the Genera-
tion R Study, a population-based cohort from fetal life onwards in Rotterdam, the Netherlands. 
In Chapter 2, studies on the influence of maternal adiposity during pregnancy on infant 
and childhood outcomes are described. In Chapter 2.1, we reviewed the childhood health 
consequences of maternal obesity during pregnancy. Evidence from observational studies 
strongly suggests that maternal pre-pregnancy obesity and excessive gestational weight 
gain are associated with increased risks of fetal pregnancy complications and adverse child-
hood cardiometabolic, respiratory and cognitive-related health outcomes. It remains unclear 
whether these associations are due to intrauterine mechanisms or explained by confounding. 
The underlying epigenetic mechanisms have been assessed in animal studies and small hu-
man studies, but have not been tested yet in large human studies. In Chapter 2.2, we studied 
the influence of maternal body mass index, and gestational weight gain on body mass index 
and subcutaneous fat mass measures at the ages of 1.5, 6 and 24 months. We observed that 
higher maternal pre-pregnancy body mass index was associated with higher body mass index 
and total subcutaneous fat mass from 6 months onwards. No associations were observed 
for central-to-total subcutaneous fat mass ratio in infancy. Maternal total and period-specific 
gestational weight gain were not associated with body mass index and subcutaneous fat mass 
measures at 1.5, 6 and 24 months. Next, we examined the associations of maternal gestational 
weight gain, diabetes and smoking on total and regional adiposity at the age of 7 years and 
explored whether these associations were through direct intrauterine mechanisms or through 
birth weight (Chapter 2.3). We observed a positive total effect of maternal gestational weight 
gain, diabetes and smoking during pregnancy on child´s body fat quantity. Maternal smoking 
was also associated with a central fat distribution in children. These effects seem to be mainly 
through intrauterine programming rather than indirect effects through birth weight. In Chap-
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ter 2.4, we assessed the associations of maternal body mass index, and gestational weight 
gain with general, abdominal, pericardial and liver fat at the age of 10 years. We observed that 
higher maternal body mass index was associated with higher body mass index, fat mass index, 
and subcutaneous, visceral, pericardial and liver fat. The associations with abdominal fat were 
independent of child´s body mass index. Higher weight gain during pregnancy, especially in 
early-pregnancy, was associated with higher body mass index but no consistent associations 
were observed with subcutaneous, visceral, pericardial and liver fat, independently of body 
mass index. In summary, findings from Chapter 2 suggest that maternal obesity and excessive 
gestational weight gain are important modifiable factors during pregnancy that are associated 
with adverse health outcomes in the offspring.
In Chapter 3, studies on the influence of infant adiposity on childhood outcomes are 
described. In Chapter 3.1, we compared the accuracy of body fat patterns and single mea-
sures for assessing body fat and clarified the use of indices based on waist circumference as 
measures of adiposity in children. Pattern 1 (body mass index, fat mass index from tetra-polar 
bioelectric impedance and waist-to-height ratio) showed stronger correlations with dual 
energy X-ray absorptiometry (DXA)-fat mass index and pattern 2 (waist-to-hip, waist-to-thigh 
and waist-to-weight ratios) showed stronger correlations with DXA-central fat. We observed 
that as compared to single measures, body fat patterns showed similar correlations with DXA-
derived measures. Single anthropometric indices seem to be enough to accurately estimate 
body fat. Waist-to-height ratio might be a proxy for total fat, while waist-to-hip, waist-to-
thigh and waist-to-weight ratios might be proxies for central fat. The influence of infant body 
mass index and subcutaneous fat mass measures on childhood adiposity and cardiovascular 
risk factors is studied in Chapter 3.2 and Chapter 3.3, respectively. We observed that infant 
body mass index and subcutaneous fat mass measures are positively associated with body 
mass index, total and abdominal fat mass at school-age. The effect estimates were stronger 
for body mass index and total subcutaneous fat mass than for central-to-total subcutaneous 
fat mass ratio, and for girls compared with boys. Also, the effect estimates were stronger for 
24 months than for 1.5 months fat mass measures (Chapter 3.2). Infant body mass index and 
subcutaneous fat mass measures were not associated with childhood blood pressure, triglyc-
erides or insulin levels. Higher total subcutaneous fat mass at 1.5 months was associated with 
lower low-density lipoprotein (LDL)-cholesterol levels while higher total subcutaneous fat 
mass at 24 months was associated with higher total-cholesterol and LDL-cholesterol levels at 
6 years, independently of body mass index. There were no associations of body mass index 
and central-to-total subcutaneous fat mass ratio with childhood cholesterol levels (Chapter 
3.3). In summary, findings from Chapter 3 suggest that infant adiposity is related to child-
hood adiposity and weakly related to childhood cholesterol levels. Finally, in Chapter 4, a 
general discussion of all studies included in this thesis, suggestions for future research and 
implications for clinical practice and policy are presented.
In conclusion, findings from this thesis suggest that maternal adiposity during pregnancy 
and infant adiposity are associated with infant and childhood adiposity and cardiovascular 
health outcomes. The observed associations are relatively small, but may be important for 
the burden of obesity and cardiovascular disease on a population level. 
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RESuMo
O Capítulo 1 inclui a introdução, os objetivos e a população em estudo desta tese. A pre-
valência de obesidade está a aumentar em todo o mundo e tem importantes implicações 
clínicas nas crianças e nos adultos. Evidência científica sugere que a obesidade e as doenças 
cardiometabólicas nas crianças e nos adultos têm origem, pelo menos parcialmente, no 
período pré- e pós-natal. Exposições adversas, durante o período pré- e pós-natal, podem 
resultar em adaptações permanentes na estrutura, fisiologia e função de vários sistemas 
de órgãos. Em particular, a adiposidade das mães durante a gravidez pode aumentar o 
risco de obesidade nos seus filhos através de mecanismos de programação intrauterina. Um 
ambiente materno obesogénico durante a gravidez está associado a sobrenutrição fetal e 
pode causar alterações permanentes no desenvolvimento dos adipócitos e no sistema de 
controlo do apetite. Os padrões de crescimento na infância, tais como um rápido ganho de 
peso pós-natal, parecem ser críticos para o desenvolvimento de obesidade e doenças cardio-
vasculares na vida adulta. Estudar a influência da adiposidade materna durante a gravidez e 
do crescimento e adiposidade infantil em medidas de adiposidade e em fatores de risco car-
diovascular ao longo da vida é importante para melhorar o conhecimento sobre a influência 
da saúde materna e infantil na saúde futura. Por isso, o objetivo geral desta tese foi estudar as 
consequências relacionadas com a adiposidade e com a saúde cardiovascular da adiposidade 
materna e infantil. Os estudos apresentados nesta tese usaram dados da Geração XXI, uma 
coorte de nascimento de base populacional no Porto, Portugal e da Generation R, uma coorte 
de base populacional desde a vida fetal em Roterdão, Holanda.
 No Capítulo 2, os estudos sobre a influência da adiposidade materna durante a gravidez na 
saúde das crianças foram descritos. No Capítulo 2.1, as consequências na saúde das crianças 
relacionadas com a obesidade materna durante a gravidez foram sumariadas numa revisão. 
Evidência de estudos observacionais sugere que a obesidade materna e o ganho de peso 
excessivo durante a gravidez estão associados com um aumento do risco de complicações da 
gravidez e de problemas de saúde cardiometabólicos, respiratórios e cognitivos nas crianças. 
Permanece por clarificar se as associações são resultado de mecanismos intrauterinos ou 
explicadas por confundimento. Os mecanismos epigenéticos subjacentes têm sido explora-
dos em estudos com animais e com amostras pequenas de seres humanos, mas ainda não 
foram testados em estudos com grande tamanho amostral. No Capítulo 2.2, nós estudamos 
a influência do índice de massa corporal materno e ganho de peso gestational no índice de 
massa corporal e medidas de massa gorda subcutânea aos 1,5, 6 e 24 meses. Nós observamos 
que um aumento no índice de massa corporal materno estava associado com um aumento 
no índice de massa corporal e massa gorda subcutânea total a partir dos 6 meses. Não foram 
observadas associações com a razão de massa gorda subcutânea central-total na infância. 
O ganho de peso gestacional total ou por trimestre não estava associado com o índice de 
massa corporal e medidas de massa gorda subcutânea aos 1,5, 6 e 24 meses. De seguida, 
nós avaliamos as associações do ganho de peso gestacional, diabetes e hábitos tabágicos na 
adiposidade total e localizada aos 7 anos e exploramos se essas associações ocorriam através 
de mecanismos intrauterinos diretos ou através do peso ao nascimento (Capítulo 2.3). Nós 
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observamos um efeito total positivo do ganho de peso, diabetes e hábitos tabágicos du-
rante a gravidez na quantidade de gordura corporal da criança. Os hábitos tabágicos da mãe 
estavam também associados com uma distribuição de gordura central nas crianças. Estes 
efeitos parecem ocorrer maioritariamente através de programação intrauterina em vez de 
serem efeitos indiretos através do peso ao nascimento. No Capítulo 2.4, nós avaliamos as as-
sociações do índice de massa corporal materno e ganho de peso gestacional com a gordura 
corporal total, abdominal, do pericárdio e do fígado aos 10 anos. Nós observamos que um 
aumento do índice de massa corporal materno estava associado com um aumento do índice 
de massa corporal, índice de massa gorda e gordura subcutânea, visceral, do pericárdio e do 
fígado. As associações com a gordura abdominal eram independentes do índice de massa 
corporal da criança. Um aumento do ganho de peso durante a gravidez, especialmente no 
início da gravidez, estava associado com um aumento do índice de massa corporal mas não 
foram observadas associações consistentes com a gordura subcutânea, visceral, do pericár-
dio e do fígado, independentemente do índice de massa corporal. Em síntese, os resultados 
do Capítulo 2 sugerem que a obesidade materna e o ganho de peso gestacional excessivo 
são importantes fatores de risco modificáveis que estão associados com problemas de saúde 
nas crianças.
No Capítulo 3, os estudos sobre a influência da adiposidade infantil na saúde das cri-
anças foram descritos. No Capítulo 3.1, nós comparamos padrões de gordura corporal e 
medidas individuais para avaliar gordura corporal e clarificamos o uso de índices baseados 
no perímetro da cintura como medidas de adiposidade nas crianças. O padrão 1 (índice de 
massa corporal, índice de massa gorda obtido a partir da bioimpedância tetrapolar e razão 
cintura-altura) apresentou correlações mais fortes com o índice de massa gorda obtido a 
partir da absorciometria de raios X de dupla energia (DXA) e o padrão 2 (razão cintura-anca, 
cintura-coxa e cintura-peso) apresentou correlações mais fortes com a gordura central obtida 
a partir do DXA. Nós observamos que quando comparado com as medidas individuais, os pa-
drões de gordura corporal apresentaram correlações semelhantes com as medidas obtidas a 
partir do DXA. Os índices antropométricos individuais parecem ser suficientes para estimar a 
gordura corporal. A razão cintura-altura pode ser usada para estimar gordura total, enquanto 
as razões cintura-anca, cintura-coxa e cintura-peso podem ser usadas para estimar gordura 
central. A influência do índice de massa corporal e medidas de massa gorda subcutânea 
durante os primeiros 2 anos de vida na adiposidade e fatores de risco cardiovascular nas 
crianças foi estudada no Capítulo 3.2 e Capítulo 3.3, respetivamente. Nós observamos que o 
índice de massa corporal e as medidas de massa gorda subcutânea nos primeiros 2 anos de 
vida estão positivamente associadas com o índice de massa corporal, e com a massa gorda 
total e abdominal em idade escolar. As estimativas de efeito eram mais fortes para o índice de 
massa corporal e massa gorda subcutânea total do que para a razão de massa gorda subcu-
tânea central-total, e para as raparigas do que para os rapazes. Além disso, as estimativas de 
efeito eram mais fortes para as medidas de massa gorda aos 24 meses do que aos 1,5 meses 
(Capítulo 3.2). O índice de massa corporal e as medidas de massa gorda subcutânea não 
estavam associados com a pressão arterial, triglicerídeos e insulina nas crianças. Um aumento 
da massa gorda subcutânea total aos 1,5 meses estava associado com uma diminuição dos 
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níveis de colesterol da lipoproteína de baixa densidade (LDL) enquanto um aumento da 
massa gorda subcutânea total aos 24 meses estava associado com um aumento dos níveis de 
colesterol total e LDL aos 6 anos, independentemente do índice de massa corporal. Não se 
observaram associações do índice de massa corporal e da razão de massa gorda subcutânea 
central-total com os níveis de colesterol nas crianças (Capítulo 3.3). Em síntese, os resultados 
do Capítulo 3 sugerem que a adiposidade durante os primeiros 2 anos de vida está asso-
ciada com a adiposidade e fracamente associada com os níveis de colesterol nas crianças. 
Finalmente, no Capítulo 4, apresentamos uma discussão geral de todos os estudos incluídos 
nesta tese, sugestões para investigação futura e implicações para a prática clínica e políticas 
de saúde.
Em conclusão, os resultados desta tese sugerem que a adiposidade materna durante a 
gravidez e a adiposidade durante os primeiros 2 anos de vida estão associadas com a adi-
posidade e saúde cardiovascular nas crianças. As associações observadas são relativamente 
pequenas, mas podem ser importantes para o impacto da obesidade e da doença cardiovas-
cular ao nível populacional. 
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Hoofdstuk 1 beschrijft de achtergrond, hypothese, de doelstelling en de opzet van het 
onderzoek beschreven in dit proefschrift. De wereldwijde prevalentie van obesitas neemt 
toe. Obesitas heeft belangrijke gevolgen voor de gezondheid van zowel kinderen als volwas-
senen. Eerder onderzoek suggereert dat obesitas en cardiometabole ziekten in de kindertijd 
en op volwassen leeftijd hun grondslag deels al vinden in de foetale en vroege postnatale 
ontwikkeling. Blootstelling aan ongunstige factoren tijdens deze foetale of vroeg postnatale 
periode leidt tot blijvende aanpassingen in de structuur, fysiologie en functie van verschil-
lende orgaansystemen. In het bijzonder zou maternale adipositas tijdens de zwangerschap 
via intra-uteriene programmering kunnen leiden tot een hoger risico op obesitas bij het kind. 
Een obesogene omgeving tijdens de zwangerschap leidt tot foetale overvoeding en zou kun-
nen leiden tot blijvende verandering in de ontwikkeling van adipocyten en het verzadigings-
systeem. Groeipatronen tijdens de peutertijd, zoals een snelle postnatale gewichtstoename, 
lijken ook belangrijk te zijn voor de ontwikkeling van obesitas en cardiovasculaire ziekten 
later in het leven. Het is van belang om meer inzicht te verkrijgen in de invloed van maternale 
adipositas tijdens de zwangerschap en de groei en adipositas van het kind tijdens de peuter-
tijd op gedetailleerde maten van lichaamssamenstelling en cardiovasculaire risicofactoren 
op latere leeftijd. Het doel van dit proefschrift was daarom om de gevolgen te onderzoeken 
van adipositas bij de moeder en in de peutertijd met betrekking tot adipositas en cardio-
vasculaire gezondheid later in het leven. Voor de studies beschreven in dit proefschrift zijn 
gegevens gebruikt van de Generation XXI, een populatie-gebaseerd geboortecohort in 
Porto, Portugal, en van de Generation R Studie, een populatie-gebaseerd cohort dat gevolgd 
wordt vanaf het vroege foetale leven in Rotterdam, Nederland.
In Hoofdstuk 2 worden studies beschreven betreffende de invloed van maternale adiposi-
tas tijdens de zwangerschap op gezondheidsuitkomsten tijdens de peuter- en kindertijd. In 
Hoofdstuk 2.1 hebben we het bestaande onderzoek naar de gevolgen van maternale 
obesitas tijdens de zwangerschap op de gezondheid van het kind samengevat. Observatio-
nele studies stellen dat maternale obesitas vooraf aan de zwangerschap en een verhoogde 
gewichtstoename tijdens de zwangerschap geassocieerd zijn met een verhoogd risico op 
complicaties bij de foetus tijdens de zwangerschap en ongunstige cardiometabole, respira-
toire en cognitieve gezondheidsuitkomsten op de kinderleeftijd. Het is niet duidelijk of deze 
associaties het gevolg zijn van intra-uteriene mechanismen of verklaard kunnen worden 
door confounding. De epi-genetische mechanismen onderliggend aan deze associaties 
zijn bestudeerd in dierstudies en kleine studies bij mensen, maar zijn nog niet onderzocht 
in grotere populatie gebaseerde studies. In Hoofdstuk 2.2 hebben we de invloed van ma-
ternale body mass index en gewichtstoename tijdens de zwangerschap op de body mass 
index en maten voor subcutaan vet bij het kind op de leeftijden van 1.5, 6 en 24 maanden 
onderzocht. We lieten zien dat hogere maternale body mass index was geassocieerd met 
een hogere body mass index en totale subcutane vetmassa vanaf de leeftijd van 6 maanden. 
Maternale body mass index was niet geassocieerd met de centraal/totaal subcutaan vet ratio 
tijdens de peutertijd. Maternale totale en periode-specifieke gewichtstoename tijdens de 
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zwangerschap waren niet geassocieerd met body mass index en maten van subcutaan vet 
op de leeftijden van 1.5, 6 en 24 maanden. Daarnaast hebben we gekeken naar de associaties 
van gewichtstoename tijdens de zwangerschap, diabetes, en roken met totale en regionale 
adipositas op de leeftijd van 7 jaar, en hebben we onderzocht of deze associaties verklaard 
werden door directe intra-uteriene mechanismen of door het geboortegewicht (Hoofdstuk 
2.3). We zagen een positief totaal effect van gewichtstoename, diabetes en roken tijdens de 
zwangerschap op de hoeveelheid lichaamsvet bij het kind. Roken tijdens de zwangerschap 
was ook geassocieerd met een centrale vetverdeling bij kinderen. Deze effecten lijken vooral 
verklaard te worden door intra-uteriene programmering en niet door indirecte effecten via 
geboortegewicht. In Hoofdstuk 2.4 onderzochten we de associaties van maternale body 
mass index en gewichtstoename tijdens de zwangerschap met totaal-, abdominaal-, peri-
cardiaal- en levervet op de leeftijd van 10 jaar. We observeerden dat een hogere body mass 
index van de moeder was geassocieerd met een hogere body mass index en  een hogere 
massa van het subcutane-,viscerale-, pericardiale- en levervet.De associaties met abdomi-
naalvet waren onafhankelijk van de body mass index van het kind. Meer  gewichtstoename 
tijdens de zwangerschap, vooral tijdens de vroege zwangerschap, was geassocieerd met 
een hogere body mass index, maar er waren geen consistente associaties met subcutaan-, 
visceraal-, pericardiaal- en levervet, onafhankelijk van de body mass index. Samengevat, de 
bevindingen beschreven in Hoofdstuk 2 suggereren dat maternale obesitas en meer ge-
wichtstoename tijdens de zwangerschap belangrijke factoren zijn die geassocieerd zijn met 
ongunstige gezondheidsuitkomsten bij kinderen.
In Hoofdstuk 3 worden studies naar de invloed van adipositas tijdens de peutertijd op 
gezondheidsuitkomsten op de kinderleeftijd beschreven. In Hoofdstuk 3.1 vergeleken we 
de patronen van lichaamsvet met enkelvoudige maten van lichaamsvet en beschreven we 
het gebruik van indexen gebaseerd op middelomtrek als maten van adipositas bij kinderen. 
Patroon 1 (body mass index, vetmassa index verkregen met tetra-polar bioelectric imped-
ance, en middelomtrek/lengte ratio) was sterker gecorreleerd aan vetmassa index verkregen 
met dual energy X-ray absorptiometry (DXA) scans en patroon 2 (middelomtrek/heupomtrek, 
middelomtrek/dijomtrek en middelomtrek/gewicht ratio’s) was sterker gecorreleerd met 
centraal vet, verkregen met DXA scans. De correlaties van lichaamsvetpatronen met maten 
verkregen met DXA scans waren gelijk aan die van de enkelvoudige maten van lichaams-
vet. Enkelvoudige antropometrische indexen lijken voldoende te zijn om de hoeveelheid 
lichaamsvet te schatten. Middelomtrek/lengte ratio zou een proxy kunnen zijn voor totaal 
vet, terwijl middelomtrek/heupomtrek, middelomtrek/dijomtrek en middelomtrek/gewicht 
ratio’s proxies zouden kunnen zijn voor centraal vet. De invloed van body mass index en 
maten voor subcutaan vet tijdens de peutertijd op adipositas en cardiovasculaire risicofac-
toren tijdens de kindertijd zijn onderzocht in respectievelijk  Hoofdstuk 3.2 en Hoofdstuk 
3.3. We hebben laten zien dat body mass index en maten voor subcutaan vet tijdens de 
peutertijd positief geassocieerd zijn met body mass index en totale en abdominale vetmassa 
op schoolgaande leeftijd. De associaties waren sterker voor body mass index en totaal sub-
cutaan vet dan voor de centraal/totaal subcutaan vet ratio en waren ook sterker voor meisjes 
dan voor jongens. Daarnaast waren de effecten sterker op de leeftijd van 24 maanden dan 
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op de leeftijd van 1.5 maand (Hoofdstuk 3.2). Body mass index en maten voor subcutaan 
vet waren niet geassocieerd met bloeddruk, triglyceriden of insuline waarden op de kinder-
leeftijd. Een hogere totale subcutane vetmassa op de leeftijd van 1.5 maand was geassocieerd 
met lagere LDL-cholesterol waarden, terwijl een hogere totale subcutane vetmassa op de 
leeftijd van 24 maanden geassocieerd was met hogere totaal-cholesterol waarden en LDL-
cholesterol waarden op de leeftijd van 6 jaar, onafhankelijk van body mass index. Body mass 
index en centraal/totaal vetmassa ratio waren niet geassocieerd met cholesterol waarden op 
de kinderleeftijd (Hoofdstuk 3.3). Samengevat, de bevindingen beschreven in Hoofdstuk 3 
suggereren dat adipositas op de peuterleeftijd gerelateerd is aan adipositas op de kinder-
leeftijd en zwak gerelateerd is aan cholesterol waarden op de kinderleeftijd. In Hoofdstuk 4 
is een algemene discussie gegeven van alle studies beschreven in dit proefschrift. Daarnaast 
worden er suggesties gedaan voor verder onderzoek en worden de implicaties voor de 
klinische praktijk en beleid beschreven.
Concluderend, de bevindingen van dit proefschrift suggereren dat maternale adipositas 
tijdens de zwangerschap en adipositas tijdens de peutertijd geassocieerd zijn met adiposi-
tas tijdens de peuter- en kindertijd en cardiovasculaire gezondheidsuitkomsten tijdens de 
kindertijd. Hoewel de gevonden effecten relatief klein zijn, zijn ze van belang voor de impact 
van obesitas en cardiovasculaire zieken op populatieniveau.
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